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Abstract 
Background: Diagnostics in Clinical chemistry laboratory is a pivotal part of 
clinical decision-making but is not exempt from ‘human errors’.  Scientific 
innovations such as automation and electronic order test requesting have 
contributed to substantial improvements in the field of laboratory science, but errors 
still occur.  One major example of such failing is connected to the prevalence of 
errors occurring in pre-analytical phase of the Total Testing Process (TTP). Pre-
analytical errors can occur at the time of patient assessment, test order entry, patient 
identification, sample collection, sample transport, or sample receipt in the 
laboratory.  Previous work and clinical insights suggest that most errors in the TTP 
are extra-laboratory (i.e. they occur before the samples reach the laboratory for 
analysis).  Such errors are frequently the results of human mistakes during 
phlebotomy practice.  Therefore to reduce these errors the pre-analytical phase of 
the TTP must be prioritised. 
Study objective: To investigate the sources of pre-analytical errors in the TTP, 
categorize these errors in order to identify the error prone steps, and evaluate error-
reporting frequencies, with the aim of improving service. 
Methods: The first part of the study was a query of the laboratory information 
management system (LIMS) for samples rejected due to pre-analytical errors.  Data 
collection was done retrospectively to cover two periods from 2007-2008 (manual 
paper test requesting) and 2012-2013 (after  implementation of electronic test 
ordering, Anglia-ICE).  Pre- and post- implementation Anglia-ICE error data were 
transferred to excel spreadsheets and compared by chi-squared test.  The 
contribution of each error category to total sample error received in the laboratory 
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was also determined.   The second part of the study was a questionnaire survey of 
pre-analytical procedures to capture the attitudes of phlebotomists towards  current 
practice in Sheffield Teaching Hospitals NHS Foundation Trust (STH NHS FT).  
Results: The results of the first part of the study indicated that of the 416,703 
specimens collected pre-Anglia ICE, 2,055 (0.49%) were recorded as errors 
compared with 1,616 errors (0.11%) of 903,814 specimens collected post-Anglia 
ICE implementation, which represents a 0.31% (p<0.05) absolute error reduction 
rate, although more samples were received post-Anglia-ICE.  The results of the 
second part (questionnaire survey) indicate that recommended procedure for 
phlebotomy practice was not strictly followed by a large percentage of the staff 
surveyed.  
Conclusion: This study is the first inquiry linking venous blood sampling (VBS) 
practices in phlebotomy to retrospective LIMS pre-analytical data in a UK NHS 
Hospital.  The results suggest low compliance by staff with recommended practice, 
which may be responsible for the prevalence of certain categories of pre-analytical 
errors in the TTP and may also be associated with increased risks to attending 
patients. It is suggested that the development of a local guideline for VBS and 
compliance to this guideline will improve phlebotomy practice, improve the quality 
of sample testing in the clinical chemistry laboratory, reduce pre-analytical errors in 
TTP and consequently improve the safety of patients. 
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Chapter 1 Review of the Literature 
 
1.1  Introduction 
“The more human beings proceed by plan, the more effectively they may be hit by accident.” 
(Friedrich Durrenmatt) 
 
Diagnostics in the clinical chemistry laboratory is a pivotal part of clinical decision-
making but is not exempt from ‘human errors’ (IOM, 2000). Generally errors 
generated in the laboratory setting are commonly referred to as ‘analytical errors’, 
which unfortunately is misleading since the analytical phase in the total testing process 
(TTP) is strictly controlled (Bonini et al., 2002; Kalra, 2004). Most errors in the 
Clinical chemistry laboratory occur before or after the laboratory testing of samples 
(Plebani, 2010). Healthcare professionals seldom consider preventable errors, 
nevertheless in reality the statistics are staggering (Hollensead et al., 2004; 
Hammerling, 2012; Šimundić, 2015).  
 
A recent publication by the World Health Organisation (WHO) revealed that 1 in 10 
patients in the developed world are at the risk of some kind of error during 
hospitalization (WHO, 2015), in addition about 10% of patients in countries that make 
up the European Union are believed to have experienced avoidable adverse events 
(European Commission on Patient Safety, 2014). It cannot be denied that laboratory 
errors play a significant role to the overall risk of error in healthcare  (Šimundić, 
2015); because laboratory medicine like any other diagnostic field is susceptible to 
errors. It is evident that most of the errors occur in the pre-analytical phase of the TTP 
(Šimundić and Lippi, 2012; Šimundić, 2015), which comprises sample collection, 
handling and transportation. It is not surprising therefore that a significant amount of 
attention is being paid to patient safety by the European Commission considering the 
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significance of laboratory testing on the total patient management decision process. 
The high error rate in the pre-analytical stage, where human participation is maximal, 
reaffirms the vulnerability of a manual process to error. Several studies (Plebani and 
Carraro, 1997; Astion et al., 2003; Carraro and Plebani, 2007; Laposta and Dighe, 
2007) indicate that human mistakes contribute largely to pre-analytical errors.  These 
researchers observed that about two-thirds of errors in the clinical chemistry 
laboratory occur in the pre-analytical phase, when compared to the analytical or post-
analytical phase. This is plausible because the pre-analytical stage requires more 
human intervention when compared to the analytical and post-analytical phases of the 
TTP.   
 
Significant advances in automation; robotics; laboratory information management 
systems (LIMS) and precision engineering have remarkably simplified many laborious 
and cumbersome procedures in the clinical chemistry laboratory.  Therefore, analytical 
errors are no longer the main factors influencing the reliability of clinical application 
of laboratory diagnostics (Ashakiran et al., 2011; Lippi and Šimundić, 2010).  There is 
growing concern about the high degree of errors reported in the literature (Adegoke et 
al., 2011; Agarwal, 2013; Astion et al., 2003; Binita et al., 2010), which undermines 
the quality of the analytical process. This calls for the active involvement of non-
laboratory workers, particularly clinicians, nurses and phlebotomists and other 
healthcare professionals, to address this issue. 
 
1.1.1 Historical perspectives     
In the 1970s a new term “pre-analytical phase” was introduced to the laboratory 
medicine lexicon (Statland and Winkel, 1977).  In the 1980s terminologies such as 
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interfering factors were introduced to professional training programmes, culminating 
in the publishing of the first book on pre-analytical variables in 1987 (Einer and 
Zawta, 1987); and these have become part of the terminologies used in clinical 
laboratory sciences vocabulary (Dybkaer, 1997) and international guidelines (CLSI, 
2004). In 1981, the Clinical Science Laboratory Institute (CSLI) introduced pre-
analytical standards to examine pre-analytical procedures, and the European 
Committee on Clinical Laboratory standards (ECCLS) followed this movement. The 
actions of these bodies meant that the term ‘pre-analytical phase’ was included in 
training and teaching programmes in clinical chemistry and laboratory medicine 
(Guder and Wahlefeld, 1983; Hagemann, 2005; ISO, 2007).   
 
Bonini et al., (2002) were among the first researchers to publish that more than 60% of 
errors in the TTP were generated in the pre-analytical stage. In the same year the 
WHO published recommendations on sample type and stability, which has led to 
greater awareness of pre-analytical variables in laboratory medicine (WHO, 2002), 
generating useful discussions at conferences and meetings around the globe (Becton-
Dickson Vacutainer Systems, 1996, 1997, 1998; IFCC, 2002; EFLM-BD, 2013). In 
2012, the European Federation for Laboratory Medicine established a working group 
(EFLM-WG) with the primary objective of increasing the level of awareness about the 
significance of the pre-analytical phase among laboratory staff and other healthcare 
professionals, who are users of the services that the laboratory provides. As part of the 
drive to raise awareness on the importance of the pre-analytical phase, the EFLM-WG 
introduced a series of biannual conferences, which attract a huge number of 
participants globally; the last meeting took place in Portugal, 2015 (EFLM-WG, 2015; 
The Pathologist, 2015). 
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Pre-analysis describes the extra-laboratory procedures preceding the analytical phase. 
The primary function of the clinical chemistry laboratory is the performance of 
biochemical analysis of body fluids such as blood (whole blood, serum or plasma), 
urine, cerebrospinal fluid, and other effusions etc.  Intrinsically, sample collection, its 
identification, storage and transport for laboratory analysis have always been part of 
the diagnostic process.  The introduction of statistical quality assurance of the 
analytical processes in the first quarter of the 1970s led to the awareness that other 
extra-analytical variables had a bearing on the capability of the clinical chemistry 
laboratory to generate accurate results (Keller et al., 1985; Gruder, 2014).  For many 
decades it has been common knowledge that factors such as patient preparation before 
the blood sample was drawn, time and site of sampling, choice of anticoagulant, 
temperature and storage, transport, centrifugation time and sample separation impacted 
on clinical chemistry laboratory results.  Since the analytical variables were still 
largely unknown these extra-analytical factors could not be measured until 2002, when 
Bonini and co-workers were able to quantify the impact of pre-analytical variables on 
overall laboratory errors in clinical chemistry.  
 
Historical examples of pre-analytical errors may help us understand how ‘seemingly 
normal’ extra-laboratory routines may impact on the analytical phase and lead to 
spurious results.  For example in the early 1960s, clinicians requested urinary amylase 
measurements in order to exclude pancreatitis as the cause of acute abdominal pain. 
Surprisingly most of the results showed increased amylase activity even though some 
of the patients showed no signs of ‘pancreatitis’.  It was soon discovered that because 
the urine samples were collected in open vessels, they apparently became 
contaminated by salivary amylase from drops of spittle from the nursing staff as they 
! 5!
held discussions over the urine samples when transporting them to the laboratory for 
analysis (Guder, 2014).  The cause of the pre-analytical error was eventually 
eliminated by collecting the samples in closed containers (Guder, 2014).  Fluid or 
blood amylase samples have now increasingly become the samples of choice for 
pancreatic amylase activity investigation. 
 
1.1.2 The clinical chemistry laboratory in Sheffield Teaching Hospital NHS 
Foundation Trust (STH NHS FT)  
The clinical chemistry department provides a comprehensive diagnostic and 
interpretative biochemistry service to the Sheffield Teaching Hospitals, other regional 
hospitals, and general practitioners (GPs). The clinical chemistry laboratory also 
provides specialist endocrinology and toxicology services. All these services are 
available to users on a regional as well as national basis. The endocrinology unit 
provides an extensive peptide and steroid hormone assay service, to include 
reproductive, adrenal and growth endocrinology. The manual endocrinology unit is 
one of only three trophoblastic tumour screening service centres in the UK. 
 
The toxicology laboratory provides a monitoring and interpretative service for a wide 
scope of therapeutic drugs (TD), drugs of abuse (DOA) as well as receiving post 
mortem (PM) samples from HM Coroners for forensic toxicology services. The trace 
metals section of toxicology provides a range of assays covering essential elements 
(selenium, zinc, copper) and also serves as a regional centre for NHS hospitals with 
renal departments requiring aluminium monitoring.  The section is equipped to 
provide occupational screening for those working with heavy metals such as lead and 
mercury. 
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The clinical chemistry department is an approved training centre for biomedical and 
clinical scientists and is affiliated to Sheffield Hallam University and University of 
Sheffield.  It has maintained continuous accreditation with the United Kingdom 
Accreditation Service (UKAS) since 1992. 
 
1.1.3 Laboratory and diagnostic errors    
“An error does not become a mistake until you refuse to correct it” – Anonymous 
A laboratory error is defined as any defect, from test ordering to reporting test results 
and appropriately interpreting and reacting on these results (Kalra, 2004; Plebani, 
2006; Lippi et al., 2009; Kalra et al., 2013). Conventionally medical errors are 
grouped into 4 types namely: errors of diagnosis, errors of treatment, errors of 
prevention and errors of miscellaneous origin (Kalra et al., 2013).  Errors in the TTP 
are associated with all of the four error groupings mentioned, albeit most medical 
errors are closely linked to ‘errors of diagnosis’.  Diagnostic errors are the leading 
cause of payout claims involving medical malpractice in the United States (Green, 
2013).   
 
According to recent data, diagnostic errors rank as the most common source, most 
costly and most precarious of medical mistakes for inpatients as well as patients for 
attending outpatient clinics or departments (Green, 2013). Despite the ubiquitous 
nature of diagnostic errors that often lead to avoidable disability or death in some 
cases, diagnostic errors still remain a relatively unmeasured subject area of patient 
safety (Kalra, 2004; Bonini, 2009; Plebani and Piva 2010).  Medical errors can result 
in physical and emotional suffering for the patient and frequently lead to a number of 
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mortalities annually, along with excess economic burden and litigations (Karla, 2004; 
Green 2013; Kalra et al., 2013).    
 
Medical errors that put patients at risk have generated a lot of media attention in recent 
years, so much so that publications such as that of the Institute of Medicine (IOM), 
estimate that preventable errors leading to about 1.5 million adverse events occur in 
the United States annually and that between 44,000 to 98,000 deaths occur annually as 
a result of medical errors, excluding unreported events (IOM, 2000; Kalra et al., 
2013).  About 55% of missed or delayed diagnoses in the ambulatory setting and about 
58% in accident and emergency departments arise from failure to request appropriate 
diagnostic and laboratory tests in the pre-analytical phase of the TTP (Plebani, 2009; 
Plebani, 2010; Plebani et al., 2011, Plebani, 2011).  
 
1.1.4 Patient safety  
Laboratory errors have the likelihood of causing irreversible harm when linked with 
patient care.  Therefore current emphasis on addressing errors in the pathology 
laboratory especially in the pre-analytical phase of the TTP, is an imperative 
component of the national and global agenda on patient safety (Lippi and Plebani, 
2009). This has informed the recent launch of the World Alliance for Patient Safety by 
the WHO in response to a World Health Assembly resolution in 2002 exhorting 
member states and the WHO to give consideration to addressing the challenging issues 
affecting patient safety (World Alliance for Patient Safety, 2004; Lippi and Plebani, 
2009).  To this end the International Federation of Clinical Chemistry and Laboratory 
Medicine (IFCC) through its Education and Management Division (EMD) have 
initiated a ‘Working Committee’ on laboratory errors and patient safety with the 
! 8!
purpose of encouraging investigations/studies on the subject of errors in pathology 
laboratory, to gather existing data on this topic, analyse it and recommend approaches 
and put in place standardized procedures to improve patient safety (IFCC-EMD, 
2015).  
Unsafe medical practices may be responsible for the yearly disabling injuries or deaths 
suffered by million of patients globally (WHO, 2013). Almost 1 in 10 patients may 
have suffered harm due to avoidable causes whilst receiving care in healthcare 
institutions with cutting-edge facilities (WHO, 2008). Investigation into understanding 
the phenomena surrounding unsafe medical practices and care and to recognise 
probable solutions may include diverse scientific strategies and methodologies. For 
instance, enquiry may be centred on a retrospective investigation of medical/pathology 
laboratory records, staff surveys, interviews, observational studies, controlled 
randomized designs or the use of simulations (WHO, 2013).  
 
1.1.5 Recent advances in understanding pre-analytical errors  
A wide gap still exists between our current knowledge of pre-analytical errors in 
routine analysis and communicating these findings to end-users of the laboratory 
service. There are several publications reflecting the immense interest, challenges, and 
complexities of the subject in the clinical chemistry laboratory. Recent literature has 
focused on the reduction of errors in all the stages of the TTP (Figure 1) in clinical 
chemistry. Many authors (Plebani and Bonini, 2002; Bates and Gawande, 2003; 
Plebani, 2006; Lippi and Guidi, 2007; Plebani et al., 2011; Plebani, 2012; Šimundić 
and Lippi, 2012; Šimundić et al., 2011; Šimundić, 2015) have undertaken extensive 
studies on errors in the pre-analytical stages. Yet, literature, citing communication of 
these outcomes to users of the laboratory service appears to be scarce. The importance 
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of information and adequate communication of this between the laboratory staff and 
users of the service cannot be overstated.  
 
1.1.6  Brain-to-brain: The Lundberg concept  
It was Lundberg (1981, 1999), who first proposed the brain-to brain loop concept 
(Figure 1.1) to describe the total testing cycle (Figure 1.2). According to Lundberg, the 
activity loop begins outside the walls of the clinical chemistry laboratory with a 
clinical question in the physician’s mind. This leads to test requesting or ordering, 
collection of the patient’s sample and identification, transportation of sample to the 
laboratory, sample separation (by centrifugation to make it suitable for analysis), 
sample aliquoting and sorting into batches (Da Rin, 2009; Plebani, 2012). Next, the 
sample is delivered for analysis on automated platforms. In the final step results are 
generated and reported, and action taken (interpretation and decision making) by the 
physician. Each stage in this complex loop, when performed correctly guarantees 
quality procedures in the clinical chemistry laboratory, thus ensuring valuable medical 
decision making and effective patient management (Lundberg, 1999; Plebani, 2012).  
 
It can be appreciated that several transitional steps are involved in the loop, some of 
which are pre-analytic (before laboratory testing of samples); some are analytic 
(relating to the actual laboratory testing of samples) and a post-analytic step that 
involve the transmission and interpretation of test results into the health records. The 
introduction of the brain-to-brain model resulted in an identification and classification 
of errors related to laboratory testing. Previous studies (Plebani and Carraro, 1997; 
Carraro and Plebani, 2007; Plebani, 2006, 2007, 2009, 2011) suggested that most 
errors in the ‘Lundberg loop’ do not occur within the analytical stage, nor do they 
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frequently fall within the ‘pre-analytical’ or ‘post-analytical’ stages under the control 
of biomedical scientists. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: Brain-to-Brain Loop Concept for Laboratory Testing. Adapted from  
Plebani et. al., (2011). Am J Clin Pathol 2011; 136:829-833.  
 
Sepulveda (2013) summarized the Lundberg loop in seven steps shown by the coloured 
numbered boxes: 
1.  The right question was asked from the patient by the clinician or physician 
2.  The right test was ordered by the physician 
3.  The right sample was collected on the right patient, at the correct time, with 
appropriate patient preparation. ! 
4.  The right technique was used collecting the sample to avoid contamination with 
intravenous fluids, tissue damage, prolonged venous stasis, or haemolysis. ! 
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5.   The sample was properly transported to the laboratory, stored at the right 
temperature, processed for analysis, and analysed in a manner that avoids 
artifactual changes in the measured analyte levels.  
6.    The analytical assay measured the concentration of the analyte corresponding to 
its “true” level (compared to a “gold standard” measurement) within a clinically 
acceptable margin of error (the total acceptable analytical error (TAAE). ! 
7.   The report reaching the clinician contained the right result, together with 
interpretative information, such as a reference range and other comments, aiding 
clinicians in the decision-making process. ! 
It has been established that most of the errors occur before and after laboratory 
analysis (Plebani, 2010), and that the pre- and the post analytical phase are responsible 
for up to 96% of total Turn around Time (TAT) anomalies (Manor, 1999; Rodriquez-
Borja et al., 2014 Rodriquez-Borja, 2015). Therefore incorrect interpretation of 
laboratory or diagnostic tests in the final stages of the brain-to-brain loop (B-T-B) also 
causes a large proportion of errors in the ambulatory and emergency settings (Kachalia 
et al., 2007). 
 
1.2  The total testing process (TTP)
§
 
The total testing process (TTP) is the sequence of events starting with the ordering of a 
test by a clinician and ending with the interpretation of the test result by the clinician 
(Figure 1.2).  The TTP concept is similar to the previously described Lundberg’s loop, 
the difference being that it occurs in phases.  To fully appreciate the processes 
involved in generating a result for a patient’s sample in a clinical chemistry laboratory 
it is imperative to elucidate the three phases of the TTP: Any analytical process in the 
clinical chemistry laboratory involves these three major stages:  
1. The pre-analytical stage, which involves patient specimen acquisition and  
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preparation. 
2. The analytical stage, which is the measurement of the test analyte.   
3. The post-analytical step, which consists of reporting results.  
 
 
Figure 1.2. Total Testing Process (TTP): Adapted from Boone (2007): Presentation at 
the Institute on Critical Issues in Health Laboratory Practice: Managing For Better 
Health, September 23–26, 2007 Atlanta, GA, USA Centers for Disease Control and 
Prevention. 
 
§The TTP begins and terminates with the patient. The patient visits a family General 
Practitioner (GP) and explains that he or she has a health problem. The GP proceeds with a 
medical assessment and if necessary, translates the patient’s medical history, signs and 
symptoms into the ordering of one or several biochemical tests. The phlebotomist performs 
patient preparation, sample collection and sample handling according to standard 
procedures (Appendix XV). The sample is thereafter transported to the clinical chemistry 
laboratory for analysis. The analytical part of the process ends with the generation of an 
accurate test result, which is then delivered to the GP. This test result, when correctly 
interpreted by the GP, will ultimately contribute to the treatment or management of the 
patient. 
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Laboratory testing in clinical chemistry is a significant source of medical errors 
affecting patient management and safety (Da Rin, 2009; Plebani, 2012). Errors 
generated in the pre-analytical phase decisively influence the total error and 
consequently the diagnostic accuracy (Lippi et al., 2009; Da Rin, 2009).  The pre-
analytical phase is probably the most important step in the TTP in the clinical 
chemistry laboratory and indeed in laboratory medicine, if total laboratory quality is to 
be achieved (Chillar et al., 2011 Guder, 2014; Plebani, 2014). This assertion is true 
because the pre-analytical phase is conceivably the most complex and highly 
vulnerable to uncertainties (such as biological variations) and untoward incidents 
(Wallin et al., 2008). Recent studies carried out by a number of investigators (Lippi et 
al., 2009; Sciacovellia and Plebani, 2009; Jo-Gile, 2011) have shown that 
approximately 93% of errors encountered within the TTP is due to the lack of 
standardised operating protocols for sample collection, which includes patient 
preparation, phlebotomy, sample handling/transportation and storage.  
 
Errors relating to pre-analytical stages of the TTP are arduous to control and therefore 
require the adoption of drastic but suitable approaches for the prevention (or 
reduction) of these errors.  A number of suitable strategies for error prevention have 
been examined and streamlined into the TTP (Ashakiran et al., 2011; Plebani, 2011).  
The major challenge for biomedical scientists and other laboratory staff has been the 
absence of an effective communication system with which to engage with the end-
users of the clinical chemistry laboratory service (i.e. physicians, nurses, consultants, 
phlebotomists and other healthcare professionals).  A good communication system is 
essential for prevention or reduction of pre-analytical errors.  
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Currently there has been increased focus on the reduction of pre-analytical errors (by 
healthcare professionals working in the clinical chemistry laboratory) and the possible 
impact on patient management by development of quality improvement ‘tools’ such as 
quality indicators (QIs) and increased analyser intelligence (Jekelis, 2005, Plebani, 
2012). 
 
1.2.1 The pre-analytical phase 
This phase involves patient assessment, test order entry, request completion, patient 
identification, specimen collection, specimen transport, and sample receipt in the 
laboratory. Errors can occur at any of these stages. Bonini et al., (2002) in a study in 
Italy, observed that pre-analytical errors were widespread in the laboratory, ranging 
from 31.6% to 75%. In a separate study, Khoury et al., (1996) reported error rates of 
39% for ‘identification’ transcription in five clinical chemistry laboratories in 
Australia. A transcription error rate of this magnitude has the likelihood of seriously 
compromising patient identification data.  
 
This finding was corroborated by Ashakiran et al., (2011), who carried out a 
prospective study over three months in the clinical biochemistry laboratory of a 
hospital in India by monitoring the frequency and types of pre-analytical errors, 
screening 139 venous blood samples per day received from in-patient wards. They 
observed that pre-analytical errors amounted to an average of   44.7 % of the samples 
per day. They recorded their findings under the following categories of pre-analytical 
variables: 
• Incorrect patient identification  
• Improper sample labelling 
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• Improper test request 
• Incorrect timing of sample 
• Insufficient sample volume 
• In-vitro haemolysis 
• Collecting sample into wrong tube or container 
• Incorrect sample handling and transport 
Ashakiran and co-workers, (2011) reported similar figures to Kalra (2004) in his work 
on pre-analytical variations. Binita et al., (2010) also agree that pre-analytical errors 
were ubiquitous with a high figure of 71.1 % in their study. Using similar variables 
Carraro and Plebani (2007) observed that among other causes of pre-analytical errors 
reported in previous studies were: ordering tests on the wrong patient, ordering the 
wrong test, transferring sample from a ‘wrong’ container into an ‘appropriate’ 
container. The most commonly reported types of errors from these previous studies, in 
the pre-analytical phase are:  a) missing sample and/or test request; b) wrong or 
missing patient identification; c) contamination from intravenous infusion route; d) 
haemolysed, clotted, and insufficient samples; e) inappropriate containers; f) 
inappropriate ratio of blood to anticoagulant, and g) inappropriate transport and 
storage conditions (Karla, 2004; Lippi et al., 2009; Binita et al., 2010; Ashakiran et 
al., 2011; Plebani et al., 2012).  
 
Although the studies discussed in the preceding paragraph describe alarming statistics 
relating to the category and frequency of errors in the pre-analytical phase, the precise 
magnitude of the error rate in the laboratory is still debatable and difficult to estimate 
simply because  ‘error’ has no ‘definite and universally accepted definition’. A 
primary limitation identified in some of these studies is the use of small sample size 
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numbers (Ashakiran et al., 2011). Other issues relate to the acknowledgement by some 
authors that some ‘errors’ may have gone unobserved (Kalra, 2004). Reduction of 
errors in the pre-analytical phase can be achieved by consciously taking specific 
rigorous pre-emptive steps that are desirable for good laboratory practice (GLP). A 
holistic approach suggested by Lippi and Guidi (2007) stressed that overcoming these 
shortcomings entails:  a) prediction of accidental events and b) efficient 
communication with healthcare providers. Effective communication is an imperative 
characteristic of the clinical chemistry laboratory. To be effective, the opportunity for 
dialogue between laboratory personnel and health care providers (users of the 
laboratory service) must be readily accessible. Provision must be adequate for 
bidirectional interaction, because the information provided is nearly always 
quantitative and interpretive. 
 
1.2.2 The analytical phase  
The analytical phase begins when the prepared patient sample is delivered to the 
analytical platforms for testing, and it ends when the test result is interpreted and 
verified by the biomedical scientist in the laboratory. Validating assay methodology, 
performance specifications such as sensitivity, specificity, accuracy, precision and 
linearity are crucial steps along the continuum which (if ignored) can lead to 
irreversible errors in the analytical phase of laboratory analysis in clinical chemistry. 
During the analytical phase, it is particularly important to design the manual work 
procedures such that the risk of placing patient samples in an incorrectly labelled test 
receptacle is minimised. A valid result provided for the wrong patient can have dire 
consequences including death. Many resources have been harnessed to improve 
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analytical quality in the clinical chemistry laboratory by establishing and investing in 
internal quality controls (IQC) and external quality assessment (EQA) schemes.  
 
The role of EQA and proficiency testing (PT) is to provide reliable information 
allowing laboratories to assess and monitor the quality status of internal procedures 
and processes, the suitability of the diagnostic systems, the accountability and 
competence of the staff, along with the definition of measurement of uncertainty 
(discussed in section 1.2.4) in laboratory results. Biomedical scientists working in the 
clinical chemistry laboratory are directly responsible for appropriately analysing EQA 
materials. They report results, identify trends or bias that may not be apparent in 
analytical runs, investigate root causes producing unacceptable performances, apply 
and monitor appropriate actions for eliminating the underlying causes, authenticate the 
effectiveness, and, retrospectively determine whether the problem affected the clinical 
decision  (Sciacovelli et al., 2011). Potential sources of errors in the analytical phase 
may be broken equipment, improper mixing of samples or reagents, interferences 
(endogenous or exogenous), not detecting errors during equipment calibration and 
quality control (Bonini et al., 2000; Boone, 2004; Carraro and Plebani, 2007; The 
Pathologist, 2015).  
 
1.2.3 The post-analytical phase 
This phase involves validation of the patient test result and then transmission of the 
results to the clinicians and other healthcare professionals, in order to arrive at a 
clinical decision to manage their patients. Test turnaround time (TAT), an important 
aspect of the quality of the testing process, relies heavily on both the pre-analytic and 
analytic phases, to the point that any delays in these phases can create potential 
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problems that adversely affect patient care. A particularly important patient safety risk 
is the reporting of ‘critical limits’ defined as values that represent situations that could 
be life threatening without treatment (Lundberg, 1981). Result reporting is subject to 
specific communication and interpretation errors, which may originate in the pre-
analytic and analytic phases. Potential sources of errors in the post-analytical phase 
are: incorrect validation of results, errors in reporting and delivering reports and 
prolonged TAT. Incorrect validation and incorrect reporting may lead to incorrect 
interpretation by the requesting physician. This may lead to wrong diagnosis or 
treatment and may cause harm to the patient.  Biomedical scientists must be aware of 
the importance of relevant clinical information when validating and authorising 
results, especially when cumulative records are available. An unexpected test result 
can highlight the possibility of an incorrectly labelled sample or request form and 
should be investigated immediately.  
 
Each individual phase of the TTP can be targeted for quality improvement (figure 1.1). 
In one study, Lippi et al., (2010) showed that the TTP error rate ranges widely from 
0.1% to 3.0%. In another study by Carraro and Plebani (2007), a decline in laboratory 
error rates from 0.47% to 0.33% was reported. They reported that the use of scientific 
innovations such as development of automation and robotics to handle some process 
previously performed manually by staff and the implementation of electronic order 
test requesting had contributed to reducing errors in the TTP.  
 
1.2.4   Sources of uncertainty in the pre-analytical stage 
In clinical chemistry measurements, the uncertainty in patient results includes both 
pre-analytical and analytical variation, as well as intra-individual biological variation. 
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The assessment of uncertainty in the pre-analytical stages in sample preparation is 
often essentially overlooked. Pre-analytical factors are diverse, ranging from 
biological and physiological events to technical details of specimen collection and 
transport (ISO, 2012). When standardized procedures are followed, pre-analytical 
variation can be minimized (Plebani, 2012) and the number of errors decreased (Kouri 
et al., 2005). Traditionally, laboratories have focused on the uncertainty in the 
analytical phase, but characterization of uncertainty should include the whole process 
from phlebotomy up to reporting of results (Kouri et al., 2005). With all uncertainties 
quantified and presented together in tabular form as an uncertainty budget, the 
laboratory will have a tool to identify important uncertainty sources (Boone, 2007; 
Magari, 2007; The pathologist, 2015; IBMS, 2016). The combined uncertainty is a 
function of the magnitude and probability distribution of the different uncertainty 
sources and the number of such sources. The uncertainty can be reduced, and 
laboratory quality improved, by focusing on the sources that contribute most to the 
combined uncertainty (Kouri et al., 2005; Magari, 2007; Cararo and Plebani, 2007; 
Carraro et al., 2012).  
 
Development and widespread implementation of a Total Quality Management (TQM) 
system is the most effective strategy to minimize uncertainty in laboratory diagnostics. 
Pragmatically, this can be achieved using three complementary actions: preventing 
adverse events (error prevention), making them visible (error detection), and 
mitigating their adverse consequences when they occur (Kouri et al., 2005; Lippi et al, 
2010). 
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1.2.5  Common errors generated in pre-analytical phase of TTP  
According to previous studies (Söderberg, 2009; Plebani and Piva, 2010; Sumera et. 
al., 2012) the most common errors generated in the pre-analytical stage are outlined 
below.  
 
1.2.5.1 Inappropriate laboratory test requisition 
The misappropriation of laboratory services through requesting inappropriate 
laboratory tests requests impacts, on total costs (Kalra, 2004; Green, 2013), and the 
inherent increased risk of diagnostic errors and injury. The estimations of 
inappropriate laboratory tests vary from 11% to 70% for general biochemistry and 
17.4% to 55% for cardiac enzymes and thyroid tests (Silverstein, 2003; Kirchner et al., 
2007). 
 
1.2.5.2 Incomplete laboratory test requisitions  
One important source of pre-analytical error is incorrect or incomplete information on 
the test request forms or labels which have been found in more than two thirds of all 
rejected samples in the laboratory (Adegoke et al., 2011). Several other studies 
confirm that test requests can be a clinically important source of errors (Kirchner et 
al., 2007). Paper - based test requests are precarious as they can be incompletely filled, 
placed in the wrong collection box, or simply be lost. Incomplete laboratory requests 
forms are rarely rejected at the service point. In many instances, the phlebotomy 
section or reception staff in the laboratory may not know the significance of the 
missing data. Specific missing information included the physician’s name, 
misidentification of patient and requested tests (CLSI, 2004; Bilic-Zule et al., 2010; 
Favaloro et al., 2012). 
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1.2.5.3 Wrong patient identification  
Patient identification is the cornerstone of patient safety (Da Rin, 2009). Correct 
patient identification is the vital task in all laboratory medicine. Therefore, efforts to 
ensure compliance with standardized identification routines should be prioritized 
(Sumera et al., 2012). Errors in patient identification before specimen collection is 
responsible for up to 25% of all pre-analytical errors (Valenstein et al, 2006). Critical 
patient identification errors occur in approximately 1 out of 1200 tests requested 
(Wiwanitkit, 2001). Mistakes in patient identification often occur during manual tasks, 
which can be avoided, using electronic technologies like barcodes, radiofrequency 
identification and wristbands (Lau et al., 2000; Dzik, 2007).  Wristbands have 
patient’s name and identification number, and sometimes have a barcode. A previous 
study by Howanitz et al.,(2002) has reported error rates of  3.05 – 7.40% while 
examining 1757,730 wristbands over 2 years, for identification wristbands mostly 
comprising of missing or incomplete wristbands, and wrong wristband on the patient. 
 
1.2.5.4 Wrong labelling of the sample containers 
Labelling of specimen containers should always be done immediately after sample 
collection while, labelling them before sample collection increases the risk of the 
specimen collection from the wrong patient. Mislabelling is responsible for 50% of all 
identification errors (Carraro, 2000). Information from SHOT (Serious Hazards Of 
Transfusion) shows that mislabelled specimens are 40 times more likely to contain the 
wrong patient’s sample (IBMS, 2014).  Ambiguous or erroneous identification of 
patients presents a risk to patient's health and can result in misdiagnosis, mistreatment, 
ill-health or mortality.    
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1.2.5.5 Poor phlebotomy practice 
Proper sample collection (phlebotomy) is an important part of good laboratory practice 
and improper collection can lead to delays in reporting, unnecessary re-draws and re-
tests, decreased end-user confidence, increased costs, incorrect diagnosis / treatment, 
injury and occasionally loss of life. Studies have shown the importance of checking for 
specimen adequacy as a critical factor in test result accuracy and usefulness (Lippi et 
al., 2006). Samples that are missing, coagulated, haemolysed, insufficient or 
inadequate volumes due to inappropriate specimen collection and handling account for 
a large percentage of pre-analytical mistakes.  
 
Improper phlebotomy practices are the bane of the clinical chemistry laboratory and 
are one of the main causes of pre-analytical errors, which occur due to lack of 
knowledge or heavy workload/ tiredness, as experienced in most NHS institutions 
seeking to save money by reducing overheads and reduction in number of staff. This 
has put a strain on the ability of the clinical chemistry laboratory to provide an 
excellent service to the users of its services. The procedure should always be 
performed by trained /qualified phlebotomists.  In the clinical laboratory, venipuncture 
is described as all of the steps involved in obtaining an appropriate and identified 
blood sample from the vein (Haverstick and Groszbach, 2014). According to 
recommended practice (CSLI, 2007, 2008), the phlebotomist should ensure that the 
patient is comfortable and if appropriate should verify whether the patient is fasting 
(for at least 12 hours or overnight as necessary for some chemistry analytes such as 
glucose and lipids); what medications are being taken or have been discontinued, as 
required (Haverstick and Groszbach, 2014). 
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1.2.5.6 Inadequate/insufficient sample volume 
Insufficient sample volume is a major factor leading to rejection of samples. The main 
reason for this anomaly is the lack of knowledge of the phlebotomist, difficult 
sampling procedures relating to paediatric patients, debilitated cases, those on 
chemotherapy, and those with difficult to localize veins. Insufficient sample 
constituted the most frequent cause of test rejection  (Hammerling, 2012) 
 
1.2.5.7 Interfering matrix (lipemia and haemolysis) 
Lipemic samples are often seen following collection after heavy meals or the due to 
pre-existing metabolic disorders (e.g. as seen in patients with hyperlipoproteinemias). 
Some of these errors can be avoided by collecting samples after an overnight fast or by 
mentioning the metabolic disorder in the requisition form. Dietary lipids interfere with 
optical reading of the instrument and can affect electrolyte values (e.g. sodium). Too 
many lipemic samples are often due to non-dissemination of information regarding 
patient preparation by the clinicians, non-compliance and/or miscomprehension by the 
patient (Dzik et al., 2003). It is the responsibility of the clinicians and the 
phlebotomists to ensure that proper patient preparation is instituted before sample 
collection.  
 
Haemolysis accounts for the majority of rejections in specimens, received in the 
laboratory (Sumera et al., 2012). Sample haemolysis occurs when blood is forced 
through a fine needle during phlebotomy, shaking the tubes containing blood sample 
vigorously, and centrifuging the sample specimens before clotting (Lippi et al., 2006). 
The introduction of vacuum tubes along with the closed system of blood collection has 
made blood collection efficient and easy. However, lack of staff training in 
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phlebotomy is an impediment for expediting sample collection and transport. Freezing 
and thawing of blood specimens also causes massive haemolysis. A study reported 
that over 95% of the haemolysed samples were due to incorrect sampling procedure or 
transportation (Lippi et al., 2006). Haemolysis leads to the extravasation of 
intracellular contents into the plasma, leading to false high values of some test analytes 
such as potassium, aspartate amino transferase, lactate dehydrogenase, folic acid, 
creatinine kinase, vitamin B12, phosphate, magnesium and ferritin. 
 
1.2.5.8 Problems with sample preparation, storage and transportation 
The length of time of sample preparation, including the speed and temperature of 
centrifugation, exposure to light and preparing aliquots, are important factors that must 
be considered before analysis.  Proper sample storage condition is paramount (this 
relates to the length of storage, temperature, freezing and thawing).  However during 
transport, a sample may be exposed to shaking, changes in light conditions, and 
changes in temperature. Transport delays to the laboratory can give rise to clinically 
important errors if transport conditions are not optimized (Meylan: Becton-Dickinson, 
1995,1996,1997; Astion et al., 2003).  
 
The National Committee for Clinical Laboratory Standards (NCCLS) H5-A3 1994 
recommended a maximum of 2 hours for transporting blood samples at a temperature 
of 10–22 °C.  Delay in transporting the specimen to the laboratory where processing 
begins, not only prolongs the time until the attending physician receives a test result 
but also impacts specimen integrity that may lead to a false-negative or false-positive 
result of analysis and a misleading answer. A delay in transporting a blood sample to 
the laboratory for measurement of ‘blood sugar’ is likely to cause a ‘falsely reduced’ 
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blood glucose result. Such errors that occur at this stage cannot be corrected later.  
These mistakes would require collection of fresh blood samples, which could be quite 
distressing for the patient. The sample preparation steps contribute to approximately 
19% of the overall cost of analysing a single sample (Sumera et al., 2012) and are 
time-consuming (37% of time spent in producing result). Other important sources of 
pre-analytical error not related to human mistakes include prescribed medications, 
which can cause errors through analytical (in vitro) or biological (in vivo) effects. 
Other patient-related physical variables such as stress, diet and exercise can also affect 
test results (Kouri et al., 2005; Blomback et al., 2009). 
 
1.3 Clinical laboratory informatics 
The Lord Carter (2008) Review of Pathology recommended that information 
technology (IT) connectivity be put in place in all NHS pathology services as a matter 
of urgency, to improve the way that pathology enabled decisions about diagnosis and 
treatment are made by assemblage and analysis of data retrieved from LIMS. Recently 
‘Order Communications’ have been comprehensively promoted as a way of improving 
efficiency and effectiveness of laboratory testing services (Yorkshire Centre for Health 
Informatics, 2014) through a number of perceived improvements in resource 
utilisation. Effective electronic communication between the clinical chemistry 
laboratory on the one hand and healthcare providers on the other hand is considered as 
an indispensable element of any efficient and effective pathology service, as it would 
help address gratuitous demands (such as unnecessary test requesting) and reduce or 
eliminate the risk of errors (Health Commissions Report, 2007). 
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Informatics relates to gathering, management, and processing of information usually 
involving computing. Medical informatics involves the design, management, and the 
study of systems that store and communicate medical information (Jackson et al., 
2008). It follows therefore that Clinical Informatics is an offshoot of medical 
informatics and is primarily concerned with the communication and management of 
information associated with laboratory analysis, generation of results and 
interpretation of test results (EFLM in the Pathologist, 2015). Efficient clinical 
laboratory operation relies heavily on informatics (Harrison and Geoffrey, 2008), since 
the function of the clinical laboratory is the creation and communication of 
information for patient diagnosis and management. Clinical informatics relates to 
processes that extend beyond the confines of clinical chemistry laboratory and may 
involve diverse ‘extra-laboratory’ processes, which embraces the support of correct 
test ordering by healthcare professionals, the accurate communication and storage of 
order requests, correct test interpretation and finally the management of information 
necessary for optimal performance by the clinical laboratory (Harrison and Geoffrey, 
2008; EFLM in The Pathologist, 2015).  
 
1.3.1       Laboratory information systems  
Laboratory information systems (LIS) form a dynamic connection between the 
biomedical scientist, the clinical chemistry laboratory analytical platforms and the 
healthcare professionals. The clinical chemistry laboratory at STH NHS FT currently 
uses microcomputers in every phase of the TTP including pre-analytical workstations, 
analytical platforms, reagent inventory control, quality control, data interpretation, and 
online monitoring of analytical performance. All these aspects are integrated through a 
common database and communications network and in this way it is able to support 
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the extensive laboratory information system (Ashwood and Bruns, 2008; The 
Pathologist, 2015). Presently the total management of the pre-analytical as well as the 
post-analytical processes are entirely dependent on computer applications. The use of 
barcode technology has facilitated the automation of all the processes from patient and 
sample identification to sample testing on the analyser platforms (Da Rin, 2009; Hill et 
al., 2010; Ashwood and Bruns, 2008; EFLM in the Pathologist, 2015). Sophisticated 
and intelligent computer software programmes are now able to produce further 
information that may be used for identifying pre-analytical errors in the TTP (Harrison 
and Geoffrey, 2008), leading to better diagnoses, which maybe useful for managing 
patients and thus improve their wellbeing and safety (Ashikiran et al., 2011; Plebani et 
al., 2012).  A key role of the LIS is to help reduce chances for errors, be it technical or 
human in origin. 
 
The information generated by laboratory workflow is received, processed and stored 
and archived by the LIS. The LIS supports a myriad of laboratory functions by 
automating the flow of virtually all the extensive database applications that are 
embedded in clinical laboratory operations (Bates et al., 2001; Harrison and 
Mcdowell, 2008). It is becoming very common in most health institutions to interface 
LIS with Electronic Health Records (EHR) in order to link patient registration 
information with electronic test requesting (commonly referred to as ‘Order coms’).  
The amalgamation of the LIS and EHR is commonly designated as Laboratory 
Information Management Systems (LIMS). A well-designed health information 
management system, which incorporates reliable, accurate and timely availability of 
data is widely acknowledged as a foundation of a robust public health system. The 
development of LIMS as part of the NHS has helped to support a variety of 
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programmes and functions such as internal and external quality assurance, research 
and information dissemination and governance (Georgiou et al., 2007). Specifically 
the LIMS systems perform a myriad of functions from pre-analytics (test ordering and 
specimen collection), analytics as well as post analytics (reporting of test results) to 
healthcare professionals. 
 
1.3.2 Laboratory test ordering: Manual versus ICE Order entry  
Conventionally healthcare providers have always ordered laboratory tests using 
manual requisitions (paper-based orders).  Healthcare providers would place a tick or 
write the name of the requested test on a pre-printed hospital laboratory order form.  
The sample would then be collected, labeled by a phlebotomist and placed in a 
specimen bag along with the requisition, and delivered to the clinical chemistry 
laboratory for analysis. However due to increasing pre-analytical errors, complexities, 
challenges, and resource constraints of modern healthcare systems (Hill et al., 2010), 
paper orders are becoming increasingly unsuitable. Manual order requests are 
gradually being replaced by electronic order entry systems, which allow direct 
healthcare provider input of diagnostic testing orders into requests into a computer 
system are known as Computerized Provider Order Entry (CPOE) systems. Anglia-
ICE is an example of a CPOE systems used by STH NHS FT. Implementation of 
laboratory CPOE systems may offer healthcare centres many benefits, including 
reduced test turnaround time, improved test utilization (Hill et al., 2010). Electronic 
requesting should improve the accuracy of patient demographic information 
(Yorkshire Centre for Health Informatics, 2014); allow better tracking of results and 
allow laboratories to report the results of tests they send away for analysis via their 
normal reporting systems.  
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1.3.3  Sources of pre-analytical information   
The Sheffield Teaching Hospital’s clinical chemistry laboratory department maintains 
an on-line (intranet) laboratory handbook that provides information about correct pre-
analytical procedures for phlebotomy staff and other healthcare professionals 
(consultants, registrars, house officers, nurses and midwives) who use the laboratory 
services to manage or treat patients. Medical, nursing and other healthcare 
professionals must be familiar with and understand the rationale of laboratory 
procedures and standards (IBMS, 2015).  Their knowledge of these procedures is 
evaluated annually through training seminars and competency assessments and 
Continuous Professional Development (CPD) portfolios.  There should be clear 
written guidelines for phlebotomists, nursing and midwifery staff who obtain samples 
from a patient on behalf of the requesting clinician or other healthcare practitioner.  
This online service is updated regularly to reflect current practices in clinical 
chemistry and procedures relating to sample collection, storage conditions, and the 
transportation of the samples to the laboratory (including those which are referred from 
external sites). The database also includes the addresses of other laboratories for referred 
tests. 
 
1.4 Approaches for reducing pre- analytical errors in clinical chemistry  
‘No measurement, no improvement’ – Lord Kelvin 
A comprehensive and methodical approach to reducing pre-analytical errors has been 
previously described (Plebani and Bonini, 2002; Bates and Gawande, 2003; Plebani, 
2006; Lippi and Guidi, 2007, Plebani et al., 2012, The Pathologist, 2015) and consists 
of five interrelated stages listed below: 
! 30!
a) Developing clear written standard operating procedures (SOPs) for routine   
and urgent clinical work. 
b) Improving healthcare professionals’ training. 
c) Acquiring automated technologies / information systems, both for support 
operations and for executive operations. 
d) Developing and monitoring quality indicators (QIs)  
e) Improving communication between laboratory staff and other healthcare 
professionals. 
 
1.4.1 Developing clear written standard operating procedures (SOPs) 
Standard Operating Procedures (SOPs) should be controlled and must be unambiguous 
(Plebani, 2006; Da Rin, 2009; Bonini, 2009; Plebani, 2011). Trained laboratory staff 
charged with performing the pre-analytical procedures must understand the procedures 
in place and follow them exactly. They need to be aware of possible errors that may 
occur if the operating procedures are not followed, and what consequences these errors 
can have on sample analysis and eventually on patient management. The ISO 15189 
Standard (2012) instructs laboratories to prepare a manual for the pre-analytical 
procedure that will give clear instructions to the patient before the collection of 
biological samples. Among other things, and depending on the type of analysis, 
patients would be instructed to control their diet, physical activities, stress, use of 
medications etc. This problem is most easily solved by the application of 
computerized referrals, where all the necessary data are obtained from the patient; 
however, the problem is much bigger when samples are collected at sites distant from 
the laboratory.  
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1.4.2 Improving healthcare professionals’ training 
Biomedical scientists and other laboratory staff have their training/competencies 
reviewed annually as part of a professional development portfolio (PDP) and 
Knowledge and skills framework (KSF). Biomedical scientists need to apply the 
knowledge and skills in a number of dimensions to achieve the expectations of their 
post (www.nhsemployers.org/SimplifiedKSF; www.ibms.org/learning/cpd/)  
 
1.4.3 Acquiring automated technologies and laboratory information systems 
The introduction of information technology (IT) and automated platforms has lead to 
an appreciable reduction in pre-analytical errors in the clinical chemistry laboratory 
(Da Rin, 2009). Computerized order entry (CoE) simplifies test ordering and 
eliminates a second person from transcribing the orders. The introduction of sample 
barcoding (to simplify specimen routing and tracking) and pre-analytical automated 
workstations abridge the process of sample separation, aliquoting and sorting into 
batches and thus reduce the number of manual steps and less staff (Jekelis, 2005; Da 
Rin, 2009) and helps to reduce human induced errors.  
 
1.4.4 Developing and monitoring quality indicators, QIs 
Performance and outcome measures can significantly improve the quality of patient 
care (Plebani, 2011). Such measurements of improvement can be achieved through the 
development and monitoring of specific quality indicators (QI) in the TTP (Mainz, 
2004; Plebani, 2006). The pre-analytical phases in clinical chemistry are more prone to 
errors than the analytical and post-analytical phase  (Plebani, 2001; 2010). Evidence 
abounds that before the turn of the century, reliable QIs and quality specifications have 
been developed and introduced for effective management of analytical processes 
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(Plebani, 2011; Sciacovelli et al., 2011). The development of these specific QIs were 
an extension to the Internal Quality Control (IQC) systems coupled with availability of 
different External Quality Assessment (EQA)1 schemes already in place, which have 
made it possible for the clinical chemistry laboratory to measure, monitor and improve 
their analytical performance on a monthly basis, although retrospectively 
(www.ukneqas.org.uk).      
 
QIs have been defined as vital tools (IOM, 2000) for enabling clinical chemistry 
laboratory staff to quantify the quality of a selected aspect of patient care by 
comparing it against a defined criteria (ISO 15189: 2012). A QI objectively measures 
and evaluates all of 6 critical domains as outlined by the IOM, namely:  
a) Patient safety, b) Patient-centeredness, c) Effectiveness, d) Efficiency, e) Equity and 
f) Timeliness. Assessment of QI is therefore based on the evidence associated with the 
aforementioned domains and can be implemented in a constant and comparable 
manner across settings and over a period (IOM, 2000); the identification of a reliable 
QI represents an essential stage in the schemes targeting evaluation and improvement 
of the quality of patient care. Although many authors are in agreement that QIs are 
important in providing information on continued improvement it has two major 
shortcomings: firstly, it is often difficult to compare data reported in the literature 
because of differences in QIs used (Plebani et al., 2012) and the methods of collecting 
these data. Secondly, while the most common errors in the pre- and post- analytical 
phases are considered, available QIs do not include appropriate choice and selection of 
tests (Barth, 2012) as well as appropriate interpretation and utilisation of laboratory 
results at the right time (Barth, 2012).  
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
1 Clinical chemistry laboratory Department participates in EQA schemes organised by UK NEQAS and HEATHCONTROL. 
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According to the international standard for medical laboratories accreditation, QI 
should be part of an articulate and integrated quality improvement approach (ISO 
15189: 2007) and should recognise the need to subdivide the TTP into phases 
(Plebani, 2006; Laposata and Dighe, 2007; Plebani, 2012). Assessing the quality of the 
clinical chemistry service using QIs means putting in place a systematic and consistent 
collection and analysis of data encompassing a comprehensive set of indicators that 
addresses all the phases of the TTP (Plebani, 2012). 
 
1.4.5 Improved communication between clinical chemistry laboratory staff 
and other healthcare professionals. 
Many mistakes generated in the TTP may be due to poor communication, action taken 
by others involved in the testing process (e.g., physicians, nurses and phlebotomists), 
or poorly designed processes, all of which are beyond the laboratory's control (Plebani, 
2006).  Inter-professional working to improve service delivery involves several 
healthcare professionals with expertise; knowledge and skill bases and experience 
being drawn together in a structure to provide services (Payne, 2000). These different 
professionals make adjustments and allowances in their responsibilities to take account 
and relate with the roles of others.  Many workers value inter-professional team 
working as a source of mutual support in the face of internal and external pressures 
(Payne, 2000) and particularly the demands of working in the NHS and spending cuts. 
Failure to initiate and maintain communication between the laboratory and the users of 
its service may be responsible for causing certain medical errors.  Clinical 
communication is highly complex and prone to errors especially during transitions of 
patient care and emergency situations.  Standardised approaches and tools may 
! 34!
provide potential solutions to improve the quality of communication and prevent 
subsequent patient harm.    
 
1.4.6 Quality indicators in the pre-analytic phase 
IOM (2000) defined quality as: 
“The degree to which health services for individuals and populations increase the 
likelihood of the desired health outcomes and are consistent with current professional 
knowledge” 
As stated above, the pre-analytical phase should be subdivided into an extra-laboratory 
pre-analytical phase and a ‘true’ pre-analytical phase, which is undertaken within the 
laboratory after sample reception. The former phase, which comprises initial 
procedures usually performed neither in the clinical laboratory nor undertaken, at least 
in part, under the control of laboratory personnel, includes test requesting, patient and 
sample identification and sample collection. The latter phase involves the steps 
required to prepare samples for analysis (order entry into computer interface, 
centrifugation and aliquotting into secondary tubes etc.). In a patient-centred scenario, 
QIs should be designed to cover all steps of the pre-analytical phase, including the 
appropriateness of test selection, which is a key issue in projects aiming to ensure 
clinical effectiveness (Sciacovelli and Plebani, 2009). The IFCC Working Group in a 
recent study have identified 16 Quality Indicators to monitor the pre-analytical phase 
of TTP (Table 1.1) 
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Table 1.1   Quality indicators in the pre-analytic phase identified by the IFCC-WG 
QI-1: Appropriateness of test request 
 
QI-2: Appropriateness of test request  
 
QI-3: Examination requisition 
 
QI-4: Examination requisition 
 
QI-5: Identification  
QI-6: Identification  
QI-7: Test request  
QI-8: Samples  
QI-9: Samples  
QI-10: Samples  
QI-11: Samples 
 QI-12: Samples  
QI-13: Samples  
QI-14: Samples  
QI-15: Samples  
QI-16: Samples 
Number of requests with clinical question (%) 
 
Number of appropriate tests with respect to the clinical question (%)  
 
Number of requests without physician’s identification (%) 
 
Number of unintelligible requests (%) 
 
Number of requests with erroneous patient identification (%)  
 
Number of requests with erroneous identification of physician (%)  
 
Number of requests with errors concerning test input (%) 
 
Number of samples lost/not received (%) 
 
Number of samples collected in inappropriate containers (%)  
 
Number of samples haemolysed (haematology, chemistry) (%)  
 
Number of samples clotted (haematology, chemistry) (%) 
 
Number of samples with insufficient volumes (%) 
 
Number of samples with inadequate sample-anticoagulant ratio (%)  
 
Number of samples damaged in transport (%) 
 
Number of improperly labelled samples (%) 
 
Number of improperly stored samples (%) 
Adapted from Sciacovelli et al., (2011).  Quality Indicators in Laboratory Medicine:   
from theory to practice. Clin Chem Lab Med. 49: 836–44.  
 
The lack of patient identification or patient misidentification have serious 
consequences for reaching the final conclusion and clinical decision, as well as for 
patient safety, thus this is one of the key indicators in the process. Errors in patient 
identification may also occur during the procedures of sample preparation. Ordering 
inappropriate tests is another pre-analytical variable with a negative impact on patient 
safety. It is the cause of unnecessary test repetitions in up to 30% of cases (Plebani, 
2006). Biomedical scientists in conjunction with clinical scientists should acquaint the 
clinician with the importance of biological variations, potentially significant in the pre-
analytical process (test selection) but also in the post-analytical process (interpretation 
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of test results). It is necessary for the clinician to understand the concept of biological 
variations that include intra-individual biological variations (deviation of results in 
relation to the person’s homeostasis) and inter-individual biological variations 
(variations between different persons in relation to the established homeostatic value). 
Based on such knowledge it is possible to select between two tests, the best one with 
the highest diagnostic value. 
 
In the pre-analytical phase, major sources of variability - which includes biological 
variability, environmental conditions, postural changes, patient identification and 
sample labelling  (Sumera et al., 2012) tourniquet time, type of container (e.g., 
vacutainer tube), phlebotomy procedure (order of sample draw, contamination, 
mixing); sample transportation (time, pneumatic tube transport systems from wards 
and clinics); sample preparation for analysis (length, temperature of centrifugation, 
preparing aliquots (Sumera et al, 2012), can occur during patient preparation for 
phlebotomy. Errors that may occur in this process often become obvious in the 
analytical and post-analytical phase as well. For instance, the effects of interferences 
may be discovered during analysis or the clinical interpretation of results (for example 
a falsely elevated potassium result is observed in ‘haemolysed’ samples; similarly a 
sample with a high degree of lipemia or protein concentration will adversely affect the 
‘true’ sodium result). For these reasons identification of quality indicators is necessary 
in order to avoid potential errors in the pre-analytical phase. 2 
 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
!
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The most frequent deviations occur during patient identification in wards or patients 
attending clinics. Therefore, this phase requires special monitoring. The ISO 15189: 
2012 Standard dictates what information a report form should include, regardless of 
whether it is in electronic or paper form, these are: 
i. Unique patient identification – The STH NHS FT clinical chemistry laboratory 
requires that at least four identifiers (surname, first names, date of birth and NHS 
number) for patient identification (PID) must be accepted for in-patients and three for 
outpatients including cross-city samples, failing these 4 identifiers means samples are 
rejected. When the sample arrives at the laboratory reception, the common practice is 
to allocate a unique barcode that is used in conjunction with the PID during the TTP. 
The PID is a defining step in TTP. 
ii. Name of requesting physician 
iii. Type of primary sample 
iv. Name of test (routine or urgent) 
v. Relevant clinical information about the patient necessary for interpretation, date and 
time of primary sample collection. 
 
1.5 Sample rejection and error reporting protocol in STH NHS FT 
The STH NHS FT clinical chemistry laboratory has in place an established rejection 
criteria, but this is not strictly adhered to (personal observation). The Trust policy on 
sample labelling is that all samples must contain the patient's full name, date of birth, 
and hospital or NHS number.  There must also be a clinical indication for the sample 
being taken, together with the requesting clinician’s name and contact details.  Failure 
to comply with this policy will result in the sample being rejected by the laboratory 
and not processed until the necessary information is provided. 
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It is sometimes difficult to reject a sample, but it must be remembered that a poor 
sample will give poor results (Sumera et al., 2012). Management should regularly 
review the number of rejected samples and reasons for rejections by conducting audit 
and training on sample collection, and revising written procedures for sample 
management as and when needed.  Staff members are always advised to record the 
reason for rejection (coded error comments) on a database and include all relevant 
information, and promptly inform the requesting clinician that the sample is unsuitable 
for testing and a request made for a repeat sample. The rejected sample is retained 
until a decision is finalized and in some circumstances, it may be necessary to proceed 
with the testing of a sample that is not optimal (Sumera et al., 2012). 
 
1.6 Research application and ethical approval 
International guidelines define research as a systematic activity (including research 
development, testing, and evaluation) designed to develop or contribute to generalizable 
knowledge (International Ethical Guidelines for Epidemiological studies, 2009).  It is 
acknowledged that whilst ‘participant-based’ research is beneficial to research groups and 
globally, there could be associated risks to the research participants.  Therefore in this 
research study appropriate steps were taken by following documented policies for 
conducting research, to protect participants by minimizing those risks.  The research plan, 
including issues relating to informed consent and confidentiality were reviewed and 
approved by both the Scientific and Ethical Review Committee (REC) of Sheffield 
Hallam University (SHU) and the Clinical Effectiveness Unit (CEU) of   STH NHS FT 
respectively.  Approval letters (No. 03062014), from the Ethics committee of SHU, 
Research Degrees Sub-Committee and as well as the approval documents from the 
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research and development office of the STH NHS FT CEU (No. 5683) are included in the 
Appendices I, II and III). 
 
     1.7 Aims and Objectives of Study 
The first part of this study involved an interrogation of the laboratory information 
management system to compare two separate periods before and after the implementation 
of Anglia-ICE (electronic test requesting) to determine whether the introduction of 
Anglia-ICE played a key role in reducing the occurrences of pre-analytical errors. This 
study, also included a survey of pre-analytical procedures in the phlebotomy units of STH 
NHS FT, in order to identify the potential sources of these errors and whether changing 
these practices may play a role in reducing the pre-analytical errors in the clinical 
chemistry laboratory. 
 
Specific aims are:  
• To investigate, categorise and determine the frequencies of pre-analytical errors in the 
TTP. 
• To conduct a survey of pre-analytical procedures by phlebotomy staff to identify key 
error prone steps in the TTP. 
• To draw any conclusions from phlebotomy staff practice and specific errors identified 
in the TTP. 
• To engage with experts and seek advice to improve phlebotomy practice in STH NHS 
FT and to communicate the outcomes from the study to service users with the aim of 
improving the service and promote patient safety. 
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Chapter 2 Materials and Methods 
 
2.1 Introduction 
 
 
The practice of phlebotomy has spanned centuries and is still one of the most common 
invasive procedures in health care (WHO, 2014). It is important to note that every step 
in the process of drawing blood affects the quality of the sample and it is thus vital for 
preventing pre-analytical errors, patient injury and even fatality (Plebani et. al., 2011; 
Salinas et. al., 2013; WHO, 2010, 2014). It is therefore imperative that healthcare 
workers undertaking phlebotomy practice are trained in procedures specific to the 
types of specimen they collect, in order to reduce pre-analytical errors, improve the 
quality of laboratory analysis and reduce harm to patients under their care.  Poorly 
collected blood samples may yield inaccurate results, which may lead to incorrect 
interpretation by the requesting healthcare practitioner, and the patient may have to go 
through the inconvenience of repeat testing. Examples of the most common pre-
analytical errors resulting from poor phlebotomy practice are inaccurate 
labelling/mislabelling of samples, sample haemolysis, contamination of sample, and 
poor sample storage practices.  
 
LIMS constitute reliable, accurate and timely availability of patient data. It is widely 
recognized as the cornerstone of a good public health system.  LIMS can support a 
variety of programs and functions including epidemiology surveillance and monitoring, 
outcomes assessment program planning and evaluation, quality assurance, policy 
analysis, research and information dissemination (Georgiou et al., 2007; Wahls and 
Cram, 2007).  LIMS have become key components of clinical and public health 
laboratory infrastructure in developed countries.  Additionally this system performs a 
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variety of functions, from ordering tests to reporting results to health care providers.  
Computerised order Entry (COE) systems hold the promise of significant improvements 
to healthcare delivery and patient care (Georgiou et al., 2007).  The introduction of 
electronic requesting for laboratory testing has shown a gradual reduction in pre-
analytical errors in the clinical chemistry laboratory over the last few years when 
compared with the old form of paper requesting (discussed in section 1.3.2).  
 
The benefits of COE systems have lead to improvements in patient outcomes, as well as 
major cost efficiencies (Green, 2013). This thesis considered the benefits of the COE 
over paper requesting within the two time periods under review. This present study  
sought the opinions of established professionals in Clinical chemistry laboratory 
practice and also sought advice from professional bodies such as IFCC, European 
Federation of Laboratory Medicine (EFLM), International Organization for 
Standardization (ISO), Clinical Science Laboratory Institute (CSLI), UKAS and the 
Institute of Biomedical Science (IBMS) etc. on strategies for reducing error rate in the 
pre-analytical phase of the total testing process (TTP), and improving the diagnostic 
services provided by the clinical chemistry laboratory. 
 
2.2 Study Design  
 
 
2.2.1 Interrogating the Laboratory Information Management System 
(LIMS) 
 
 
The first part of this study was a restrospective interrogation of LIMS to retrieve data of 
laboratory errors. This included all test requests booked in as a set code “ERROR” in the 
clinical chemistry laboratory of STH NHS FT to cover two different periods (i.e. two years 
prior to the introduction of Anglia-ICE and two years post-implementation of Anglia-ICE 
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electronic test requesting). Anglia-ICE was implemented in STH NHS FT in 2010. The 
two periods were: 
a) Pre-introduction of electronic requesting (2007 - 2008) 
b) Post implementation of electronic requesting (2012 - 2013) 
2.2.2 Pilot study - for the purpose of categorizing errors 
A pilot study was carried out to extract data for the purpose of categorising errors in pre-
analytical phase. A list of all sample errors (i.e. requests booked in as set code “error”) in 
the clinical chemistry laboratory between February - March in 2013 were extracted from 
LIMS. Examples of such errors were: sample contamination errors, haemolysed sample 
errors, incorrect sample type and clotted sample errors. Results from the pilot study can be 
found in the Appendix XII. 
 
2.2.3  Statistical Analysis – LIMS study 
 
Pre-analytical raw data extracted from LIMS were entered into Excel 2010 spread sheet 
(Microsoft Corp., Redmond, WA) for pre-processing and coding. Differences in error 
frequencies between Pre-ICE procedure requesting and Post-ICE requesting procedure 
were compared using Chi-squared test.  A p-value less than 0.05 was considered 
statistically significant.  Chi-squared calculations and raw data from LIMS study are 
included in Appendices VII and VIII. 
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2.3 Questionnaire survey 
 
 
The second part of the study was a questionnaire survey of pre-analytical practice of 
staff in the phlebotomy unit in STH NHS FT only and did not include phlebotomy units 
of A&E department and GP practice centres.  The questionnaire survey was conceived 
on a cross-sectional study design. This study design collects data at one point in time 
and the matter of inquiry is captured as it manifests itself during the period of data 
collection (Polit and Beck, 2014). Significant practical advantages with the cross 
sectional study design are that it is economical and easy to manage (Polit and Beck, 
2014). This design is also suitable when numerous variables are to be measured at the 
same time. Since the study investigated a moderate sample size of respondents and also 
several different practices, these features made the cross sectional design suitable. One 
important limitation with the cross sectional design is that ‘causality’ is difficult to 
establish since the exposure and the outcome will be measured at the same time. 
However, cross-sectional studies are appropriate when there is a strong theoretical 
framework guiding the analysis (Polit and Beck, 2014).  
 
The questionnaire survey was undertaken because it has several benefits over interviews 
and observational studies - possibility for a greater number of respondents and no 
interview bias (Polit and Hungler, 1999; Polit and Beck, 2014). The questionnaire 
survey also allows for confidentiality, which is an advantage since this will increase the 
chance of a ‘truthful response’. Questionnaires appear more suitable when using large 
sample sizes and for measuring practices (Polit and Beck, 2014). However, a 
questionnaire provides a measure of the reported practice, which does not necessarily 
correspond to the performed practice. This was considered when interpreting the results 
(Solderberg, 2009). Qualitative studies such as a questionnaire survey could be valuable 
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to provide a deeper understanding of important aspects of the pre-analytical phase that 
could not be gained by a quantitative approach. Insights in perceptions of the 
phlebotomy practices among medical and laboratory staff are useful when developing 
strategies for improving pre-analytical quality in the TTP. 
 
 
  
2.3.1 Questionnaire Design and Validation 
 
The questionnaire used for this study was developed and adapted from Wallin et al., 
(2010). The questionnaire was based on international procedures and recommendations for 
blood sampling (WHO, 2010, 2014), and designed to address phlebotomy practices and 
incident reporting in STH NHS FT as well as address the background characteristics of the 
respondents, such as years of experience and level of training in phlebotomy practice. 
After an initial pilot study, the questionnaire was further discussed and developed (for 
structure, construction, content, clarity, understanding and layout). The discussions 
involved experts in clinical chemistry testing and hospital staff with extensive phlebotomy 
experience including medical officers, staff nurses, section heads of phlebotomy units, 
medical laboratory assistants, clinical scientists, and biomedical scientists, laboratory 
manager in-charge of the clinical chemistry laboratory and the supervisory team for this 
study. Relevant and current literature and international guidelines (WHO, 2014) regarding 
the development of questionnaires was also accessed.  
 
Wide-ranging consultations with experts in questionnaire design from the Clinical 
Effectiveness Unit (CEU) of STH NHS FT were made to guarantee that respondents 
clearly read and understood the content, then validated before the main research 
commenced. The questionnaire was limited to three pages to ensure the completion in a 
reasonable time frame. The questionnaire contained 18 questions, including a few open-
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ended questions and sections for comments/suggestion in order to enable respondents to 
offer suggestions/opinions/comments relating to their practice.  80 copies of the 
questionnaire, including an introductory letter relating to the study were distributed to the 
two phlebotomy units of STH NHS FT.  A copy of the questionnaire and error/incident 
reporting proforma are presented in Appendices IV, V and IX. The respondents were asked 
to return the completed questionnaires in envelopes, which were anonymised and sealed 
before delivery to the investigator. 
 
 
2.3.2 Ethical considerations  
 
 
This study did not require patients to attend STH NHS FT. This study was a survey of 
volunteer phlebotomy unit staff across both campuses of STH NHS FT only. Respondents 
were asked to state how they performed phlebotomy/error-reporting practices (Soderberg, 
2009). The survey was to identify error prone steps in the TTP in order to be able to 
appropriately target interventions to improve practice. Identifying reported phlebotomy 
practice deficiencies has the potential to draw out a certain risk of ‘feelings of guilt and 
self-criticism’ among the respondents (Soderberg, 2009; Polit and Beck, 2014). This risk 
cannot be overlooked, but in order to minimise it, the questionnaire was strictly 
anonymous which should increase the likelihood of a ‘truthful’ answer. An informed 
consent was made available to the respondents, explaining fully the procedures involved in 
the research; the return of the completed questionnaires was translated as acceptance of 
consent to participate in the study, which was stated on the questionnaire. 
 
 
2.3.3 Statistical analysis of questionnaire data 
 
Completed questionnaire data and background characteristics of the respondents were 
typed in to an Excel 2010 for Macintosh data sheet (Microsoft Corp., Redmond, WA) and 
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then transferred to Statistical package for Macintosh, Version 23 (SPSS Inc., Chicago, IL), 
and basic descriptive statistics were used.  Further analyses of data were performed with 
Prism 7 statistical software (GraphPad Software, Inc. 7825 Fay Avenue, La Jolla, CA 
92037, USA) and Stats Direct statistical package (Stats Direct Ltd, 9 Bonville Chase, 
Altrincham, Cheshire WA14 4QA, UK).  Some raw data and statistical analysis data from 
the questionnaire study are included in   Appendices VI and X. 
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Chapter 3 Results I (LISM study) 
 
 
3.1        Laboratory information management system (LIMS) study 
data collection and processing 
 
The first part of this thesis concerned the occurrence of errors in the pre-analytical phase 
of the TTP.  To achieve this aim, a database search of the LIMS was instigated, setting 
the search criteria as “samples rejected for pre-analytical errors’’ including the ‘error 
comments’ generated.  The data collection was done retrospectively by querying APEX 
software and the LIMS system.  The search included collection of data, booked into the 
system as a set code “ERROR” in the clinical chemistry laboratory of STH NHS FT to 
cover the period from 2007 to 2008 prior to the introduction of electronic test requesting 
(figure 3.1) and from 2012 to 2013 after migration to electronic test requesting (figure 
3.2 below). 
 
Figure 3.1 Screen capture of pre-analytical data from 2007- 2008 (pre Anglia-ICE 
implementation) 
 
!
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Figure 3.2 Screen capture of pre-analytical data from 2012-2013 (pre-ICE 
implementation) 
 
!
 
Between March 2007 and March 2008, a total of 2,055 pre-analytical errors (representing 
0.49% errors) in total samples tested were recorded in LIMS (table 3.1), with a mean of 
171 pre-analytical errors per month.  The total number of samples received in the clinical 
chemistry laboratory from various requesting centres in and around Sheffield was 
416,703 in the same period (table 3.1 and table 3.2).  Between April 2012 and April 2013 
a total of 903,814 samples were received (table 3.1 and 3.2) from the same sources for 
test requests (table 3.2 and figure 3.3), out of which 1,616 samples (representing 0.18% 
errors) were rejected as a result of one category of pre-analytical error or another, with a 
mean of 135 pre-analytical errors per month within the study period.  
 
Hence, all clinical chemistry laboratory test requests entered into the LIMS, in addition 
to the documented pre-analytical errors from the clinical chemistry laboratory were 
accessible for comparison. Overall an absolute error reduction rate of 0.31% was 
achieved (table 3.1), following the introduction of electronic test requesting.   
 
  
 
 
 
   Table 3.1 Overall error rates and differences from pre- and post-Anglia-ICE study 
 
                                                           Pre - ICE (2007 - 2008)                                              Post - ICE (2012 - 2013)                                                                
All centres in Sheffield       Total Errors   Total Samples received       % Errors                         Total Errors       Total Samples received         % Errors                           % Difference 
                                                 2,055                      416,703                     0.49                              1,616                       903,814                         0.18                                0.31 
      Chi-squared test (x
2
)
  
 
P <0.05 
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Table 3.2 Comparison of pre-analytical errors and their frequencies in the pre-analytical 
phase of TTP, prior to and after implementation of Anglia-ICE electronic requesting 
ERROR TYPE PRE-ICE 
FREQUENCY 
        (2007-2008) 
% POST-ICE 
FREQUENCY 
      (2012-2013) 
% P- VALUE SIGNIFICANCE 
INCORPAT 212 10.3% 49 3.0% 1.53E-17 S*^ 
NOFLOX 87 4.2% 30 1.9% 4.70E-05 S*^ 
LEAKTRANS 35 1.7% 7 0.4% 0.000328502 S*^ 
NOPRESV 8 0.4% 0 0.0% 0.012041577 S*^ 
EXLIGHT 16 0.8% 26 1.6% 0.018861059 S*?  
ICEERROR 0 0.0% 11 0.7% 0.00017989 S*?  
INCORSAM 171 8.3% 167 10.3% 0.036256617 S*?   
NOICE 17 0.8% 27 1.7% 0.019729926 S*?  
OLDSAMP 25 1.2% 36 2.2% 0.017351079 S*?  
TIMEDEL 0 0.0% 8 0.5% 0.001407849 S*?  
UNREQ 13 0.6% 57 3.5% 1.94E-10 S*?  
WRCONT 10 0.5% 35 2.2% 4.43E-06 S*?  
WRPRES 16 0.8% 36 2.2% 0.000225719 S* v 
BROKCENTI 4 0.2% 1 0.1% 0.278923528 NS 
BSHAEM 31 1.5% 13 0.8% 0.05166242 NS 
EXAIR 2 0.1% 0 0.0% 0.209684004 NS 
EXMATCH 1 0.1% 0 0.0% 0.375133544 NS 
EXTIME 1 0.1% 0 0.0% 0.375133544 NS 
ILLEGIBL 2 0.1% 1 0.1% 0.709111404 NS 
INCOMPL 186 9.1% 129 8.0% 0.251237783 NS 
INSUFF 99 4.8% 97 6.0% 0.11289448 NS 
LABERRO 26 1.3% 18 1.1% 0.675727716 NS 
LOST 15 0.7% 9 0.6% 0.518520517 NS 
NOEDTA 168 8.2% 159 9.8% 0.078935649 NS 
NOSAMP 287 14.0% 233 14.4% 0.696382596 NS 
SAMCLOT 6 0.3% 6 0.4% 0.675994078 NS 
SAMCONT 24 1.2% 28 1.7% 0.150574085 NS 
SINTEG 3 0.1% 7 0.4% 0.097477046 NS 
SWAPDET 47 2.3% 32 2.0% 0.524694148 NS 
TESTNAV 30 1.5% 31 1.9% 0.280717382 NS 
UNCODED 83 4.0% 63 3.9% 0.828901941 NS 
UNLABL 427 20.8% 300 18.6% 0.094699319 NS 
WRTEST 3 0.1% 0 0.0% 0.124398148 NS 
TOTAL NO OF 
ERRORS 
RECORDED 
2055 100.0% 1616 100.0%     
TOTAL 
NUMBER OF 
SAMPLES 
RECEIVED 
416703   903814       
Legend: 
For Significance   p<0.05  
NS  - No significant change in error rate 
S
*?  - Decrease in error frequency post Anglia-ICE implementation 
S
*?  - Increase in error frequency post Anglia-ICE implementation 
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Table 3.3 Total number of samples received from requesting centres between the two 
periods under review. 
 
SOURCE OF TEST 
REQUEST 
Year 
2007-2008 
% of 
Total 
Year 
2012-2013 
% of 
Total 
Increase / 
Decrease 
in Total 
*A/E 6357 1.526 10472 1.159 4115 
*DAYCASE 2301 0.552 13649 1.510 11348 
ENVIRONMENTAL 15 0.004 9 0.001 -6 
**GP PRACTICE 154719 37.129 350041 38.729 195322 
*INPATIENT WARD 115896 27.813 179414 19.851 63518 
*INPATIENT II 238 0.057 305 0.034 67 
UNKNOWN 22341 5.361 65901 7.291 43560 
*OUTPATIENT 88409 21.216 214161 23.695 125752 
PRIVATE 3493 0.838 17338 1.918 13845 
PMI 1017 0.244 29 0.003 -988 
REFERRED PATIENT 19215 4.611 40499 4.481 21284 
STUDY SAMPLES 2702 0.648 11996 1.327 9294 
TOTAL 416703 
 
903814 
 
487111 
 
Legend 
*  Test request centres where Anglia-ICE had already been implemented in 2010. 
** Centre with the most test requisition per year 
A/E – Accident and Emergency department of STH NHS FT 
PRIVATE – Private patients attending STH NHS FT 
PMI - Private medical insurance 
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Figure 3.3 Total number of samples received from requesting centres between the two periods under review  
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During the conduct of the present studies, an electronic order entry (Anglia-ICE or 
COES) system had already been in place in STH NHS FT.  The central features include 
printing of the patient’s name and NHS identification number, the time and date of 
sampling and a short sampling instruction on each test tube label.  The implementation 
also included standardized routines for ordering of tests and handling of test tube labels.  
The electronic order entry should have eliminated most of the investigated error-prone 
test request practices, but will not cover several of the important manual VBS practices 
surveyed in this thesis.  
 
3.2 Coding of pre-analytical errors from LIMS 
According to recommended practice, each sample rejected due to a pre-analytical error is 
registered into the LIMS database by the laboratory staff.  It usually includes a 
standardized ‘error coded comment’.  Any explanatory or advisory comment is entered 
as free text to support the reason for rejection, if applicable.  After the database search, 
the data was extracted from the LIMS and transferred into an excel spreadsheet for 
further statistical manipulation in order to classify or categorize the error.  However a 
large percentage of the errors had been registered unto the LIMS database only as ‘free 
texts comments’ (in order to describe the nature of the pre-analytical errors) and not as 
‘‘coded comments,’’ which should be the standard protocol.  The recording of these pre-
analytical errors as free text comments in the LIMS created a problem as it made the pre-
statistical process of  ‘cleaning the data’ very arduous.  To get around this problem a 
system of coding was devised by the researcher (table 3.4).  Thirty-three (33) error codes 
were generated and assigned to groups of generically similar pre-analytical error 
comments, in order to assign the errors into categories.  
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Table 3.4 Coding and categorisation of pre-analytical error in the Pre-analytical phase of TTP 
 
 ERROR CODE PRE-ANALYTICAL ERROR TYPE 
1 BROKCENTI Sample broken in centrifuge 
2 BSHAEM Haemolysed sample received in laboratory 
3 EXAIR Sample contains un-expelled air  
4 EXLIGHT Sample exposed to light  
5 EXMATCH Patient identity mismatched 
6 EXTIME Late arrival of ‘timed sample’ request 
7 ICEERROR Electronic order generated error (Anglia ice/COE) 
8 ILLEGIBL  Patient’s details illegible  
9 INCOMPL Incomplete patient’s details  
10 INCORPAT Incorrect patient details /wrong patient sample  
11 INCORSAM Incorrect sample type 
12 INSUFF Insufficient sample received 
13 LABERRO Laboratory reception error 
14 LEAKTRANS Sample leaked in transit 
15 LOST Sample lost in transit/lost in laboratory 
16 NOEDTA No EDTA sample received 
17 NOFLOX No fluoride oxalate sample revived for glucose/ lactate 
request  
18 NOICE Sample not received on ice (e.g. ammonia request) 
19 NOPRESV Sample received without appropriate preservative 
20 NOSAMP No sample received / empty sample container 
21 OLDSAMP Sample received more than 24 hours (left on cells) 
22 SAMCLOT Sample arrived in laboratory clotted 
23 SAMCONT Sample received contaminated  
24 SINTEG Compromised sample integrity  
25 SWAPDET Swapped patient demographics  
26 TESTNAV Test not routinely available in laboratory 
27 TIMEDEL Delay in receiving timed sample in laboratory 
28 UNCODED Unspecified pre-analytical error type  (e.g. no clinical 
details or duplicated requests)  
29 UNLABL Unlabelled sample received 
30 UNREQ Unrequested test received (no test requests) 
31 WRCONT Sample received in wrong container  
32 WRPRES Sample received in wrong preservative  
33 WRTEST  Wrong test request received 
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For example, code UNLABL represents unlabeled sample errors; code INSUFF 
represents ‘insufficient or inadequate sample volumes’ etc. (table 3.4).  The coded data 
was transferred to an Excel 2010 for Macintosh data sheet (Microsoft Corp., Redmond, 
WA) and then transposed to Statistical package for Macintosh, Version 23 (SPSS Inc., 
Chicago, IL).  Calculations of specimens with errors were presented as percentages.  
Statistical differences in error frequencies between pre-electronic test requesting 
procedure and post-electronic requesting procedure were compared using a Chi-squared 
test.  A p-value of less than 0.05 was considered statistically significant.  
 
3.3 Results of LIMS Study 
A descriptive analysis of the frequencies and percentages of the Pre-ICE and Post-ICE 
analytical errors and the total number of samples received for the study periods is 
provided in table 3.2.  Samples for testing are collected from various STH NHS FT 
departments including accident and emergency department (A/E), in-patient wards, out-
patient wards, specialist clinics, day-case units, phlebotomy units, private clinics, 
referrals and clinical trial (study samples) and from the majority of General Practice (GP) 
Surgeries spread across Sheffield. The largest numbers of test requests are received from 
the GP practices and from in-patient wards of both hospitals. Samples from the inpatient 
and outpatient wards are delivered to the clinical chemistry laboratory through the 
Pneumatic Tube System Transport (PTST) or hand delivered by the 
phlebotomists/hospital porters. Samples outside the hospitals (GP and Private Clinics and 
study samples etc.) are delivered by vans to the central receiving point in phlebotomy unit 
at stipulated times or delivered by pre-arranged taxis and dropped off at the laboratory. 
The highest numbers of requests were those received from GP practices during both 
periods of this study (table 3.3 and figure 3.3). 154,712 samples were received in 2007-
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2008 representing 37.1% of the total samples received in that year. In 2012-2013 study 
years the request from the GP centres rose to 350,041 (38.7% of total samples received).  
Samples received from the inpatient wards in 2007-2008 were 115,896 (27.8% of total 
samples received), increasing to 197,414 (19.9%). Similarly, outpatient requests rose 
sharply from an initial 88,409 (21.2%) to 214,161 representing 23.7% of the total samples 
received for the 2012 - 2013 study period. The total numbers of samples received from 
the other centres are presented in table 3.3.  
 
Figure 3.3 presents a bar chart of the percentages of the total number of samples received 
for both periods under study. Although more requests were received in 2012-2013 from 
most of the centres (excluding Environmental and private medical insurance (PMI), there 
appears to be an overall decrease in requests received from the A&E unit and inpatient 
wards of STH NHS FT as a percentage of the total numbers of samples received in the 
laboratory for testing, when both periods were compared. Overall GP surgeries, inpatient 
and outpatient wards show definitive increases in percentages between the two study 
periods.   
 
Breakdown of retrospective data from LIMS revealed that, of the total pre-analytical 
sample errors received for the Pre-ICE period, 427 (20.8%) were recorded as unlabelled 
errors (UNLABL); 287 (14.0%) were reported as no sample received errors 
(NOSAMP).  Other results for the pre - and post-ICE test requesting periods are 
presented in table 3.2. There were significant reductions in frequencies for INCORPAT 
(incorrect patient details/ wrong patient sample), LEAKTRANS (sample leaked in 
transit), NOFLOX (no fluoride oxalate sample received for glucose/ lactate request) and 
NOPRESV (samples received with no preservative).  Of particular importance is the 
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significant Post-ICE reduction in INCORPAT (incorrect patient details /wrong patient 
sample errors) where the researcher observed an absolute reduction in error rate, which 
appears to be directly linked to implementation of Anglia-ICE, as entry of data is a pre-
requisite.  
 
Further analysis of the data shows no significant changes in absolute terms for 18 of the 
pre-analytical error categories in the present study. Interestingly when the frequencies 
of these pre-analytical errors were calculated as a proportion (per every 100,000) of the 
total number of samples received from various requesting centres, pre- and post-
implementation of Anglia ICE, an abrupt reduction in frequencies was observed post 
Anglia-ICE implementation for most error types, except WRPRES, WRCONT, 
SINTEG, ICEEROR and TIMEDEL (figure 3.4).  However these apparent reductions 
in error rates failed to yield any significance (p > 0.05) when a chi-squared test was 
applied (Appendix VII).  One theory underpinning this study was that the introduction 
and implementation of Anglia-ICE in STH would considerably reduce patient 
identification related errors and eliminate the requesting of tests that were not routinely 
available (TESTNAV) in the clinical chemistry laboratory. There were no statistical 
significant changes in relation to these errors. The most probable explanation for this 
result may be linked to the non-implementation of the electronic order systems by a 
majority of the requesting centre outside STH NHS FT e.g. GP Practices and private 
clinics, where most of the samples for biochemical testing are manually requested and 
are therefore prone to a multiplicity of human errors. 
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Figure 3.4 Error type as a fraction of the total samples received within the 2 study periods under review 
!
•  Pre%Anglia,ICE%(2007,2008)%
•  Post%Anglia,ICE%(2012,2013)%
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3.4 Discussion – LIMS study results 
Pre-analytical errors in the clinical chemistry laboratory have a high possibility of 
causing serious harm or fatalities to patients. In a study by Bonini et al., (2002) a high 
frequency of laboratory errors resulted from the misidentification of samples such as 
illegible patient details, incomplete patient details, incorrect patient details /wrong 
patient sample (INCORPAT), and swapped patient demographics (SWAPDET). In a 
similar investigation by Valenstein et al., (2006) involving monitoring of sample 
misidentification for over 5 weeks in pathology laboratories at 120 institutions, they 
observed that of the 6,705 errors reported, 4,852 (72%) errors were categorised. Of 
these, 55.5% were due to primary specimen labelling errors. Valenstein and co-workers 
estimated that such sample misidentification errors could result in as many as 160,900 
adverse events per year (Valenstein et al, 2006). Consequently, it appears that accurate 
patient identification and verification of samples would address many of the reported 
sources of pre-analytical error and may considerably result in improved patient care and 
safety (Hill et al., 2010).  
 
Following the introduction of Anglia ICE system of electronic test ordering in 2010, 
there appears to be a gradual decrease in the 2012/2013 study period in some pre-
analytical error incidences when compared with the 2007/ 2008 period. Thus there 
appears to be an absolute error reduction of 0.31% even though more samples were 
received during the post-Anglia-ICE period from all the requesting centres in Sheffield. 
The use of Anglia-ICE or similar computerised bar-coding systems to match specimens 
to patients has been shown to improve the accuracy of specimen labelling and patient 
identification in studies by others (Hayden et al., 2008; Hill et al., 2010).  
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Previously, a 3-year study by Hayden et al., (2008) in a large oncology hospital (St. 
Jude Children’s Research Hospital in Memphis, Tennessee, U.S.A), showed a 
significant decrease in the ‘mislabelled sample’ error rate from 0.03% to 0.005% after 
the implementation of COE systems combined with bar-coding systems. A similar COE 
system was also used by Hill et al., (2010), in an emergency department of John 
Hopkins University School of Medicine Hospital and had been shown to significantly 
reduce clinical laboratory specimen identification error. In a cohort pre- and post-
intervention study conducted within a 61-month period, with a 2-component structured 
intervention, with retrospective data, Hill and co-workers (2010) observed a reduction 
in the mislabelled specimen rate from 0.42% to 0.31% after the implementation of a 
computerised bar-code-based verification process. These results support this present 
study where an absolute error reduction rate of 0.31% was achieved, which is an 
improvement on that reported by Hill and co-workers. !
 
Although the clinical chemistry laboratory's labelling errors have reduced with the 
introduction of Anglia ICE software and bar-code labelling in the phlebotomy units, in-
patient and out-patient wards, the is not applicable to GP centres and private clinics 
across the city of Sheffield. These are the other sources of test requests, but were yet to 
implement the Anglia-ICE system this study was conducted. While it may be argued 
that the introduction of Anglia ICE may have been directly responsible for the 
reduction of some pre-analytical errors previously detailed in the results section, there 
is the potential that electronic order systems might also have no advantage at all in 
reducing some pre-analytical errors or may in the worse scenario, lead to an increase of 
other types of ordering errors not identified or reported to the clinical chemistry 
laboratory (Hill et al., 2010). For example, errors such as SWAPDET (swapped patient 
! 61!
demographics) may be generated in an electronic order system when patients with 
similar surnames or first names occur next to each other on a computer screen or 
database and selecting the wrong patient by the requesting healthcare professional can 
be easily done.  Analysis of data has also shown that Anglia-ICE has not been able to 
reduce a category of pre-analytical errors such as EXLIGHT (sample exposed to light), 
NOICE (sample not received on solid ice), OLDSAMP (sample received after more 
than 24 hours delay), TIMEDEL (delay in receiving timed sample in laboratory), 
WRCONT (sample received in wrong container) and WRPRES (sample received in 
wrong preservative).   
 
In fact the errors (mentioned in previous paragraph) have increased in frequencies post-
introduction of Anglia-ICE, because all these error types are usually associated with 
pre-analytical operation that directly involve manual procedures or requiring human 
intervention. Of notable concern is the increase in electronic order generated errors 
(ICEERROR). This is not unexpected as there were teething IT issues and technical 
problems which were commonplace, especially since the new system had been in use 
for less than 2 years and it is probable that this error category will reduce over the 
coming years. Thus a radical approach to reducing the occurrence of a majority of these 
errors that continue to rely on manual processing may involve frequent re-
training/education programmes for service users by clinical chemistry laboratory 
professionals and experts (The Pathologist, 2015). 
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Chapter 4 Results II (questionnaire study) 
 
4.1  Questionnaire study for evaluation of practice 
 
A questionnaire survey of pre-analytical practice/procedures was conducted in STH 
NHS FT to capture the attitudes of staff of the phlebotomy unit towards current 
practice.  80 copies of anonymous questionnaires were sent out to respondents with 
18 questions, including open-ended questions and sections for comments/suggestions.  
The response rate was 85% as 68 participants returned completed questionnaires.   
 
The questions were designed as statements describing laboratory procedures and 
answers were offered as frequency of particular procedure performed in the 
respondent’s ward or centralized phlebotomy unit on a three or six-grade Likert scale, 
testing self-reported frequency.  For example questions 4 to 5 were graded as: Yes = 
1, No = 2, don’t know =3; Questions 6,7, 10 to 17 were recorded as: Always = 1, 
Often = 2, Seldom = 3, Never = 4.  Unanswered questions were recorded as 5 and 
comments/suggestions were recorded as 6.   
 
The questions were also divided in 4 sections, to include questions regarding training 
and routine procedures in phlebotomy practice (7 items), questions regarding patient 
identification, the handling of test requests and test tube labelling (5 items), questions 
concerning sampling, sample storage, and information search procedures (5 items) 
and finally questions relating to error/incident reporting (2 items). There were only 
two open-ended questions.  
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4.1.1 Employment, training and routine procedures in phlebotomy practice  
(Questions 1 – 5) 
Of all the respondents (n = 68) that took part in the questionnaire survey only 13% 
(n=9) had been in employment for 5 years approximately, in the phlebotomy unit of 
STH NHS FT (figure 4.1). 3% (n=2) of the respondents had been in employment for  
between 10-22 years. The mean number of years in employment for all respondents is 
9 years. 51% (n=35) of the respondents reported to have attended training in the last 
year (figure 4.1b), while a total of 43% (n=27) had been given refresher training in 
the previous 2-5 years. However 6% of the staff stated that they had not had the 
opportunity of attending any refresher training since they were first employed by the 
Trust. There was no correlation between the number of years in employment and 
years of training (figure 4.2).  53% (n=36) of all the respondents reported to carry out 
the VBS procedure every workday, 35% (n=24) of the respondents perform this duty 
every week, while 9% (n=6) of the staff perform this duty at least once a month. Only 
3% (n=2) reported to perform VBS less often in relation to the options provided 
(figure 4.3).  
 
88% (n=60) of the respondents stated that they were aware of documented 
information (printed manuals/SOPs/phlebotomy handbook and online laboratory 
VBS manual), to assist with their VBS duties, while 12% (n=12) of the staff was 
oblivious to this source of information (figure 4.4a). 91% (n=62) of the respondents 
reported that they were aware of the presence of undocumented information (such as 
posters and leaflets) in the phlebotomy unit, to assist with their VBS duties, while 8% 
(n=6) of the respondents simply did not know or were not aware that such sources of 
information exist (figure 4.4b).  
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Figure 4.1b Distribution of length of time of staff in recent VBS  
training  in STH NHS FT phlebotomy unit 
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Figure 4.2 Correlation between length of service and years in VBS training  
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Figure 4.3 Percentage of phlebtomy staff  carrying out VBS in wards/units  
of STH NHS FT 
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52% (n=35) of all the respondents stated that they would be interested in receiving 
further training in VBS and sample handling, 35% (n=24) of the staff were not 
interested in seeking further training, while 13% (n=9) have not considered whether 
they would be interested or not in taking up the opportunity for further training 
(figure 4.5a).  62% (n=42) of respondents indicated an interest in receiving 
information about VBS techniques, 22% (n=15) were not interested, while 13% (n=9) 
of the respondents were unsure (figure 4.5b).  3% did not respond with any answer. 
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Figure 4.4a  Percentage of staff with awareness of documented routines for VBS 
in phlebotomy unit in STH NHS FT
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Fig 4.5a Percentage of staff signifying interest in receiving further  training
 in phlebotomy practise in STH NHS FT 
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Figure 4.5b  Percentage of staff signifying interest in receiving further training 
in phlebotomy practise in STH NHS FT
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4.1.2 Patient Identification (PID) processes undertaken by phlebotomists 
(Question 6) 
 
In the questionnaire survey, 88% of the respondents reported that they always follow 
the procedure of asking the patient to state his/her name and surname in order to 
identify the patient (figure 4.6a). 10% of the respondents reported to only ‘often 
follow this procedure’. In addition to asking the patients to state their names only 7% 
of the respondents have considered verifying patient’s identification from past 
knowledge, while 84% of the respondents in the survey reported to never use 
previous acquaintance with the patient as a process of identifying patients (figure 
4.6b). About 25% of the respondents stated that they ‘always checked the wristbands 
of in-patients’ (patients on admission on the wards). 13% of the respondents seldom 
checked wristbands for patient identification, while 41% have never bothered to 
check at all (figure 4.6c).  
!
31% of the respondents reported to seldom ask the patient’s family/relative or carer 
for the patient name and identification number (figure 4.6d). 49% of the respondents 
reported never to use this means for patient identification, while about 5% reported to 
‘often or always ask a patient’s relative’ as a means for identifying their patients 
before the VBS procedure. 10% of the participants did not respond to the question in 
section 6 (d). 
!
!
65% of the respondents reported to never use the patient health card for identification 
purposes (figure 4.6e); 22% of the respondents did not respond to this question at all.  
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Q6a. How often do you check patient ID  by asking for their names?
        Figure 4.6 (a-e) Staff approaches to patient identification procedures before VBS
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79% of the respondents returned no comment to the question when asked to comment 
whether the respondents would consider checking the identity of patients by other 
means different from the options provided in questions 6(a-e) before performing 
VBS.  
 
Only 21% of respondents made the following three common observations below:  
1. ‘I sometimes asked for translators for patients who could not communicate in English 
language’ 
2. ‘In addition to question 6a above, I always ask the patient to state their DOB, NHS or 
hospital number, GP practice they attend and home address’ 
3. ‘I always ask for the patient to confirm their DOB, NHS or hospital number and 
home address as stated in the patient demographics’ 
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
 
!
 
 
 
!
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4.1.3  Managing sample test requests   
96% of the respondents reported to always follow the procedure of comparing the 
patient’s identification details with information provided on the test request form 
(figure 4.7a), while only 4% of the total respondents stated to often perform this 
procedure.  
 
Of all the respondents, 53% reported to always use test requests that another 
colleague had completed (figure 4.7b), while 23% of the respondents reported to 
never use test requests that another colleague has completed. 69% of the respondents 
reported to always check information on the test request, especially if another 
colleague has completed it, while 13% of the respondents stated to often perform this 
check. 7% of the respondents stated to never perform this check (figure 4.7c).  
 
With regards to questions around the entering sampling time on the test request, 29% 
of respondents stated to always adjust the sampling time if the marked time differed 
by more than 30 minutes from the actual sampling collection time, while 31% 
responded to never adjust sampling time even if there are variations (figure 4.7d). To 
seldom adjust the sampling time, if the marked time differed by more than 30 minutes 
was reported by 16% of the respondents. 46% of all respondents reported to always 
sign the test requests, 21% seldom performed this task, while 26% never sign the test 
requests at all (figure 4.7e).  
 
 
 
 
 
!
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Q7a.  How often do you compare patient’s ID with information on test 
requests?
Figure 4.7 (a-e) Staff approaches to test request procedures 
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Q7e.  How often do you  sign a test request form?
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4.1.4 Responsibility for marking sampling time on sample/request forms 
According to the survey statistics for this section, 49% of the respondents reported to 
never allow other colleagues to mark the sampling time on test requests that they 
were responsible for (figure 4.8).  47% reported to occasionally let another colleague 
mark the sampling time while only 4% of the respondents would allow another 
colleague to mark the sampling time on a daily basis.   
!
!
4.1.5  Marking sampling time on sample/request forms 
 
Of the respondents, 75% reported to marking sampling time on the test 
request/samples, 0-30 minutes after drawing the blood sample (figure 4.9).  A small 
percentage (6%) reported to marking sampling time 0-30 minutes before sampling, 
while 7% have never bothered marking sampling time at all.  
!
!
!
!
4.1.6 Vacutainer tube labeling (Question 10)  
56% of the respondents stated to never label the tubes before approaching the patient, 
while 7% reported to often/seldom label the tubes before approaching the patient 
(figure 4.10a).  16% of respondents stated to always label the vacutainer tubes 
alongside the patient before blood sampling (figure 4.10b); 24% of respondents stated 
to seldom carry out the tube labeling procedure alongside the patient before blood 
sampling, while 37% of the respondents reported to never label the tubes alongside 
the patients, immediately before sampling.  Another 24% did not respond to this 
question (figure 4.10b).  71% of the respondents reported to always label the 
vacutainer tubes themselves alongside the patient, immediately after sampling, while 
4% of the respondents never perform this tube labeling procedure (figure 4.10c).  
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Figure 4.8 Staff responses regarding marking of sampling time by 
colleagues during VBS
           Figure 4.9 Staff responses regarding sampling time during VBS
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Q10a.  When or where do you label the vacutainer sample tube. 
Is it before you approach the patient
Figure 4.10(a-f) Staff responses regarding sample tube labelling during VBS
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Q10b.  When or where do you label the vacutainer sample tube. 
Is it alongside the   the patient, immediately before sampling?
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Q10c.   When or where do you label the vacutainer sample tube. 
Is it alongside  the patient, immediately after sampling?
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Q10d.  When or where do you label the vacutainer sample tube. 
Is it at a later occassion after VBS?
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Q10e.  When or where do you label the vacutainer sample tube. 
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another staff member label the tube after you have performed VBS?
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Only 6% of the respondents reported to seldom label the tubes at a later occasion, 
different from the options provided (figure 4.10d).  74% of all the respondents 
reported to never allow another colleague to label the vacutainer tubes either before 
or after blood sampling, while less than 5% of the respondents reported to seldom 
allow another colleague to label the tubes (figure 4.10e and 4.10f). 
!
4.1.7 Patient preparation, venous stasis, and venipuncture (Question 11, 12 
and 13) 
54% of the respondents reported not to check the time of patient's rest, prior to blood 
sampling.  Most of the respondents commenced sampling whenever they felt that the 
patient was ready (figure 4.11).  35% reported to allow 0-5 minutes before sampling, 
while 4% allowed 6-10 minutes before sampling.  None of the respondents in this 
study considered the other options provided (Appendix V).  
!
A significant number of the respondents (71%) reported to always remove the 
tourniquet after blood sampling (figure 4.12c); 34% reported to keeping the stasis on, 
for as long as necessary, especially where there may be difficulty in sampling (figure 
4.12d). 53% of the respondents reported to never remove the tourniquet before the 
first sample is drawn, while 3-10% stated to always or seldom release stasis before 
first draw.  28% and 24% respectively of the respondents reported to always or 
seldom remove venous stasis during sampling (figure 4.12b).  Only 34% of 
respondents reported to always release the tourniquet as soon as practicable.  30% of 
the participants did not respond to any of the other options provided. 
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Figure 4.11. Staff responses regarding patient preparation before VBS
Figure 4.12a. Staff responses regarding use of stasis during VBS
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Figure 4.12(b-d). Staff responses regarding use of stasis during VBS
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32% of the respondents reported to always use the online laboratory manual, 21% 
reported to often use the online manual, while 12% stated that they seldom use the  
online manual when unsure about a pre-analytical procedure (figure 4.13b).   
 
Only 15% of the respondents reported to always use the print version of the manual, 
while 24% of them reported to often use the print version of the handbook (figure 
4.13a).  As high as 52% of the respondents reported to call the clinical chemistry 
laboratory for information regarding VBS procedure and sample handling, while 
13% and 25% stated that they seldom or often call the clinical chemistry laboratory 
for advice (figure 4.13c).  35% and 28% of respondents stated to always or often 
ask another colleague for VBS information respectively (figure 4.13d).  A few, 10% 
of the respondents, reported to seek the assistance of medically qualified personnel 
or consult the phlebotomy handbook, when responding to the question in the survey 
on information search procedure – ‘aside from the options provided, by which other 
means should you collect samples if you are unsure of how a sample should be 
collected’  (fig 4.13e).  
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Q13a. What do you do if you are not sure of how a sample should 
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Figure 4.13(a-e). Staff responses regarding access to the laboratory handbook
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4.1.8 Sample handling procedures (Questions 14 and 15) 
To always carry out the practice of inverting vacutainer tubes containing additives 
or anticoagulants several times after filling with blood sample, was reported by 84% 
of the respondents, while 7% of them reported to ‘often perform this practice’ 
(figure 4.14a). 2% and 11% reported to always or often use an automatic vacutainer 
tube inverter to ensure proper tube inversion and mixing of blood, while 74% of the 
staff reported to never using this device (figure 4.14b).  
 
50% of the respondents reported to using a vacutainer tube rack or stand for vertical 
tube storage, while 34% stated to never use the device (figure 4.15a).  68% of all the 
respondents reported never to put the vacutainer tubes in their laboratory coat 
pockets.  Similarly 63% stated never to store the samples in the refrigerator after 
VBS (figure 4.15d).  59% of the respondents stated to never store the samples lying 
on the phlebotomy work bench/station, while 4% have reported to often leave the 
samples on the workbench (figure 4.15c). 
!
Only 49% of the participants recorded comments to question 15(e).  The most 
common comments are reproduced below:  
1. ‘I place the vacutainer tubes in a specimen pouch ready to be delivered to the 
chemistry laboratory.’ 
2. ‘We do not store the vacutainer sample tubes in the ward; we bag them and send 
them to the laboratory via the pneumatic transport system.’ 
3. ‘After VBS, samples are placed in racks on the phlebotomist’s trolley ready to be 
delivered to the clinical chemistry laboratory.’  
!
!
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 and before filling the next tube? 
Figure 4.14(a-b). Staff responses regarding sample handling during VBS
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Q15a. How do you store vacutainer tubes after VBS? 
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Figure 4.15(a-e). Staff responses regarding sample storage  after VBS
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4.1.9 Incident reporting in phlebotomy and staff suggestions (Questions 16 
and 17) 
Of all respondents surveyed in the phlebotomy unit, 94% (n=64) reported to have 
never filed an incident report relating to a VBS procedure.  Only 3% of respondents 
have filed four pre-analytical error-related incidents and just 2% have filed either one 
or two error incidents regarding the VBS procedure (figure 4.16a).   
 
77% of all the respondents stated to have never written any error reports since they 
had been employed by the Trust, while 24% of them did not provide answers to this  
question in section 16b of the questionnaire survey (Appendix V). 93% of the 
respondents did not respond to question 16c, while 7% of them stated that a senior 
member of staff  (rather than themselves) had the responsibility of reporting any pre-
analytical error event or incident. 
 
81% of the respondents did not give any plausible reason(s) for refraining from filing 
an incident/error report when asked in questions 17a-d (figure 4.17a).  35% of the 
respondents stated that the unit head was  responsible for filing or reporting all pre-
analytical errors relating to VBS; 18% are not in agreement with this view, while 
47% did not respond with any answer  (figure 4.17e).  None of the respondents 
provided answers to question 17f, when asked if they were concerned about possible 
consequences if they refrained from filing an error report. 
The three most common reasons/comments reported by 18% of all the respondents 
for not filing or reporting previous errors were: 
1. ‘I have never had any reason to file an incident/error report’. 
2. ‘I was not aware that there is a form for reporting errors’. 
3. ‘I was never informed that I had to file error reports’. 
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Figure 4.16(a-c). Staff responses regarding error reporting in phlebotomy practice
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Figure 4.17(a-g). Staff responses regarding error reporting responsibilities in phlebotomy practice
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4.2 Respondents comments/suggestions for improving phlebotomy service  
(Question 18) 
Of all respondents in this questionnaire survey, only 24% (n=16) responded with 
suggestions on how the services in the phlebotomy unit, especially VBS and sample 
handling procedures, could be improved.  
The main suggestions provided are given below: 
1. We need a more efficient pneumatic tube transport system.  The current 
system breaks down too frequently. 
2. There is a need for current and frequent in-house VBS training for staff to 
improve service to patients. 
3. I would appreciate re-fresher training/updates every quarter to broaden our 
VBS knowledge and practical skills base. 
4. Staff need training visits to all STH NHS FT clinical laboratory 
departments to see how these blood samples we collect are processed. 
5. Permanent phlebotomy staff should be encouraged to visit or rotate 
through specialist clinics and wards in STH NHS FT to compare notes and improve 
their experience. 
 
 
 
 
 
 
 
 
 
 
 
 
 
!
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Figure 4.18 Staff responses regarding suggestions to improve 
phlebotomy practice in STH NHS FT
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4.3  Discussion on questionnaire study regarding phlebotomist practice 
 
 
Reducing pre-analytical errors in the clinical chemistry laboratory is still considered 
to be one of the greatest challenges to biomedical scientists and other professionals 
in laboratory medicine (Simundic and Lippi, 2012). A large percentage of pre-
analytical errors are often outside the direct control of the clinical chemistry 
laboratory (Simundic, 2015). Most laboratories still focus solely on analytical 
quality (Plebani and Piva, 2010), but the pre-analytical phase is still poorly 
standardised as there are numerous local, national and international guidelines that 
exist about best practice in the pre-analytical phase of TTP, but these are not often 
implemented or checked (Lippi et al., 2005; Soderber et al., 2009). 
Misidentification of patients is still a major source of pre-analytical errors (Lippi et 
al., 2006; Wallin, 2008; Lippi et al., 2009; Sölderberg, 2009; Woodworth and Pyle, 
2013), and this is largely as a result of non-compliance with local and national 
guidelines in place (Plebani, 2012).  
 
Phlebotomy staff involved with sample collection, are unaware that, what seem to 
be ‘small errors’ in their practice, can have an impact on sample quality and 
processing and consequently the clinical chemistry laboratory’s ability to produce 
accurate results. The resulting ‘domino effect’ may have dire consequences on 
patient safety.  Suppose a sampling error occurs and is not detected at the start of 
the TTP, the further the erroneous sample advances through the analytical process, 
the greater the impact on laboratory efficiency (Chalwa et al., 2010; Sciacovelli et 
al., 2011), laboratory cost (Green, 2013) and ultimately patient care (The 
Pathologist, 2015).  
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Members of the European Federation for Clinical Chemistry and Laboratory 
Medicine (EFLM) working group, at a recent meeting in Portugal in 2015, are of the 
opinion that there is a lack of understanding of the consequences of pre-analytical 
errors (The Pathologist, 2015) as there is a disconnection between where the error 
occurs and where its impact is seen.  All health professionals must know more about 
what the pre-analytical error risks are and their effects on test results. There still 
exists inadequate training for phlebotomists and other healthcare professionals on 
VBS procedures as evidenced by this study.  
 
Clinical chemistry laboratories need to take more responsibility to try to minimize 
the errors especially in the pre-analytical phase of the TTP where they occur. 
Healthcare professionals in the hospital setting generally have very limited 
knowledge of the pre-analytical phase and the impact it has on the TTP. They are of 
the opinion that the analytical phase is the most error prone stage. There is therefore 
a need to be more pragmatic and move away from this way of thinking that in order 
to reduce pre-analytical errors in the TTP, biomedical scientists and laboratory 
professionals must work closely with other healthcare professionals and support 
staff such as phlebotomists to provide the necessary training and education needed. 
 
The IBMS, the UK professional body for biomedical science and the ISO 15189 
(2012) standard, define the minimum criteria (table 4.3) that must be in place on the 
sample tube for receipt and identification of specimens for laboratory testing. The 
phlebotomist must identify the patient by asking for their full names, date of birth 
(DOB). Their NHS or hospital number should be checked (CLSI, 2007; IBMS, 
2016). Every person registered with the NHS in England and Wales has their own 
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unique NHS number made up of 10 digits appearing in a 3-3-4 format (IBMS, 
2016). Other parts of the UK use the Health and Care number system (Northern 
Ireland) or the Community Health Index (CHI) number (Scotland).  
 
 
In the questionnaire survey, 88% of the respondents on the survey reported that they 
always follow this procedure described above in identifying the patient. This is 
paramount, to avoid mix up of patients with similar or the same surnames/forenames, 
which may have dire consequences, leading to patient harm or in some instances, 
fatalities (Kalra et al., 2013; Plebani, 2015). 10% of the respondents reported to only 
often follow this procedure. Sample and request form information, which can be in 
paper or electronic format (Anglia-ICE), must be compatible (IBMS, 2015, 2016).!
The SOP for sample acceptance by the clinical biochemistry laboratory must define 
locally agreed and minimum acceptable identification criteria and the course of 
action to be followed when these criteria are not satisfied (IBMS, 2015).  
 
The SOP must be in accordance with national guidance and information given by 
other sources such as the Health and Care Professions Council (HCPC), the Royal 
College of Pathologists (RCP) and the!International Organization for Standardization 
standard (ISO 15189:2012), which promotes global harmonization of clinical 
practices.!Laboratory professionals, regulatory authorities, and accreditation bodies 
to ensure competence use ISO 15189. Samples or request forms received without the 
minimum essential identification criteria may be rejected, not processed and 
appropriate coded comments recorded on the LIMS stating the reason for rejection.  
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Table 4.3 IBMS professional guidance document for the receipt and identification 
of samples (adapted from IBMS, 2016).!  
 Essential Desirable 
Patient’s Sample 1. NHS, CHI or Health 
and Care number* 
2. Patient’s full names  
3. DOB and Hospital 
number 
 
1. Date and time** 
2. Nature of specimen, 
including qualifying 
details, e.g. site of 
sampling  
Request Forms 
(Electronic or Paper) 
1. NHS, CHI or Health 
and Care number* 
2. Patients full names  
3. DOB and Hospital 
number 
4. Gender 
5. Patient location and 
destination of report 
6. Patient’s consultant, 
GP or name of 
requesting healthcare 
professional 
7. Details of 
investigations required 
1. Relevant clinical detail 
including medication if 
applicable 
2. Date and time 
specimen was 
collected** 
3. Patient’s address and 
post code 
4. Requesting healthcare 
professional’s contact 
details 
*The use of NHS (or CHI or Health Care number) on paper and electronic patient 
records is mandatory as required by the NHS Operating Framework (2008/2009).  
NHS /CHI/ Health Care number thus becomes the primary patient identifier (IBMS, 
2016)  
**!Date and time collected is usually essential for clinical biochemistry samples.   
 
 
Considering the findings in this questionnaire survey, in light of the sample 
acceptance requirements, e.g. if 10% of the respondents only ‘often’ follow standard 
procedure there is a likelihood that the samples with these error types such as 
swapped patient demographics (SWAPDET), incorrect patient details /wrong patient 
sample (INCORPAT) or incomplete patient’s details (INCOMPL) to be rejected – 
indicating that frequent re-training/re-certification of phlebotomy unit staff on 
essential labelling protocol is required for correct patient identification in order to 
prevent the samples being rejected.  The findings relating to identification of patients 
before VBS procedures agree with previous findings, demonstrating some serious 
shortcomings, and indicates that there is need to improve practice. A previous study 
reported critical sample misidentification errors in the clinical chemistry laboratory 
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(Bonini et al., 2002). A separate study in the USA estimated that sample 
misidentification incidents resulted in 160,000 adverse events every year (Valenstein 
et al., 2006). In another study in a large Thailand hospital clinical pathology 
laboratory it was established that critical patient identification errors occurred in 
approximately 1 out of 1200 test requested (Wiwanitkit, 2001).  No adverse events 
relating to sample misidentification or any other type of pre-analytical errors was 
reported in STH before or during the period of this study. 
 
It is interesting to note that majority of the respondents in the survey reported to never 
use previous acquaintances with the patient as a process of identifying patients. This 
finding is supported by a previous study (Wallin, 2008). This statistic is encouraging but 
still leaves much room for improvement to achieve practice that is fit for purpose. 
Söderberg (2009) observed that only 41% of respondents reported to never use previous 
knowledge as a means of identifying patients in a previous study of pre-analytical errors 
in a primary health care in Sweden. Only 7% of the respondents from this study have 
considered verifying patient’s identification from past knowledge.  
 
Using previous acquaintances or past knowledge of patients as a means of identification 
poses a risk of misidentification of patients (Wallin et al., 2007; Söderberg et al., 2009). 
Correct patient identification could also be enhanced by using a photo ID system, as 
practised in some countries such as Sweden (Söderberg et al., 2009). The photo ID 
system is not currently in use in the UK. Valenstein and co-workers (2006) found in a 
previous study undertaken in 120 American pathology laboratories that errors in patient 
identification, before specimen collection, is responsible for up to 25% of all pre-
analytical errors (Valenstein et al., 2006). 
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Mistakes in patient identification often occur during manual tasks. Using electronic 
technologies such as barcodes, radiofrequency identification and wristbands should 
reduce pre-analytical errors compared with manual (Lau et al., 2000; Dzik, 2007). 
Wristbands have the patient’s name and identification number, and sometimes have a 
barcode. Other studies have reported error rates of 0.3-11% for identification 
wristbands, mostly comprising of missing or incomplete wristbands, and wrong 
wristband on the patient (Howanitz et al., 2002; Wallin et al., 2007; Söderberg et al., 
2009; Hoffmeister and De Moura, 2015).  A quarter of the respondents stated that they 
always checked the wristbands of in-patients. This is good practice and is in line with 
the policy governing patient sample and request form identification (IBMS, 2016). 
However a large percentage of the phlebotomy staff are not following the recommended 
standard procedure and are not using wristbands for identification of patients.  
 
In this study, nearly half of the respondents never bothered to check wristbands for the 
purpose of patient identification, this is poor practice and may lead to incorrect 
identification of the patient (Howanitz et al., 2002) and may cause harm to the patient. 
A number of healthcare facilities in some countries including the USA, Sweden, and the 
UK have developed the barcoded wristbands to assist in patient identification and 
verification (Wallin et al., 2007; Sölderberg, 2009). Although previous studies 
(Howanitz, 2005; Lippi et al., 2006, Lippi et al., 2009) have established that barcoded 
wristbands have significantly reduced patient misidentification in hospital wards and 
clinics, this approach is still inadequate in drastically reducing incidental patient 
mismatch or total misidentifications of patients in a high turnover phlebotomy service 
(Lippi et al., 2006, Lippi et al., 2009) such as STH NHS FT.  
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A third of the respondents reported to seldom ask the patient’s family/relative or care 
provider for their name and identification number. Although close to half of the 
respondents (49%) reported never to use this means for identifying their patients 
before the VBS procedure there is a need for further education and training to 
improve service delivery and reduce errors arising from misidentification. Proper 
patient identification is particularly valuable when performing VBS on young 
children, the elderly or adult patients with reduced mental capacity or dementia. In 
these cases a healthcare professional, relative or guardian should identify patients that 
are unable to speak or identify themselves.  
 
As such many hospitals now employ translators for non English-speaking patients in 
order to correctly identify the patient. Frequent re-education and monitoring of 
phlebotomy staff would help reduce pre-analytical identification errors and ensure 
greater compliance.  More than a two-thirds of the respondents reported never to use 
the patient health card for identification purposes; 22% of the respondents did not 
respond to the question at all. These responses were not unexpected since the health 
card system is not used in most hospitals across the UK, including STH NHS FT, 
where this study was carried out. The healthcare card introduced in some countries 
such as Sweden, contains name, address and identification number, but no 
photograph, and should therefore never be used for identification purposes 
(Sölderberg, 2009).  
 
4.3.1 Patient preparation prior to phlebotomy 
According to recommended practice (CSLI, 2007, 2008), the phlebotomist should 
ensure that the patient is comfortable and if appropriate should verify whether the 
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patient is fasting (for at least 12 hours or overnight as necessary for some chemistry 
analytes such as glucose and lipids); what medications are being taken or have been 
discontinued as required (Haverstick and Groszbach, 2014). The patient should be 
seated or in a supine position, since the body position causes changes in plasma 
volume that influence the test results, and should be in this state of rest for about 15 
minutes (Kiechle, 2013; WHO, 2014) before blood is collected. Diurnal and 
positional variations (Haverstick et al., 2009), affect other analytes such as cortisol, 
adrenocorticotropin, iron and lipid, which should be considered by the phlebotomist. 
More than half of the respondents reported not to check the time of the patient’s rest 
prior to blood sampling. Most of the respondents commenced sampling whenever 
they felt that the patient was ready. Failure to allow time for patient rest for about 15 
minutes is undesirable practice (Kiechle, 2013; WHO, 2014).  
 
Previous findings (Kiechle, 2013; Söderberg, 2009) suggest that insufficient patient 
rest may increase the risk of post-analytical errors by complicating the use of 
reference limits when managing the patient. Although a very small percentage (5%) 
of phlebotomy staff in the current survey appear to be working more in line with the 
guidelines (by allowing 6-10 minutes patient rest before sampling), none of the 
respondents in this study considered the other options (11-15 minutes, or more than 
15 minutes), which are in line with recommended procedure, indicating that more 
education is needed to alert staff on the importance of patient rest before VBS. This is 
another important area of pre-analytical phase of the TTP that needs improvement in 
order to reduce errors. However in everyday practice, allowing adequate “rest time” 
for patients may not be achievable due to pressures of number of people coming 
through the service. For a moderately staffed phlebotomy unit the average waiting 
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time between patients is about 10 minutes (Mijailovic et al., 2014). It is also possible 
to argue that due to extended waiting times on extremely busy specialist clinic days; 
most patients waiting in the queue would have attained the ideal rest time prior to 
VBS procedure.  
 
The responses recorded for venous stasis from this present survey are varied and are 
not in line with recommended practice (CSLI, 2007, 2008; WHO, 2014). The 
tourniquet should be applied approximately three to four inches above the 
venepuncture site and venous stasis should be on the arm no longer than one minute 
(CSLI, 2007, 2008). A good rule of thumb to determine the one-minute tourniquet 
time is to remove the tourniquet when blood starts to flow into the first tube of blood 
being drawn. Only a quarter of respondents reported to always release the tourniquet 
as soon as practicable. A significant number of the respondents reported to removing 
tourniquet after blood sampling and a third of the respondents reported to keeping the 
stasis on, for as long as necessary, especially where there may be difficulty in 
sampling.  
 
Prolonged venous stasis should be avoided since this may result in clinically 
significant effects on some plasma analytes (Haverstick et al., 2009; Lippi et al., 
2009; Haverstick and Groszbach, 2014), causing haemoconcentration and 
haemolysis. According to Haverstick and Groszbach (2014) haemolysis can result in 
the spurious elevation of such analytes as potassium, iron, magnesium, aspartate, 
phosphate and lactate dehydrogenase. In their study Lippi et al. (2005), established 
that potassium, calcium, and albumin showed clinically significant differences after 1 
minute of venous stasis. A few of the participants did not respond to any of the 
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options provided.  These varied responses from the phlebotomy unit staff suggest that 
respondents appear to be unsure about how to properly use a tourniquet during VBS. 
Incorrect venous stasis could lead to pre-analytic errors such as ‘haemolysed sample 
received in laboratory’ (BSHAEM).  Therefore there exists a gap in the VBS training 
that needs attention. 
 
4.3.2 The handling of test requests  
 
Before any VBS procedure, the patient’s details comprising of their full names, DOB 
and unique NHS number must always be compared with the corresponding 
information on the test request (paper or electronic) forms (IBMS, 2016; CLSI, 2016; 
ISO 15189, 2012). Strict adherence to this practice decreases the risk associated with 
test requests containing erroneous information (Solderberg, 2009). A few of the 
respondents were not consistent in performing this task according to recommended 
guidelines, and non-conformity to this practice has previously been reported as an 
important source of pre-analytical error (Plebani and Piva, 2010; Plebani, 2012), 
resulting in sample rejection (Dale and Novis, 2002; Lippi et al., 2009; Plebani, 2012; 
Plebani and Piva, 2015). Failure to check test request forms has also been linked to 
higher test request error frequencies (Plebani, 2006, 2007, 2009, 2010). 
 
The practice of using test requests that another colleague has completed may increase 
the risks associated with erroneous test requests (Wagar et al., 2006; Wallin et al., 
2008; Söderbeg, 2009). More than half of the respondents surveyed reported to always 
use test requests that another colleague has completed. This result is in line with 
previous work by Söderberg in 2009. He reported that 89% of the participants use test 
request completed by another colleague in a questionnaire survey of sources of pre-
analytical error in primary health care. This may lead to higher error frequencies with 
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the possible adverse consequences for patients (Valenstein et al., 2006; Plebani, 
2015).  23% of the respondents reported to never use test requests that another 
colleague has completed. Based on this high proportion of staff using partial or 
completed test request paper work, which another colleague has completed, it is 
evident that more training is needed to improve practice in this area, in order to reduce 
associated risks with erroneous test requesting (Wallin et al., 2008; Söderbeg, 2009; 
Plebani, 2012). 69% of the respondents reported to always check information on the 
test request especially if another colleague has completed it, while 13% of the 
respondents only often perform this check. This data indicates that a minority of the 
staff (18%) are not complying with the recommended guidelines, which could lead to 
the risk of an erroneous test request, as corroborated by previous reports (Valenstein 
et al., 2006; Kirchner et al., 2007). 
 
With regards to the question around the sampling time on the test request, 29% of the 
respondents stated to always adjust the time, if the marked time differed by more than 
30 minutes from the actual sampling time. The! date and time the sample was 
collected is essential for biochemistry samples (IBMS, 2016; ISO 15189 Standard, 
2012). Time of sampling is crucial for time-specific assays such as ammonia, 
calcium, glucose and the Oral Glucose Tolerance Test (OGTT) (Haverstick et al., 
2009; Harverstick and Groszbach, 2014), and for analytes with circadian variation 
e.g. cortisol, insulin and serum iron (Harverstick and Groszbach, 2014), therapeutic 
drug monitoring samples e.g. digoxin, cardiac enzymes (Harverstick and Groszbach, 
2014) and antibiotic assays. It is thus alarming to find that 31% of the respondents 
reported to never adjust the sampling time on the request forms if it is needed. This 
result appears to be in line with previous studies, which indicate that not adjusting the 
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sampling time may be a source of some clinically significant pre-analytical error 
(Wallin et al., 2008; Söderbeg, 2009; Plebani, 2012) and may be responsible for the 
increase in time-related pre-analytical errors e.g. 0.5% increase in errors due to delay 
in receiving sample in laboratory (TIMEDEL) and 1.7% sample not received on ice 
(NOICE) in Post-ICE electronic requesting (Table 3.1). More VBS training and 
education is required to further reduce this error frequency (Plebani and Carraro, 
2007; Plebani, 2007). 
 
Close to half of all respondents reported to always sign the test requests, while about 
a quarter of them were not conforming to established standards by not signing the test 
request at all. Signing test requests is an important aspect of the pre-analytical stage 
of the TTP as it can help in the audit process (Lippi et al., 2009; Lippi and Plebani, 
2009; Bilic-Zulle et al., 2010) when errors are reported (i.e. incident reporting). 
Signing test requests therefore represents an important area for improving patient 
safety (Howanitz, 2005) and must be encouraged through further training and 
education at STH NHS FT. 
 
4.3.3 Responsibility for marking sampling time on sample/request forms 
According to the survey statistics for this section, up to half of the respondents 
reported to never allow other colleagues to mark the sampling time on test requests 
that they were responsible for. This is in line with standard VBS procedure (Kiechle, 
2013) as it signifies ownership and responsibility (Wu et al., 1997; National Audit 
Office, 2005). To occasionally let another colleague mark the sampling time on the 
request form and vacutainer tube was reported by 47% of the respondents. This 
indicates that personally marking the sample time on the test request by the 
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phlebotomist during VBS is an aspect that needs considerable improvement (CLSI, 
2007; Wallin et al., 2007; Söderberg et al., 2009). Sampling time in VBS can have a 
huge advantage in prioritising assays in the clinical chemistry laboratory (especially 
time specific assays such as glucose or cardiac enzymes).  
Results from this current survey indicate that the majority of the respondents reported 
to marking sampling time on the test request/samples, 0-30 minutes after drawing the 
blood sample. However, around a quarter of the respondents did not respond to the 
questions or have were not following standard procedures regarding marking 
sampling time. Close attention must be paid to recording time of sampling during 
VBS (Billic-Zulle et al., 2010). Failure to observe and mark sampling time may lead 
to the rejection of the samples and another replacement sample being requested, 
which would certainly impact on the turnaround time (Lippi et al., 2006; Haverstick 
and Groszbach, 2014) for some analytes (ammonia, bicarbonate, electrolytes and 
glucose), whose concentration in plasma/serum might significantly change over a 
short period of time (Howanitz, 2005; Lippi et al., 2009). In the event that the sample 
is delivered for analysis it may lead to the generation of an erroneous result due to 
sample deterioration over time, caused by analyte instability. Serious consequences to 
the patient may result from such pre-analytical errors of not marking sampling time 
on blood samples. More frequent training is needed to improve this aspect of 
phlebotomy practice. 
 
4.3.4 Vacutainer tube labelling  
The test requester must ensure that samples are correctly labelled and request forms 
are completed to agreed standards (IBMS, 2016). Unlabelled vacutainer tubes, test 
request forms and other phlebotomy equipment or consumables must be taken to the 
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patient’s side prior to any VBS procedure (Kiechle, 2013; WHO, 2014). According to 
recommended guidelines vacutainer tubes should always be labelled immediately 
alongside the patient (CLSI, 2010; WHO, 2014) after VBS, to avoid mislabelling or 
‘unlabelled sample’ errors (Wallin et al., 2009; Kiechle, 2013; WHO, 2014).  A 
significant number of the respondents reported to always label the vacutainer tubes 
themselves alongside the patient, immediately after sampling. This is in line with 
recommended practices (CLSI, 2007, 2008, 2010; WHO, 2014; IBMS, 2016).  
 
About a quarter of the respondents did not respond to this question, while a small 
number of staff recorded varying responses that seem to suggest that they were 
unsure about following recommended standard procedures available for VBS. This 
indicates unacceptable practice and associated with increased risks of the wrong 
patient’s blood in the labelled vacutainer tube (CLSI, 2007; Wallin et al., 2008; 
Soderberg et al., 2009; Harverstick and Groszbach, 2014). The results from the pre-
analytical data in this study indicate that errors such as incorrect patient details 
/wrong patient sample (INCORPAT), incomplete patient’s details (INCOMPL) and 
swapped patient demographics (SWAPDET) are common in the laboratory and may 
be associated with incorrect vacutainer tube labelling. 
 
It is important to correctly identify the patient so that the blood sample is collected 
from the correct patient into the correctly labelled container (Lippi et al., 2006; 
Kiechle, 2013; WHO 2010).! In cases where an inadequately labelled sample is 
received from a patient who is not easily accessible for a repeat (e.g. cerebrospinal 
sample), then the sample may be processed at the discretion of senior staff in the 
clinical chemistry laboratory, in accordance with local protocols (STH NHS FT 
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clinical chemistry laboratory SOP). The report should show a clear disclaimer 
detailing the shortcomings of the sample and/or request and alerting the requesting 
practitioner to take responsibility for the results, and for any action taken as a result 
of the report (IBMS, 2016).  A large percentage of the staff reported that they never 
ask another colleague to label the vacutainer test tubes before or after sampling, but 
will always label the vacutainer tubes themselves, in line with SOPs (Kiechle, 2013). 
Nevertheless this result suggests that the remaining number of the respondents will 
ask another colleague to label a vacutainer tube, either before or after sampling. Such 
practice will increases the risk of unlabelled, mislabelling or sample mismatches 
(EXMATCH, SWAPDET), and are important sources of pre-analytical errors in the 
clinical chemistry laboratory (Plebani and Carraro, 2007; Plebani, 2007; Sciacovelli 
and Plebani, 2009).  
 
Mislabelled tubes or tubes with incomplete patient demographics may result in 
adverse events (Kalra, 2004; Valenstein et al, 2006) and in some cases, fatalities. 
Drawing blood from the wrong patient, or labelling the correct patient’s sample with 
a different patient’s label can undoubtedly contribute to pre-analytical errors in the 
laboratory (CLSI, 2008; IBMS, 2016). The vacutainer tube labelling procedures 
adopted by staff as reported in the questionnaire survey clearly demonstrates an 
association with a significant risk  (CSLI, 2010; ISO 15189; 2012; IBMS, 2015), 
resulting from mislabelling / inadequate labelling of vacutainer tubes, and represents 
a significant area of patient safety improvement (Kalra, 2004; Plebani, 2009) that 
needs to be addressed. 
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4.3.5 Online laboratory manual and information search  
The online laboratory manual is available through the STH NHS FT intranet 
(http://STH NHS FTweb/LabMed_nhs/Handbook). It is a source of accurate 
information on test requesting, VBS procedures, and sample handling. Online 
laboratory manuals should be considered the preferred source of information for VBS 
procedures, since they can be updated periodically. However in this present survey 
only a third of the phlebotomy staff use this online resource regularly. One 
explanation for the low reported use of the online manual may include complicated 
access to the manual (Söderberg, 2009) via the intranet server. It is of utmost 
importance that VBS instructions are regularly updated and easily accessible since 
pre-analytical information from laboratories changes over time (Blechner et al., 2006, 
Georgiou et al., 2007). User information should be underpinned by laboratory SOPs 
and standards (IBMS, 2016).  
 
The online manual must easily be accessible, be user friendly, and the users must be 
aware of its existence. Consultants, registrars and house officers, nursing and other 
healthcare professionals working in the hospitals must be familiar with and 
understand the rationale of laboratory procedures and standards. There should be 
clear written guidelines for those who obtain blood samples from a patient on behalf 
of the requesting practitioner (IBMS, 2016). Although a large percentage of the staff 
stated that they were aware of the availability of documented information (printed 
and on-line versions of the laboratory handbook) to assist with VBS procedure, only 
15% of the respondents have used the printed version of the handbook on a regular 
basis. The probable explanation for the low number of staff using the printed version 
of the on-line manual may be due in part to the dynamics surrounding the job such as 
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staff shortage and the cumbersome nature of updating paper-based laboratory 
manuals, which may lead to inaccurate or obsolete information (Blechner et al., 
2006), some of which may jeopardize the safety of patients. The results in this part of 
the questionnaire survey show that information search procedures in the phlebotomy 
unit are in need of improvement.  
 
4.3.6 Specimen handling procedures  
Based on international recommendations (Valenstein et al., 2006; CLSI, 2010; IBMS, 
2016), vacutainer tubes containing additives such as anticoagulants (EDTA and 
lithium heparin) or enzyme inhibitors (fluoride-oxalate) should be gently inverted 
after sampling to mix with the blood. In this way clotting of the blood is prevented. A 
majority of the phlebotomy staff (n=57) reported to always perform this procedure. 
This adherence to high-quality practice may be responsible for the very low 
frequencies of clotted sample errors (below 0.5%), received in the clinical 
biochemistry laboratory department between the two periods under survey. However 
a few respondents (n=11) do not adequately mix blood samples after VBS. Some 
authors have reported that inadequate inversion of vacutainer tubes may have some 
pre-analytical effects in clinical chemistry laboratory testing (Kiechle, 2013; 
Harverstick and Groszbach, 2014). Only a small number (n=8) reported to always or 
often use an automatic vacutainer tube inverter to ensure proper tube inversion and 
mixing of blood.  
 
The inverter device is not routinely available in all the units and phlebotomy 
workstations, which may explain why a larger percentage of the staff  have reported 
to never use the device. Not having this device does not appear to have any 
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disadvantageous effects on the majority of biochemical test requests that utilize 
serum samples in clinical chemistry but may have effects on a number of biochemical 
requests that utilize plasma samples such as glucose and parathyroid hormones 
(Ashwood and Bruns, 2008). Results also show that half of the respondents (n=34) 
reported the acceptable practice of using a vacutainer tube stand for vertical tube 
storage. Vertical storage of test tubes is recommended for proper coagulation of 
serum samples used in clinical chemistry (CLSI, 2010). The survey results indicate 
that half of the respondents are not following recommended practice.  
 
Although none of the respondents reported to storing test tubes ‘lying horizontally’ 
on a workbench top or on other surfaces in line with recommendation, there is an 
urgent need for laboratory professionals to raise awareness of the pre-analytical 
issues arising from sample handling in VBS procedures through continuous training 
and education (The Pathologist, 2015) and move towards upholding international 
standards.  More than half of all the respondents reported to never put the vacutainer 
tubes in their laboratory coat pockets or store them in the refrigerator after VBS, 
which still suggests that a high percentage of staff do this indicating a low level of 
compliance and therefore more education of staff is needed.  
 
4.3.7 Incident/error reporting in phlebotomy  
A significantly high number of respondents surveyed in the phlebotomy unit (n=64), 
reported to have never filed an incident report relating to VBS procedure. According 
to the survey only a handful of the phlebotomy staff stated to have filed either one or 
two error incidents regarding VBS procedure. These numbers are very low indeed. 
Two previous studies indicate that some hospitals have reported low frequencies of 
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pre-analytical incident reporting (Söderberg et al., 2009; Söderberg, 2009). Söderberg 
and co-workers (2009) found out that 69% of the phlebotomy staff in a public health 
centre reported that they had never filed an incident or error report. In this present 
survey, 77% (n=52) of all the respondents have never written any error reports since 
they have were employed by the Trust. A possible reason for the low incident 
reporting frequencies could be that the significance of an error in the VBS process 
may not be considered at the time of blood sampling (Söderberg, 2009). However, it 
is arguable that most respondents are likely to be familiar with an incident in VBS 
(Söderberg, 2009) that would require a report, considering that the average time in 
employment is about 9 years. About 20% of the respondents have indicated, among 
other factors, that lack of time and the complicated process of error reporting 
currently in place, may have contributed to the reasons for the majority of the staff 
refraining from filing an error report.!Pre-analytic phase incident reporting is a means 
to achieve increased patient safety (IOM, 2000).  
 
Patient safety and care could be improved by continuously applying useful 
information gained from incident reporting to improve pre-analytical practices in the 
clinical chemistry laboratory (National Quality Forum, 2009). A high percentage of 
the staff did not give any plausible reason(s) for not filing an incident/error report. 
35% of all the respondents stated that the section or unit leaders are assigned the 
responsibility of recording pre-analytical an incident/error. All the respondents 
(n=68) appear unconcerned about possible consequences that may arise from not 
reporting error incidents. The relatively low incident reporting frequencies among the 
respondents may arise because they have not been given the opportunity to be 
involved in the process of incident or error reporting. Therefore, when designing 
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strategies for increased incident reporting, it is important to consider the barriers and 
opinions reported by the staff (Lippi et al., 2009; Lippi and Plebani, 2009; Söderberg, 
2009; Billic-Zulle et al., 2010). Considering these aspects, increased reporting of pre-
analytical incidents regarding phlebotomy practice in STH NHS FT NHS should be 
intensified through continuous education and training, specifically defining whose 
responsibility it is to report or file errors.  
 
4.3.8 Staff opinions and suggestions  
The staffs desire to increase and develop their competence should be considered a 
valuable resource when attempting to improve the VBS procedure. The healthcare 
system is going through challenging times as a result of reorganizations, spending 
cuts to some services and staff shortages.  The implementation of any change must 
embrace the opinions and suggestions of frontline staffs such as phlebotomists and 
nurses who perform VBS on a daily basis.  Educational efforts in VBS must be 
designed to improve quality, reduce the most common pre-analytical errors in TTP, 
and ensure patient safety at all times. 
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5 General Discussion 
5.1 General considerations from this study 
Most procedures in the pre-analytical stage of the TTP rely heavily on human 
involvement and are therefore prone to human error. Unfortunately human errors are 
currently likely to increase, with the decrease in staffing levels in most UK NHS 
Trusts over the recent years and ‘insufficient funding for technological solutions 
leaving healthcare years behind other industries’ (European Federation of Clinical 
Chemistry and Laboratory Medicine, EFLM in the Pathologist, 2015). Before the 
implementation of the electronic request system - Anglia-ICE, specimen labelling 
was a manual process of visually comparing the identity on the stamped labels 
usually comprising 4 patient identifiers, with the identification details on the patient’s 
wristband (described in Chapters 1 and 3). The information on the vacutainer test 
tube and the request form was then entered into the laboratory computers in the 
clinical chemistry department, and subsequently transferred to the LIMS. If the 
sample was rejected, a comment was added describing the reason for its unsuitability 
for testing.  
The electronic-requesting system (Anglia-ICE) was implemented in 2010, allowing 
users of the laboratory service to print out pre-completed VBS/ test request order 
forms. The system was initially trialled in the acute unit of the STH NHS FT and 
gradually rolled out to all inpatient and outpatient wards, but has not yet been 
extended to GP surgeries or private clinics. The move to electronic requesting was 
necessitated by the gradual increase in the number of samples received in the clinical 
chemistry department. A total of 903,814 samples were received in 2012/2013, which 
is double the number of samples received in 2007/2008 (416,703 samples). The direct 
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implication of this surge is an increased workload on the clinical chemistry laboratory 
as well as longer turn-around-time to process samples, since a substantial proportion 
of the pre-analytical phase involves manual procedures. 
The clinical chemistry laboratory, through the LIMS system, keeps a record of each 
sample analysed in the laboratory as part of the standard quality assurance 
management. The system also keeps a record of how many samples were rejected due 
to one specific error type (e.g. haemolysis, insufficient sample or sample lost in 
transit) or a combination of errors such as sample identification errors.  The total 
number of samples received, the total number of samples with pre-analytical errors 
from all the requesting centres pre and post-implementation of Anglia ICE were 
recorded. On each of these occasions, the discovery of the pre-analytical error 
depends on the detection by the test-ordering healthcare professional, the 
phlebotomist who performs VBS, the medical laboratory assistant or the biomedical 
scientist that an anomaly has occurred. If the error is not detected the consequences 
could be serious. 
The primary source of most samples received in the laboratory in 2007/2008 was 
from GP surgeries across Sheffield, outpatient and inpatient wards of STH NHS FT. 
These three centres also delivered most of the samples to the clinical chemistry 
laboratory in 2012/2013. However despite the number of samples increasing by 
487,111 in the 4-5 year period, fewer samples were rejected for pre-analytical errors 
in 2012/2013, following the introduction of Anglia-ICE system.  It is possible that a 
high percentage of these errors pre- and post-Anglia ICE may be linked to samples 
received from GP surgeries and private clinics, which have not had the Anglia-ICE 
system implemented during this period of this study. Therefore, targeting these 
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centres for future pre-analytical error reduction strategies is important. The 
questionnaire study involved the phlebotomy units of inpatient and outpatient wards 
of STH NHS FT only (both centres deliver about 45% of the total samples to the 
clinical chemistry laboratory. The decision to exclude phlebotomy units of GP 
practice centres and A&E departments is predicated on the difficulties that may arise 
from bureaucratic bottlenecks that are usually encountered when trying to evaluate 
practice in such environments.  
5.2 Findings from this study 
This present study involved an investigation of the LIMS and assessment of pre-
analytical errors to compare two separate time periods before and after the 
implementation of Anglia-ICE. The study also investigated whether the introduction 
of the electronic test requesting system played a key role in reducing the occurrences 
of pre-analytical errors. This study also included a survey of pre-analytical procedures 
in the phlebotomy units of   STH NHS FT, to identify the potential sources of these 
errors and whether phlebotomy practices contributed to pre-analytical error reduction 
in the clinical chemistry laboratory.  
The specific aims were: 
• To investigate, categorise and determine the frequencies of pre-analytical errors in the 
TTP. 
• To conduct a survey of pre-analytical procedures by phlebotomy staff to identify key 
error prone steps in the TTP. 
• To draw any conclusions from phlebotomy staff practice and specific errors (e.g. 
haemolysis or labelling errors) identified in the TTP. 
• To engage with experts and seek advice to improve phlebotomy practice in STH NHS 
FT and to communicate the outcomes from the study to service users with the aim of 
improving the service and promote patient safety. 
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Of all the published procedures on the reduction of pre-analytical errors in the TTP, 
the methodologies described by Söldreberg (2009) and Hill et al., (2010) relate 
closely to the study design in this present research. Both previous studies investigated 
separate aspects of pre-analytical errors in the laboratory. While Sölderberg (2009) 
investigated sources of pre-analytical errors in primary health care in Sweden, Hill 
and co workers (2010) investigated the reduction of labelling errors by introduction of 
an electronic ordering system in the emergency department of John Hopkins 
University School of Medicine Hospital, USA.  The results of this present study 
concurred with the separate findings from both these previous studies. There were 3 
key findings from this study: 
Firstly, the results show a definitive decrease in the occurrence of specific pre-
analytical errors following the implementation of the Anglia-ICE system in 2010. It is 
likely that Anglia-ICE has contributed to the decreased pre-analytical error rates.  The 
implementation of electronic requisitioning of laboratory samples has certainly 
significantly reduced the rate of one error-prone manual test requesting procedure that 
is related to patient identification - incorrect patient details (INCORPAT).  Overall an 
absolute pre-analytical error reduction rate of 0.31% was attained and the result agrees 
with previous findings of Hill et al., (2010) who achieved a 0.31% reduction in 
institutional sample labelling error rate. Although it has been argued that introduction 
of new and advanced technology such as electronic test ordering combined with 
sample bar-coding systems (Valenstein et al., 2006) can go far in reducing patient 
identification errors, it is certainly also the case that electronic systems will increase 
other types of ordering errors (Hill et al., 2010) not detected or reported to the 
laboratory such as electronic order generated errors, no-test request errors and 
unspecified pre-analytical error types.  For illustration, it is fairly easy to select the 
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wrong patient’s details from two different patients with very similar surnames and 
their names appear closely together on the computer screen of an electronic order 
system. There is therefore a need for continuous evaluation of practice and monitoring 
(Sölderberg, 2009) by experts in clinical chemistry laboratory practice. 
Secondly, a number of patient identification and test ordering errors were still 
recorded in the LIMS post Anglia-ICE implementation (e.g. patient’s details illegible, 
incomplete patient details, swapped patient demographics, test not routinely available 
in laboratory, unspecified pre-analytical error type, unlabelled sample received, 
unrequested test received, wrong test request received - indicating that the electronic 
test ordering alone is not sufficient for a reliable error-free pre-analytical procedure. 
Nonetheless the implementation of Anglia-ICE technology is still the way forward to 
reduce errors associated with manual paper-based test requests.   
Thirdly, there appears to be considerable underreporting of pre-analytical errors in the 
phlebotomy units of STH NHS FT, where this study was carried out.  Underreporting 
or filing of pre-analytical incidents can lead to clinically important errors (Kolovos et 
al., 2008).  Results show that more than 95% of phlebotomy staff had never filed an 
error incident regarding the VBS procedure.  These findings are supported by results 
from a previous study by Söderberg (2009), where 69% of respondents in the 
investigated primary health care setting in Sweden, stated to have never filed an 
incident report regarding VBS practice. Shortage of time and the complicated process 
of error reporting currently in place have been voiced as possible reasons for most of 
the VBS staff refraining from filing an error report. Other reasons for a lack of 
compliance are fear of punishment, a lack of perceived benefits and the assumption 
that error reporting is the Manager’s duty (Bates et al., 1995; Kalra et al., 2013). This 
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contrasts with practice that exists in the clinical chemistry laboratory, where error 
reporting by staff is greatly encouraged.  
Therefore, it is crucial to douse the blame and shame culture that surrounds staff, 
causing them to keep vital evidence or information about errors away from other 
colleagues or senior members of staff (Darosa and Pugh, 2012). Increased reporting of 
pre-analytical incidents regarding phlebotomy practices in STH NHS FT should be 
intensified through continuous education and training, specifically defining whose 
responsibility it is to report or file errors. Education about errors and their 
preventability may result in approaches to decrease errors and improve quality, and 
prevention that can better happen through learning about mistakes and near misses 
(Kalra et al., 2013). 
The finding of undesirable practices within the questionnaire survey largely reflect the 
lack of standardised procedures in place for VBS, including sample handling, storage 
and transport. Although there is a copy of a controlled documentation for VBS in the 
quality management system software on the intranet server of STH NHS FT, staff still 
relied mainly on uncontrolled documents (such as leaflets kept in the unit), asking 
other colleagues about standard procedures relating to VBS or calling the laboratory 
for information when they are confronted with any challenging aspect of their 
practice. Hence improvements are needed to deliver an excellent service to users.  
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5.3 Is there a relationship between the LISM study and staff responses in 
the questionnaire survey? 
Evidence of possible linkage between the two parts of the separate studies (i.e. the 
pre-analytical error frequency statistics from LIMS and the phlebotomy staff 
questionnaire survey) exists.  High frequencies of unlabelled tubes, mislabelled tubes, 
incorrect sample tubes and incomplete patient demographics on sample tubes have 
been identified through the LIMS database, which directly supports the results in the 
questionnaire survey relating to patient identification procedures and vacutainer tube 
labelling. A high percentage of the respondents were not following the recommended 
standard procedure for identification of patients. In the questionnaire study, nearly 
half of the respondents never checked wristbands for patient identification; this is 
undesirable practice and may lead to improper identification of the patient. Correct 
patient identification and correct tube labelling are undoubtedly the most crucial 
procedures in laboratory medicine.  Hence, there is a need to prioritize efforts to 
ensure compliance by staff with standardized patient identification practices.   
 
The demonstration that occurrence of vacutainer tubes labelling errors increased post 
Anglia-ICE, raises some concerns.  Results from the questionnaire survey show low 
compliance with recommended practice.  According to recommended guidelines, 
vacutainer tubes should always be labelled immediately alongside the patient (CLSI, 
2010; WHO, 2014) after VBS to avoid labelling errors (Wallin et al., 2009; Kiechle, 
2013; WHO, 2014).  A high percentage of the respondents reported to always label 
the vacutainer tubes alongside the patient after VBS procedure, however a 
considerable number did not, but reported to label the sample tubes alongside the 
patient, before VBS procedure. This is not in line with recommended practices (CLSI, 
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2007, 2008, 2010; WHO, 2014; IBMS, 2016).  About a third of the total numbers of 
respondents were unsure about which standard procedure was available for vacutainer 
tube labelling in VBS. This indicates unacceptable practice and associated with 
increased risks of the wrong patient’s blood in the labelled vacutainer tube (CLSI, 
2007; Soderberg et al., 2009; Harverstick and Groszbach, 2014, IBMS, 2016).  
 
The questionnaire survey also revealed that close to 30% of the phlebotomy staff will 
ask another colleague to label a vacutainer tube, either before or after sampling, a 
practice which increases the risk of unlabelled, mislabelling or sample mismatches 
and are important sources of pre-analytical errors (Plebani and Carraro, 2007; Plebani, 
2007; Sciacovelli and Plebani, 2009). These findings appear to be the result of a 
combination of factors relating to staff shortages and time pressures on the service. 
Therefore there is a need for adequate staffing to maintain VBS standards (Lippi et. 
al., 2006), which provides appropriate of expertise (Ashikiran et. al., 2011). 
Mislabelled tubes or tubes with incomplete patient demographics may result in 
adverse events (Kalra, 2004; Valenstein et al, 2006) and in some cases, fatalities. 
Drawing blood from the wrong patient, or labelling the correct patient’s sample with a 
different patient’s label can undoubtedly contribute to pre-analytical errors in the 
laboratory (CLSI, 2008; IBMS, 2016).  
 
The vacutainer tube labelling procedures adopted by staff, as reported in the 
questionnaire survey clearly demonstrates an association with a significant risk  
(CSLI, 2010; ISO 15189; 2012; IBMS; 2015), resulting from mislabelling/ inadequate 
labelling of vacutainer tubes, and represents a significant area for patient safety 
improvement (Kalra, 2004; Plebani, 2009) that needs to be addressed. 
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Results from this present study also show a decrease in the error frequencies of 
haemolysed sample events during VBS procedures, but this decrease was not 
statistically significant.  Therefore there appears to be was no established correlation 
between the reduction in the number of haemolysed samples (observed post Anglia-
ICE) and VBS practices (including extent of staff training or length of practice).  
While the reduction in haemolysed sample errors cannot also be directly linked to 
implementation of Anglia-ICE, it may be down to improvements in good VBS 
practices and optimized transport conditions (including the use of the pneumatic tube 
transport system (Fernadez, et al., 2006)), for sample delivery to the clinical 
chemistry laboratory in STH NHS FT.  It may be worthwhile to consider a future 
study that would directly link sample haemolysis to time of stasis (use of tourniquet) 
during VBS.   
 
Common errors can also be made in the transportation of phlebotomy samples, thus it 
is important that the clinical chemistry laboratory and phlebotomy staff are made 
aware of the optimum time and transport conditions, especially for blood samples. 
The occurrences of other errors such as sample received contaminated, sample 
received in wrong container and sample received in wrong preservative, may be 
avoided by implementing good practices. These include strictly adhering to the 
correct order of draw, not drawing the blood sample immediately after catheter 
insertion, and never collecting from an infusion line.  
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5.4 Limitations of study 
One of the limitations of this present study was the relatively small sample size of 68 
respondents involved in the questionnaire survey. This study was conducted in the 
phlebotomy units of the inpatient and outpatient wards of STH NHS FT only.  A 
larger sample size (including the phlebotomy units of A&E, GP surgeries and private 
clinics) would probably produce improved outcomes. 
 Another constraint to this study is that the research methodology was restricted to a 
questionnaire study only. Although the anonymity offered by the questionnaire 
approach may well have yielded more open responses from respondents, a mixed 
methodology to include direct observational studies combined with structured 
interviews could have offered more participant involvement (Polit and Beck, 2014) 
This study is the first inquiry linking VBS practices in phlebotomy to retrospective 
LIMS pre-analytical data by comparing two separate periods pre- and post electronic 
order requesting in an NHS hospital, which meant that there were very few published 
studies available for reference purposes or to compare results of findings, although 
there were a number of published articles on electronic order requesting, which relates 
to this present study and these are cited in this thesis.  
It is important to emphasize that the data presented in this study represent only those 
pre-analytical errors that were identified by laboratory personnel and recorded in 
LIMS. Nonetheless, an electronic test requisition system can introduce new source(s) 
of error not readily detectable by laboratory staff. There is no knowledge of how 
many pre-analytical sample errors went undetected or unreported. No harm or injury 
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were linked to any patient as a direct result of a pre-analytical event during the period 
of this study.  
Lastly, there were some difficulties encountered with the returns of completed 
questionnaires. Several participants took over two months to return their completed 
questionnaires.  
 
 5.5 Recommendations for practice in STH NHS FT  
Based on the findings from the questionnaire survey the following recommendations 
for practice in STH NHS FT (See appendix XVI) were identified: 
• The development of a vigorous incident reporting and error filing system. This 
reporting can be a valuable data collection tool for designing approaches for future 
VBS training. 
• A thorough review of all pre-analytical procedures in the TTP, with specific focus on 
manual tasks involving patient identification and vacutainer test tube labelling. 
• Focus on frequent training and competency assessment to involve all phlebotomy 
staff performing VBS procedures. 
• Development of a standardized coding system for entry of all categories of pre-
analytical errors in LIMS.  
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5.6 Recommendation for future research  
• Extend the questionnaire survey to include other requesting centres such as GP 
surgeries, and private clinics to increase sample size. 
• Future studies should consider mixed methodologies such as questionnaire survey 
combined with observational studies, face-to-face interviews for better staff 
participation experience. 
• Future studies should involve NHS hospitals in other regions of the UK to compare 
outcomes between pathology laboratories to improve pre-analytical practice and 
subsequently reduce or eliminate pre-analytical errors in the clinical chemistry 
laboratory.  
 
Findings from this study will be submitted for publication in a scientific journal and 
will be presented at scientific meetings such as the IBMS congress to share and 
promote good practice in clinical chemistry. A service evaluation report, based on the 
findings from this study and included in appendix XVI of this thesis, has already been 
submitted to the Clinical Effectiveness Unit (CEU) of STH NHS FT for 
consideration. 
 
The outputs of the research will be extremely beneficial not only in terms of 
consolidating the implementation of the outcomes but also in the transferability of 
findings to other pathology departments. To facilitate this, a website 
(http://preanalytics.omegapl.com) has been commissioned to discuss the outcomes of 
the research as well as create a forum to discuss issues relating to pre-analytical 
testing. 
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5.7 Conclusion 
In general, improvements to clinical chemistry laboratory services require periodic 
objective evaluation of practices (Shaw, 2003), procedures, staff and organizations 
against valid and unambiguous standards, to identify and implement appropriate 
changes.  Most pre-analytical errors detected in the clinical chemistry laboratory are 
avoidable. By strengthening the education of healthcare professionals (doctors, 
nurses, phlebotomists and clinical support staff) about pre-analytical quality and 
establishing a comprehensive system of quality in the pre-analytical phase that entails 
systematic monitoring of non-conformance (EFLM in The Pathologist, 2015), desired 
outcomes of reduction in errors can be achieved.   
Continual local observational studies with error frequency assessment and risk 
analysis of pre-analytical practice errors, combined with direct feedback, discussions 
and reflection amongst involved personnel, seems to be the most efficient strategy for 
sustained good pre-analytical practices.  
Overall the key steps to improve the pre-analytical phase are standardization of VBS 
procedures, education, re-training, clear definition of responsibilities and fluid 
communication with phlebotomy staff, development of new technologies and 
automation, all of which require continuous funding and monitoring. Continuous 
professional development and further training in VBS should be encouraged among 
staff and support staff in the phlebotomy unit. The loop will not be complete without 
continuous feedback from the users of the laboratory service - we can only improve 
the phases of laboratory services that we can measure. 
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Dear Mr Sholademi, 
 
This letter relates to your research proposal: 
 
TITLE: Reducing pre-analytical errors in clinical chemistry through effective 
communication with service users. 
 
This proposal was submitted to the Faculty Research Ethics Committee for 
ethics and scientific review in October 2013.  It has been reviewed by two 
independent reviewers and has been passed as satisfactory on 11th October 
2013.  You will need to ensure you have all other necessary permission in 
place before proceeding, for example, from the Research Governance office of 
any sites outside the University where your research will take place.  This 
letter can be used as evidence that the proposal has been reviewed ethically 
and scientifically within Sheffield Hallam University. 
 
Good luck with your project. 
 
 
 
 
Dr Peter Allmark 
On behalf of the Faculty Research Ethics Committee 
Faculty of Health and Well-being 
Sheffield Hallam University 
32 Collegiate Crescent 
S10 2BP 
 
0114 225 5727 
p.allmark@shu.ac.uk 
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5683- Identification and Reduction of Pre-analytical Errors in Clinical 
Chemistry - approved as SE 
  
Dear Benjamin, 
  
Project 5683- Identification and Reduction of Pre-analytical Errors in Clinical Chemistry has 
been approved as service evaluation. Please use this number when corresponding with me. 
  
It has been be included on the Directorate’s Clinical Audit and Effectiveness Programme to 
ensure that the project’s progress can be monitored throughout all the stages of the cycle. The 
project is now on the programme as a locally managed project.  Any project that is progressing 
as planned with be issued a green colour status, any with a minor problem – hoping to resolve - 
is issued an amber status and any which has a significant problem will be issued a red status. 
Please remember to keep me informed of your project status at all times. The progress of 
projects is reported regularly to the Trust Clinical Audit and Effectiveness Committee (CEC) and 
Directorate meetings. If you let me know of any problems, I will try to resolve them in a timely 
fashion to prevent any escalation procedures. 
  
It was expected that on completion of the project you will submit a final written report in the 
STHFT CEU format. Please find attached the report template and separate guidance. The same 
headings should be used when you prepare a presentation. This is not only built into the terms 
and conditions of the Clinical Audit Policy but the report is also used as evidence of compliance 
for the NHS Litigation Authority Level 2 assessment. The report is used as evidence for: 
! Care Quality Commission (CQC) Essential Standards for Quality and Safety 
! CQC Engagement in Clinical Audit Performance Indicator 
! NHSLA and Information Governance Standards 
! Department of Health Quality Accounts 
! Providing assurances to the Trust Board 
! NHS Sheffield Commissioner contractual obligations 
! Meeting NICE guidance (all types) 
! NCAPOP programme  
  
The Trust actively encourages that all project findings are disseminated within your 
Directorate/Speciality groups, along with stakeholders, to agree and monitor action plans 
following any recommendations for change. All audits require this formal report (a presentation 
is not appropriate since it does not outline all the relevant points in the report such as the action 
plan). An audit cannot be closed on the programme unless the action plan has been 
implemented. 
  
If you need to discuss this email further with me then I am available Monday to Thursday. 
  
Kind regards, 
 
  
Christine 
Appendix III
##
 
 
 
 
Service Manager  
NGH 
Sheffield  
10/07/2014 
 
 
Identification and Reduction of Pre-analytical Errors in Clinical Chemistry Staff 
Questionnaire 
 
YOUR OPINION MAKES A DIFFERENCE 
 
Dear Sir/Madam, 
 
The Clinical Chemistry team at the Sheffield Teaching Hospitals are constantly looking for ways to 
improve the service delivered. One of the ways we do this is by asking you about the service that you 
work in. Your feedback is very important to us.  We ensure that we take a note of all comments 
received and use them to help us improve. We would be grateful if you could complete the following 
questionnaire giving us your opinions.  
 
The questionnaire is completely anonymous and will only take you about 10 minutes to complete. 
You do not have to take part if you don’t want to. Your answers will be used to help us to improve our 
services.  
 
This questionnaire concerns the collection and handling of venous blood samples for clinical 
chemistry analysis. You will be asked to complete a series of yes/no questions. You will also be 
asked how often you carry out a task in a specified manner. Please select the most suitable 
alternative from the choices given. This means that you should not mark an answer between two 
alternatives. Finally I will ask for your opinion and suggestions. Mark your answers by placing a tick in 
the box (!) beside the most suitable alternative. If you wish to change an answer, fill in the 
incorrectly marked box completely (!) 
 
Please do not write your name on this questionnaire. 
 
Please return your completed questionnaire in the boxes provided in the phlebotomy reception 
 
May I take this opportunity to thank-you in advance for completing this questionnaire. 
 
If you have any questions about this survey please ask to speak to Benjamin Sholademi. 
 
Signed  
  
            
Project Lead 
 
Please turn over 
 
CJC#19/3/14#BS#project#
APPENDIX IV
  
 
 
 
 
The Questionnaire 
The questionnaire proposed for this project will address phlebotomy practices in STH. The 
development of the questionnaire has be undertaken in discussion with experts in questionnaire design 
and validated. The discussions also involved experts in clinical chemistry department and the 
phlebotomy unit:  Phlebotomists, Medical Laboratory Assistants and Biomedical Scientists. Relevant 
literature and international guidelines regarding the development of questionnaires has also informed 
the design and content of the questionnaire.  
The return of a completed questionnaire (paper or electronic versions) will be taken as consent§ to 
participate in the study  
 
Data collected will be pooled to provide an overview of training and phlebotomy practices in STH and 
identify areas for improvement. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
§
This%proviso%has%been%included%in%the%questionnaire%to%satisfy%ethical%requirement.%
!!
APPENDIX V
 The%following%section%contains%questions%regarding%training%and%routine%procedures%in%
phlebotomy%practice.%
 
1b)%How%long%have%you%been%employed%in%your%current%unit?!!!!!!!!!!!!!!!!…….year(s)……..!month(s)!
!
2)%How%long%ago%was%your%most%recent%phlebotomy%training?!!
A)!5years! ?!!!!B)!4years!?!!!C)!3!years!?!!!!D)!2!years!?!!!!!!!!E)!!<!2!years!?!!!!!
!
3)%How%often%do%you%carry%out%venous%blood%sampling?%
!! ! A)!Every!workday!?! ! C)!Every!week!!!!!?!!
!! ! B)!Every!month!!?! ! D)!Less!often! !?! ! E)!Never!!!!?!!!!!!!!
!
4a)%Does%your%unit%have%documented%routines%for%the%handling%of%venous%blood%samples?%
!! A)! !Yes!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!B)! !No! C)! !Don’t!know!!
  
4b)%%Does%your%unit%have%undocumented%information%such%as%posters%regarding%common%sample%
requirements%and%the%order%of%draw%for%venous%blood%sampling?%%
! A)! !Yes!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!B)! !No! C)! !Don’t!know!!
!
5a)%Would%you%be%interested%in%receiving%further%training%in%phlebotomy%and%the%handling%of%blood%samples%
in%your%unit?%
! A)! !Yes!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!B)! !No! C)! !Don’t!know!! !!
!
5b)%Would%you%be%interested%in%receiving%information%about%blood%sampling%techniques?%
!!!!!!!A)! !Yes!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!B)! !No! ! ! C)! !Don’t!know!
%
The%following%questions%concern%patient%identification,%the%handling%of%test%requests%and%test%tube%labeling.!!
%%%(It%is%important%for%you%to%mark%one%alternative%for%each%row%in%the%following%section.)!
 
6)%How%often%and%how%do%you%check%patient%identification%when%collecting%blood%samples?%
 Always% Often% Seldom% Never%
a)!By!asking!the!patient!to!state!his/her!
name!and!surname!
A!  B!  C!  D!  
b)!Since!I!already!know!the!patient,!I!don’!t!
have!to!check!this!
A! ! B! ! C! ! D! !
c)!By!checking!the!identification!wristband! A! ! B! ! C! ! D! !
d)!By!asking!the!patient’s!family!
A! ! B! ! C! ! D! !
e)!By!checking!the!patient’s!health!care!
card!
A! ! B! ! C! ! D! !
f)!By!other!means!(please!state!below)!
!!!
%
7)%How%often%do%you%perform%the%following%tasks?%
! Always% Often% Seldom% Never%
a)!Compare!the!patient’s!name!and!Hospital!
number!with!the!information!on!the!test!request!
???! ???! ???! ???!
b)!Use!test!requests!that!somebody!else!has!
completed!
???! ???! ???! ???!
c)!Check!the!information!on!the!test!request,!if!
somebody!else!has!completed!it!
???! ???! ???! ???!
d)!Adjust!time!of!sampling!on!the!request,!if!the!
marked!time!differs!with!more!than!30!min!from!
the!actual!sampling!time?!
???! ???! ???! ???!
e)!Sign!the!test!request! ???! ???! ???! ???!
!
!
 8)%How%often%does%someone%else%mark%the%sampling%time%on%the%test%request?%
A)!Daily!?! B)!Weekly!?! C)!Monthly!?! D)!Occasionally!?! !E)!Never!?!
!
9)%When%do%you%mark%the%time%of%sampling%on%the%test%request,%if%you%do%it%yourself?%
I!never!mark!time!of!sampling! ???!
More!than!30!min!before!sampling! ???!
0W30!min!before!sampling! ???!
0W30!min!after!sampling! ???!
More!than!30!min!after!sampling! ???!
 
10)%When%or%where%do%you%label%the%test%tube?%
! Always% Often% Seldom% Never%
a)!Before!I!approach!the!patient! ???! ???! ???! ???!
b)!Alongside!the!patient,!immediately!before!
sampling!
???! ???! ???! ???!
c)!Alongside!the!patient,!immediately!after!sampling! ???! ???! ???! ???!
d)!At!a!later!occasion! ???! ???! ???! ???!
e)!A!different!person!labels!the!test!tube!before!
sampling!!
???!
!
???!
!
???!
!
???!
!
f)!A!different!person!labels!the!test!tube!after!
sampling!
???! ???! ???????! ???!
 
The%following%questions%concern%sampling,%sample%storage,%and%information%search%procedures.!
(It%is%important%that%you%mark%one%alternative%for%each%row%in%the%following%section.)!
!
11)%How%long%do%you%usually%allow%your%patient%to%rest%(supine%or%sitting)%prior%to%venous%blood%sampling?%
A)!Not!at!all!?! B)!0W5!min!?! C)!6W10!min!?! D)!11W15!min!?! E)!More!than!15!min!!!?!!
F)!I!do!not!check!the!time!!?!
%
12)%If%you%use%stasis%(tourniquet)%when%performing%venous%sampling,%when%do%you%remove%it?%
! Always% Often% Seldom% Never%
a)!Before!the!first!sample!is!collected! ???! ???! ???! ???!
b)!During!sampling! ???! ???! ???! ???!
c)!After!sampling!is!completed! ???! ???! ???! ???!
d)!I!keep!the!stasis!for!as!long!as!necessary!if!there!is!
difficulty!in!sampling.!
???! ???! ???! ???!
e)!Other!reasons!(please!state)!
!
!
%
13)%What%do%you%do%if%you%are%not%sure%of%how%a%sample%should%be%collected?!
! Always% Often% Seldom% Never%
a)!I!check!the!print!version!of!the!sample!handling!
manual!issued!in!the!laboratory!(available!in!the!
unit)!
???! ???! ???! ???!
b)!I!look!up!the!online!laboratory!handbook!
available!on!STH!intranet!
???! ???! ???! ???!
c)!I!call!the!clinical!chemistry!laboratory! ???! ???! ???! ???!
d)!I!ask!a!colleague!! ???! ???! ???! ???!
e)!By!other!means!(please!state)!
!
!!!!
%
%
 %
%
14)%How%often%do%you%carry%out%the%following%tasks?%
! Always% Often% Seldom% Never%
a)!Invert!each!test!tube!with!anticoagulants/!additives!
several!times!immediately!before!the!next!tube!is!
filled?!
???! ???! ???! ???!
b)!Use!an!automated!test!tube!inverter! ???! ???! ???! ???!
!
15)%How%do%you%store%the%test%tubes%immediately%after%sampling?%
! Always% Often% Seldom% Never%
a)!I!put!them!into!test!tube!racks!on!the!workbench! ???! ???! ???! ???!
b)!I!put!them!in!the!pocket!of!my!uniform! ???! ???! ???! ???!
c)!I!lay!them!on!the!work!bench!! ???! ???! ???! ???!
d)!I!keep!them!in!the!fridge! ???! ???! ???! ???!
e)!By!other!means!(please!state)!
!!!!!
!
!!!
!
These%final%questions%concern%error%(incident)%reporting,%ranking%and%suggestions%
!!(It%is%important%that%you%to%mark%one%alternative%for%each%row%in%the%following%section)!
!
16)%Approximately,%how%many%error%reports%have%you%filed%after%observing%or%making%an%error%in%venous%
blood%sampling?%
A!)!Number!of!times!(please!indicate)……………………………………………………………………!!!!!!!!!!!!
B!)!I!have!never!written!any!error!reports!! ! ?!
C!)!Another!member!of!staff!reports!on!my!behalf!! ?!
!
17)%If%you%have%refrained%from%filing%an%error%log/report:%What%was/were%the%reason/reasons?!!
%%%%%%%(Please%complete%the%questions%below%even%if%you%have%never%filed%any%report)%
! Always% Often% Seldom% Never%
a)!I!did!not!have!enough!time!! ???! ???! ???! ???!
b)!I!do!not!know!how!to!fill!an!error!log! ???! ???! ???! ???!
c)!I!am!not!bothered,!procedure!is!too!cumbersome! ???! ???! ???! ???!
d)!Nobody!else!fills!error!logs/report! ???! ???! ???! ???!
e)!The!section/unit!head!takes!responsibility!of!filling!
error!log/report!
???! ???! ???! ???!
f)!I!am!concerned!about!possible!consequences!(please!specify!below)!!
!
g)!Any!other!reason(s)!
%
18)% Do% you% have% any% suggestions% for% how% the% collection% and% handling% of% venous% blood% samples% could% be%
improved%in%your%unit/section?%
%
%
%
%
%
%
Thank%you%for%completing%the%questionnaire!%
Please%place%the%questionnaire%in%the%enclosed%anonymous%returning%envelope%
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ERROR$TYPE$1:$BROKECENTI$
$
 
       
         TIME ERROR TYPE 
       
 
BROKECENTI BROKECENTI 
  
Expected Values 
  Post- ICE 1 1615 1616 
 
2.2 1613.8 1616 
 Pre- ICE 4 2051 2055 
 
2.8 2052.2 2055 
 TOTAL SAMP 
ERR 5 3666 3671 
 
5 3666 3671 
 
         
         
     
chi-squared statistic = 1.172327451 
 
      
p-value =  0.278923528 
 
         
         Confidence Interval for Difference P3-P1, based on Normal approximation 
   
         
 
p1 = 0.062% 
 
s.e.(p1 - p3) = 0.001152404 
   
 
p3 = 0.195% 
      
         
 
Confidence 95% 
 
Lower limit -0.000931011 
   
    
Upper limit 0.003586331 
   
 
Difference 0.133% 
      
         
         
         Z-test for difference P3-P1 (two-sided), based on Normal approximation 
    
         
 
p = 0.001362027 
 
s.e.(p1 - p3) = 0.001226203 (based on null hypothesis) 
         
 
Z-statistic = 1.082740713 
      
 
p-value =  0.139461764 (one-tailed) 
    
  
0.278923528 (two-tailed) 
    
         $
!
!
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!
ERROR$TYPE$4:$ICEERROR$
$
Chi-squared test for 2x2 table 
      
        
TIME ERROR TYPE 
      
 
ICEERROR ICEERROR 
  
Expected Values 
 
Post- ICE 11 1605 1616 
 
4.8 1611.2 1616 
Pre- ICE 0 2055 2055 
 
6.2 2048.8 2055 
TOTAL SAMP ERR 11 3660 3671 
 
11 3660 3671 
        
        
     
chi-squared statistic = 14.03028374 
      
p-value =  0.00017989 
        
        
Confidence Interval for Difference P3-P1, based on Normal approximation 
  
        
 
p1 = 0.681% 
 
s.e.(p1 - p3) = 0.00204537 
  
 
p3 = 0.000% 
     
        
 
Confidence 95% 
 
Lower limit -0.010815782 
  
    
Upper limit -0.00279808 
  
 
Difference -0.681% 
     
        
        
        
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
   
        
 
p = 0.002996459 
 
s.e.(p1 - p3) = 0.001817264 (based on null hypothesis) 
        
 
Z-statistic = -3.745702036 
     
 
p-value =  0.999910055 (one-tailed) 
   
  
1.99982011 (two-tailed) 
   $      
     
     
ERROR$5:$ILLEGIBL$
$
Chi-squared test for 2x2 table 
      
        
TIME ERROR TYPE 
      
 
ILLEGIBL ILLEGIGBL 
  
Expected Values 
 
Post- ICE 1 1615 1616 
 
1.3 1614.7 1616 
Pre- ICE 2 2053 2055 
 
1.7 2053.3 2055 
TOTAL SAMP ERR 3 3668 3671 
 
3 3668 3671 
        
        
     
chi-squared statistic = 0.139166129 
      
p-value =  0.709111404 
        
        
Confidence Interval for Difference P3-P1, based on Normal approximation 
  
        
 
p1 = 0.062% 
 
s.e.(p1 - p3) = 0.000925108 
  
 
p3 = 0.097% 
     
        
 
Confidence 95% 
 
Lower limit -0.001458754 
  
    
Upper limit 0.002167602 
  
 
Difference 0.035% 
     
        
        
        
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
   
        
 
p = 0.000817216 
 
s.e.(p1 - p3) = 0.000950072 (based on null hypothesis) 
        
 
Z-statistic = 0.373049767 
     
 
p-value =  0.354555702 (one-tailed) 
   
  
0.709111404 (two-tailed) 
   $      
     
     
     
ERROR$$6:$INCOMPL$
$
Chi-squared test for 2x2 table 
      
        
TIME ERROR TYPE 
      
 
INCOMPL INCOMPL 
  
Expected Values 
 
Post- ICE 129 1487 1616 
 
138.7 1477.3 1616 
Pre- ICE 186 1869 2055 
 
176.3 1878.7 2055 
TOTAL SAMP ERR 315 3356 3671 
 
315 3356 3671 
        
        
     
chi-squared statistic = 1.316407655 
      
p-value =  0.251237783 
        
        
Confidence Interval for Difference P3-P1, based on Normal approximation 
  
        
 
p1 = 7.983% 
 
s.e.(p1 - p3) = 0.009247283 
  
 
p3 = 9.051% 
     
        
 
Confidence 95% 
 
Lower limit -0.007440125 
  
    
Upper limit 0.028808558 
  
 
Difference 1.068% 
     
        
        
        
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
   
        
 
p = 0.085807682 
 
s.e.(p1 - p3) = 0.009312097 (based on null hypothesis) 
        
 
Z-statistic = 1.147348097 
     
 
p-value =  0.125618892 (one-tailed) 
   
  
0.251237783 (two-tailed) 
   $      
     
     
     
ERROR$7:$INCORPAT$
$
Chi-squared test for 2x2 table 
      
        
PERIOD ERROR TYPE 
      
 
INCORPAT INCORPAT 
  
Expected Values 
 
Post- ICE 49 1567 1616 
 
114.9 1501.1 1616 
Pre- ICE 212 1843 2055 
 
146.1 1908.9 2055 
TOTAL SAMP ERR 261 3410 3671 
 
261 3410 3671 
        
        
     
chi-squared statistic = #NUM! 
      
p-value =  1.527E-17 
        
        
Confidence Interval for Difference P3-P1, based on Normal approximation 
  
        
 
p1 = 3.032% 
 
s.e.(p1 - p3) = 0.007950889 
  
 
p3 = 10.316% 
     
        
 
Confidence 95% 
 
Lower limit 0.057257779 
  
    
Upper limit 0.088424691 
  
 
Difference 7.284% 
     
        
        
        
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
   
        
 
p = 0.071097794 
 
s.e.(p1 - p3) = 0.008544343 (based on null hypothesis) 
        
 
Z-statistic = 8.525083473 
     
 
p-value =  0 (one-tailed) 
   
  
0 (two-tailed) 
   $      
     
     
 
     
    
ERROR$8:$INCORSAM$
$
Chi-squared test for 2x2 table 
      
        
TIME ERROR TYPE 
      
 
INCORSAM INCORSAM 
  
Expected Values 
 
Post- ICE 167 1449 1616 
 
148.8 1467.2 1616 
Pre- ICE 171 1884 2055 
 
189.2 1865.8 2055 
TOTAL SAMP ERR 338 3333 3671 
 
338 3333 3671 
        
        
     
chi-squared statistic = 4.384994146 
      
p-value =  0.036256617 
        
        
Confidence Interval for Difference P3-P1, based on Normal approximation 
  
        
 
p1 = 10.334% 
 
s.e.(p1 - p3) = 0.009719222 
  
 
p3 = 8.321% 
     
        
 
Confidence 95% 
 
Lower limit -0.039179231 
  
    
Upper limit -0.00108058 
  
 
Difference -2.013% 
     
        
        
        
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
   
        
 
p = 0.092073005 
 
s.e.(p1 - p3) = 0.009612962 (based on null hypothesis) 
        
 
Z-statistic = -2.094037761 
     
 
p-value =  0.981871692 (one-tailed) 
   
  
1.963743383 (two-tailed) 
   $      
     
    
    
ERROR$$9:$INSUFF$
$
Chi-squared test for 2x2 table 
      
        
TIME ERROR TYPE 
      
 
INSUFF INSUFF 
  
Expected Values 
 
Post- ICE 97 1519 1616 
 
86.3 1529.7 1616 
Pre- ICE 99 1956 2055 
 
109.7 1945.3 2055 
TOTAL SAMP ERR 196 3475 3671 
 
196 3475 3671 
        
        
     
chi-squared statistic = 2.513227876 
      
p-value =  0.11289448 
        
        
Confidence Interval for Difference P3-P1, based on Normal approximation 
  
        
 
p1 = 6.002% 
 
s.e.(p1 - p3) = 0.00756492 
  
 
p3 = 4.818% 
     
        
 
Confidence 95% 
 
Lower limit -0.026676541 
  
    
Upper limit 0.002977401 
  
 
Difference -1.185% 
     
        
        
        
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
   
        
 
p = 0.053391446 
 
s.e.(p1 - p3) = 0.007474578 (based on null hypothesis) 
        
 
Z-statistic = -1.585316333 
     
 
p-value =  0.94355276 (one-tailed) 
   
  
1.88710552 (two-tailed) 
   $
 
    
     
     
ERROR$10:$LABERRO$
Chi-squared test for 2x2 table 
      
        
TIME ERROR TYPE 
      
 
LABERRO LABERROR 
  
Expected Values 
 
Post- ICE 18 1598 1616 
 
19.4 1596.6 1616 
Pre- ICE 26 2029 2055 
 
24.6 2030.4 2055 
TOTAL SAMP ERR 44 3627 3671 
 
44 3627 3671 
        
        
     
chi-squared statistic = 0.174974974 
      
p-value =  0.675727716 
        
        
Confidence Interval for Difference P3-P1, based on Normal approximation 
  
        
 
p1 = 1.114% 
 
s.e.(p1 - p3) = 0.003590927 
  
 
p3 = 1.265% 
     
        
 
Confidence 95% 
 
Lower limit -0.005524634 
  
    
Upper limit 0.008551543 
  
 
Difference 0.151% 
     
        
        
        
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
   
        
 
p = 0.011985835 
 
s.e.(p1 - p3) = 0.003618106 (based on null hypothesis) 
        
 
Z-statistic = 0.418300101 
     
 
p-value =  0.337863858 (one-tailed) 
   
  
0.675727716 (two-tailed) 
   $ !
!ERROR!11:!LEAKTRANS!
!
Chi-squared test for 2x2 table 
      
        
TIME ERROR TYPE 
      
 
LEAKTRANS LEAKTRANS 
  
Expected Values 
 
Post- ICE 7 1609 1616 
 
18.5 1597.5 1616 
Pre- ICE 35 2020 2055 
 
23.5 2031.5 2055 
TOTAL SAMP ERR 42 3629 3671 
 
42 3629 3671 
        
        
     
chi-squared statistic = 12.9004579 
      
p-value =  0.000328502 
        
        
Confidence Interval for Difference P3-P1, based on Normal approximation 
  
        
 
p1 = 0.433% 
 
s.e.(p1 - p3) = 0.003288712 
  
 
p3 = 1.703% 
     
        
 
Confidence 95% 
 
Lower limit 0.00625419 
  
    
Upper limit 0.019145704 
  
 
Difference 1.270% 
     
        
        
        
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
   
        
 
p = 0.011441024 
 
s.e.(p1 - p3) = 0.003535895 (based on null hypothesis) 
        
 
Z-statistic = 3.591720744 
     
 
p-value =  0.000164251 (one-tailed) 
   
  
0.000328502 (two-tailed) 
   ! !
ERROR$12:$LOST$$
Chi-squared test for 2x2 table 
      
        
TIME ERROR TYPE 
      
 
LOST LOST 
  
Expected Values 
 
Post- ICE 9 1607 1616 
 
10.6 1605.4 1616 
Pre- ICE 15 2040 2055 
 
13.4 2041.6 2055 
TOTAL SAMP ERR 24 3647 3671 
 
24 3647 3671 
        
        
     
chi-squared statistic = 0.416835082 
      
p-value =  0.518520517 
        
        
Confidence Interval for Difference P3-P1, based on Normal approximation 
  
        
 
p1 = 0.557% 
 
s.e.(p1 - p3) = 0.00263689 
  
 
p3 = 0.730% 
     
        
 
Confidence 95% 
 
Lower limit -0.003438246 
  
    
Upper limit 0.006898173 
  
 
Difference 0.173% 
     
        
        
        
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
   
        
 
p = 0.006537728 
 
s.e.(p1 - p3) = 0.002679506 (based on null hypothesis) 
        
 
Z-statistic = 0.645627665 
     
 
p-value =  0.259260258 (one-tailed) 
   
  
0.518520517 (two-tailed) 
   $
$
$
$
$
$
$ !
ERROR$13:$NOEDTA$
Chi-squared test for 2x2 table 
      
        
TIME ERROR TYPE 
      
 
NOEDTA NOEDTA 
  
Expected Values 
 
Post- ICE 159 1457 1616 
 
143.9 1472.1 1616 
Pre- ICE 168 1887 2055 
 
183.1 1871.9 2055 
TOTAL SAMP ERR 327 3344 3671 
 
327 3344 3671 
        
        
     
chi-squared statistic = 3.086681263 
      
p-value =  0.078935649 
        
        
Confidence Interval for Difference P3-P1, based on Normal approximation 
  
        
 
p1 = 9.839% 
 
s.e.(p1 - p3) = 0.009561623 
  
 
p3 = 8.175% 
     
        
 
Confidence 95% 
 
Lower limit -0.035379702 
  
    
Upper limit 0.002101173 
  
 
Difference -1.664% 
     
        
        
        
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
   
        
 
p = 0.089076546 
 
s.e.(p1 - p3) = 0.009470834 (based on null hypothesis) 
        
 
Z-statistic = -1.756895348 
     
 
p-value =  0.960532176 (one-tailed) 
   
  
1.921064351 (two-tailed) 
   $ !
ERROR$14:$NOFLOX$
$
Chi-squared test for 2x2 table 
      
        
TIME ERROR TYPE 
      
 
NOFLOX NOFLOX 
  
Expected Values 
 
Post- ICE 30 1586 1616 
 
51.5 1564.5 1616 
Pre- ICE 87 1968 2055 
 
65.5 1989.5 2055 
TOTAL SAMP ERR 117 3554 3671 
 
117 3554 3671 
        
        
     
chi-squared statistic = 16.56701124 
      
p-value =  4.69608E-05 
        
        
Confidence Interval for Difference P3-P1, based on Normal approximation 
  
        
 
p1 = 1.856% 
 
s.e.(p1 - p3) = 0.005568101 
  
 
p3 = 4.234% 
     
        
 
Confidence 95% 
 
Lower limit 0.012858132 
  
    
Upper limit 0.034684688 
  
 
Difference 2.377% 
     
        
        
        
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
   
        
 
p = 0.031871425 
 
s.e.(p1 - p3) = 0.005840269 (based on null hypothesis) 
        
 
Z-statistic = 4.070259357 
     
 
p-value =  2.34804E-05 (one-tailed) 
   
  
4.69608E-05 (two-tailed) 
   $ !
ERROR$15:$NOICE$
$
Chi-squared test for 2x2 table 
      
        
TIME ERROR TYPE 
      
 
NOICE NOICE 
  
Expected Values 
 
Post- ICE 27 1589 1616 
 
19.4 1596.6 1616 
Pre- ICE 17 2038 2055 
 
24.6 2030.4 2055 
TOTAL SAMP ERR 44 3627 3671 
 
44 3627 3671 
        
        
     
chi-squared statistic = 5.435634073 
      
p-value =  0.019729926 
        
        
Confidence Interval for Difference P3-P1, based on Normal approximation 
  
        
 
p1 = 1.671% 
 
s.e.(p1 - p3) = 0.003762787 
  
 
p3 = 0.827% 
     
        
 
Confidence 95% 
 
Lower limit -0.015810341 
  
    
Upper limit -0.001060488 
  
 
Difference -0.844% 
     
        
        
        
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
   
        
 
p = 0.011985835 
 
s.e.(p1 - p3) = 0.003618106 (based on null hypothesis) 
        
 
Z-statistic = -2.331444632 
     
 
p-value =  0.990135037 (one-tailed) 
   
  
1.980270074 (two-tailed) 
   $ !
ERROR$16:$NOSAMP$
$
$
$
$
Chi-squared test for 2x2 table 
      
        
TIME ERROR TYPE 
      
 
NOSAMP NOSAMP 
  
Expected Values 
 
Post- ICE 233 1383 1616 
 
228.9 1387.1 1616 
Pre- ICE 287 1768 2055 
 
291.1 1763.9 2055 
TOTAL SAMP ERR 520 3151 3671 
 
520 3151 3671 
        
        
     
chi-squared statistic = 0.152262442 
      
p-value =  0.696382596 
        
        
Confidence Interval for Difference P3-P1, based on Normal approximation 
  
        
 
p1 = 14.418% 
 
s.e.(p1 - p3) = 0.011611516 
  
 
p3 = 13.966% 
     
        
 
Confidence 95% 
 
Lower limit -0.027281955 
  
    
Upper limit 0.018234353 
  
 
Difference -0.452% 
     
        
        
        
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
   
        
 
p = 0.141650776 
 
s.e.(p1 - p3) = 0.0115933 (based on null hypothesis) 
        
 
Z-statistic = -0.390208203 
     
 
p-value =  0.651808702 (one-tailed) 
   
  
1.303617404 (two-tailed) 
   $ !
ERROR$17:$OLDSAMP$
$
Chi-squared test for 2x2 table 
      
        
TIME ERROR TYPE 
      
 
OLDSAMP OLDSAMP 
  
Expected Values 
 
Post- ICE 36 1580 1616 
 
26.9 1589.1 1616 
Pre- ICE 25 2030 2055 
 
34.1 2020.9 2055 
TOTAL SAMP ERR 61 3610 3671 
 
61 3610 3671 
        
        
     
chi-squared statistic = 5.660509825 
      
p-value =  0.017351079 
        
        
Confidence Interval for Difference P3-P1, based on Normal approximation 
  
        
 
p1 = 2.228% 
 
s.e.(p1 - p3) = 0.00439616 
  
 
p3 = 1.217% 
     
        
 
Confidence 95% 
 
Lower limit -0.018728092 
  
    
Upper limit -0.001495463 
  
 
Difference -1.011% 
     
        
        
        
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
   
        
 
p = 0.016616726 
 
s.e.(p1 - p3) = 0.004250106 (based on null hypothesis) 
        
 
Z-statistic = -2.379182596 
     
 
p-value =  0.991324461 (one-tailed) 
   
  
1.982648921 (two-tailed) 
   $ !
ERROR$18:$SAMCLOT$
$
Chi-squared test for 2x2 table 
      
        
TIME ERROR TYPE 
      
 
SAMCLOT SAMCLOT 
  
Expected Values 
 
Post- ICE 6 1610 1616 
 
5.3 1610.7 1616 
Pre- ICE 6 2049 2055 
 
6.7 2048.3 2055 
TOTAL SAMP ERR 12 3659 3671 
 
12 3659 3671 
        
        
     
chi-squared statistic = 0.174670309 
      
p-value =  0.675994078 
        
        
Confidence Interval for Difference P3-P1, based on Normal approximation 
  
        
 
p1 = 0.371% 
 
s.e.(p1 - p3) = 0.001925012 
  
 
p3 = 0.292% 
     
        
 
Confidence 95% 
 
Lower limit -0.004566118 
  
    
Upper limit 0.002979792 
  
 
Difference -0.079% 
     
        
        
        
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
   
        
 
p = 0.003268864 
 
s.e.(p1 - p3) = 0.001897811 (based on null hypothesis) 
        
 
Z-statistic = -0.417935771 
     
 
p-value =  0.662002961 (one-tailed) 
   
  
1.324005922 (two-tailed) 
   $ !
ERROR$19:$SAMCONT$
$
Chi-squared test for 2x2 table 
      
        
TIME ERROR TYPE 
      
 
SAMCONT SAMCONT 
  
Expected Values 
 
Post- ICE 28 1588 1616 
 
22.9 1593.1 1616 
Pre- ICE 24 2031 2055 
 
29.1 2025.9 2055 
TOTAL SAMP ERR 52 3619 3671 
 
52 3619 3671 
        
        
     
chi-squared statistic = 2.066425361 
      
p-value =  0.150574085 
        
        
Confidence Interval for Difference P3-P1, based on Normal approximation 
  
        
 
p1 = 1.733% 
 
s.e.(p1 - p3) = 0.004019076 
  
 
p3 = 1.168% 
     
        
 
Confidence 95% 
 
Lower limit -0.013525144 
  
    
Upper limit 0.002229343 
  
 
Difference -0.565% 
     
        
        
        
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
   
        
 
p = 0.014165078 
 
s.e.(p1 - p3) = 0.003928956 (based on null hypothesis) 
        
 
Z-statistic = -1.437506647 
     
 
p-value =  0.924712957 (one-tailed) 
   
  
1.849425915 (two-tailed) 
   $ !
ERROR$20:$SINTEG$$$
Chi-squared test for 2x2 table 
       
         
TIME ERROR TYPE 
       
 
SINTEG SINTEG 
  
Expected Values 
  
Post- ICE 7 1609 1616 
 
4.4 1611.6 1616 
 
Pre- ICE 3 2052 2055 
 
5.6 2049.4 2055 
 
TOTAL SAMP ERR 10 3661 3671 
 
10 3661 3671 
 
         
         
     
chi-squared statistic = 2.746344653 
 
      
p-value =  0.097477046 
 
         
         
Confidence Interval for Difference P3-P1, based on Normal approximation 
   
         
 
p1 = 0.433% 
 
s.e.(p1 - p3) = 0.001837999 
   
 
p3 = 0.146% 
      
         
 
Confidence 95% 
 
Lower limit -0.006474241 
   
    
Upper limit 0.000730583 
   
 
Difference -0.287% 
      
         
         
         
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
    
         
 
p = 0.002724053 
 
s.e.(p1 - p3) = 0.00173293 (based on null hypothesis) 
         
 
Z-statistic = -1.6572099 
      
 
p-value =  0.951261477 (one-tailed) 
    
  
1.902522954 (two-tailed) 
    $ !
ERROR 21: SWAPDET 
Chi-squared test for 2x2 table 
      
        
TIME ERROR TYPE 
      
 
SWAPDET SWAPDET 
  
Expected Values 
 
Post- ICE 32 1584 1616 
 
34.8 1581.2 1616 
Pre- ICE 47 2008 2055 
 
44.2 2010.8 2055 
TOTAL SAMP ERR 79 3592 3671 
 
79 3592 3671 
        
        
     
chi-squared statistic = 0.404656585 
      
p-value =  0.524694148 
        
        
Confidence Interval for Difference P3-P1, based on Normal approximation 
  
        
 
p1 = 1.980% 
 
s.e.(p1 - p3) = 0.004783929 
  
 
p3 = 2.287% 
     
        
 
Confidence 95% 
 
Lower limit -0.006307262 
  
    
Upper limit 0.012445394 
  
 
Difference 0.307% 
     
        
        
        
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
   
        
 
p = 0.021520022 
 
s.e.(p1 - p3) = 0.004824618 (based on null hypothesis) 
        
 
Z-statistic = 0.636126234 
     
 
p-value =  0.262347074 (one-tailed) 
   
  
0.524694148 (two-tailed) 
   
! !
ERROR 22: TESTNAV 
Chi-squared test for 2x2 table 
      
        
TIME ERROR TYPE 
      
 
TESTNAV TESTNAV 
  
Expected Values 
 
Post- ICE 31 1585 1616 
 
26.9 1589.1 1616 
Pre- ICE 30 2025 2055 
 
34.1 2020.9 2055 
TOTAL SAMP ERR 61 3610 3671 
 
61 3610 3671 
        
        
     
chi-squared statistic = 1.163613544 
      
p-value =  0.280717382 
        
        
Confidence Interval for Difference P3-P1, based on Normal approximation 
  
        
 
p1 = 1.918% 
 
s.e.(p1 - p3) = 0.004317784 
  
 
p3 = 1.460% 
     
        
 
Confidence 95% 
 
Lower limit -0.013047329 
  
    
Upper limit 0.003878073 
  
 
Difference -0.458% 
     
        
        
        
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
   
        
 
p = 0.016616726 
 
s.e.(p1 - p3) = 0.004250106 (based on null hypothesis) 
        
 
Z-statistic = -1.078709203 
     
 
p-value =  0.859641309 (one-tailed) 
   
  
1.719282618 (two-tailed) 
   
! !
ERROR 23: TIMEDEL 
 
Chi-squared test for 2x2 table 
      
        
TIME ERROR TYPE 
      
 
TIMEDEL TIMEDEL 
  
Expected Values 
 
Post- ICE 8 1608 1616 
 
3.5 1612.5 1616 
Pre- ICE 0 2055 2055 
 
4.5 2050.5 2055 
TOTAL SAMP ERR 8 3663 3671 
 
8 3663 3671 
        
        
     
chi-squared statistic = 10.19548576 
      
p-value =  0.001407849 
        
        
Confidence Interval for Difference P3-P1, based on Normal approximation 
  
        
 
p1 = 0.495% 
 
s.e.(p1 - p3) = 0.001745927 
  
 
p3 = 0.000% 
     
        
 
Confidence 95% 
 
Lower limit -0.008372448 
  
    
Upper limit -0.001528542 
  
 
Difference -0.495% 
     
        
        
        
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
   
        
 
p = 0.002179243 
 
s.e.(p1 - p3) = 0.001550403 (based on null hypothesis) 
        
 
Z-statistic = -3.193037075 
     
 
p-value =  0.999296076 (one-tailed) 
   
  
1.998592151 (two-tailed) 
   
! !
ERROR 24: UNCODED 
Chi-squared test for 2x2 table 
      
        
TIME ERROR TYPE 
      
 
UNCODED UNCODED 
  
Expected Values 
 
Post- ICE 63 1553 1616 
 
64.3 1551.7 1616 
Pre- ICE 83 1972 2055 
 
81.7 1973.3 2055 
TOTAL SAMP ERR 146 3525 3671 
 
146 3525 3671 
        
        
     
chi-squared statistic = 0.046703567 
      
p-value =  0.828901941 
        
        
Confidence Interval for Difference P3-P1, based on Normal approximation 
  
        
 
p1 = 3.899% 
 
s.e.(p1 - p3) = 0.006484159 
  
 
p3 = 4.039% 
     
        
 
Confidence 95% 
 
Lower limit -0.011304572 
  
    
Upper limit 0.014112864 
  
 
Difference 0.140% 
     
        
        
        
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
   
        
 
p = 0.03977118 
 
s.e.(p1 - p3) = 0.006497364 (based on null hypothesis) 
        
 
Z-statistic = 0.216110082 
     
 
p-value =  0.414450971 (one-tailed) 
   
  
0.828901941 (two-tailed) 
   
!
 
ERROR 25: UNLABL 
Chi-squared test for 2x2 table 
      
        
TIME ERROR TYPE 
      
 
UNLABL UNLABL 
  
Expected Values 
 
Post- ICE 300 1316 1616 
 
320.0 1296.0 1616 
Pre- ICE 427 1628 2055 
 
407.0 1648.0 2055 
TOTAL SAMP ERR 727 2944 3671 
 
727 2944 3671 
        
        
     
chi-squared statistic = 2.792619347 
      
p-value =  0.094699319 
        
        
Confidence Interval for Difference P3-P1, based on Normal approximation 
  
        
 
p1 = 18.564% 
 
s.e.(p1 - p3) = 0.013177808 
  
 
p3 = 20.779% 
     
        
 
Confidence 95% 
 
Lower limit -0.003685706 
  
    
Upper limit 0.047970354 
  
 
Difference 2.214% 
     
        
        
        
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
   
        
 
p = 0.198038682 
 
s.e.(p1 - p3) = 0.013250044 (based on null hypothesis) 
        
 
Z-statistic = 1.671113206 
     
 
p-value =  0.04734966 (one-tailed) 
   
  
0.094699319 (two-tailed) 
   
!
 
ERROR 26: UNREQ 
Chi-squared test for 2x2 table 
      
        
TIME ERROR TYPE 
      
 
UNREQ UNREQ 
  
Expected Values 
 
Post- ICE 57 1559 1616 
 
30.8 1585.2 1616 
Pre- ICE 13 2042 2055 
 
39.2 2015.8 2055 
TOTAL SAMP ERR 70 3601 3671 
 
70 3601 3671 
        
        
     
chi-squared statistic = 40.52292805 
      
p-value =  1.94322E-10 
        
        
Confidence Interval for Difference P3-P1, based on Normal approximation 
  
        
 
p1 = 3.527% 
 
s.e.(p1 - p3) = 0.004910795 
  
 
p3 = 0.633% 
     
        
 
Confidence 95% 
 
Lower limit -0.038571225 
  
    
Upper limit -0.019321262 
  
 
Difference -2.895% 
     
        
        
        
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
   
        
 
p = 0.019068374 
 
s.e.(p1 - p3) = 0.004547176 (based on null hypothesis) 
        
 
Z-statistic = -6.36576217 
     
 
p-value =  1 (one-tailed) 
   
  
2 (two-tailed) 
   
!
 
ERROR 27: WRCONT 
Chi-squared test for 2x2 table 
      
        
TIME ERROR TYPE 
      
 
WRCONT WRCONT 
  
Expected Values 
 
Post- ICE 35 1581 1616 
 
19.8 1596.2 1616 
Pre- ICE 10 2045 2055 
 
25.2 2029.8 2055 
TOTAL SAMP ERR 45 3626 3671 
 
45 3626 3671 
        
        
     
chi-squared statistic = 21.067563 
      
p-value =  4.4337E-06 
        
        
Confidence Interval for Difference P3-P1, based on Normal approximation 
  
        
 
p1 = 2.166% 
 
s.e.(p1 - p3) = 0.003933021 
  
 
p3 = 0.487% 
     
        
 
Confidence 95% 
 
Lower limit -0.024500816 
  
    
Upper limit -0.009083656 
  
 
Difference -1.679% 
     
        
        
        
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
   
        
 
p = 0.01225824 
 
s.e.(p1 - p3) = 0.003658486 (based on null hypothesis) 
        
 
Z-statistic = -4.589941503 
     
 
p-value =  0.999997783 (one-tailed) 
   
  
1.999995566 (two-tailed) 
   
!
 
ERROR 28: WRPRES 
Chi-squared test for 2x2 table 
      
        
TIME ERROR TYPE 
      
 
WRPRES WRPRES 
  
Expected Values 
 
Post- ICE 36 1580 1616 
 
22.9 1593.1 1616 
Pre- ICE 16 2039 2055 
 
29.1 2025.9 2055 
TOTAL SAMP ERR 52 3619 3671 
 
52 3619 3671 
        
        
     
chi-squared statistic = 13.60387746 
      
p-value =  0.000225719 
        
        
Confidence Interval for Difference P3-P1, based on Normal approximation 
  
        
 
p1 = 2.228% 
 
s.e.(p1 - p3) = 0.004151815 
  
 
p3 = 0.779% 
     
        
 
Confidence 95% 
 
Lower limit -0.022628747 
  
    
Upper limit -0.006353932 
  
 
Difference -1.449% 
     
        
        
        
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
   
        
 
p = 0.014165078 
 
s.e.(p1 - p3) = 0.003928956 (based on null hypothesis) 
        
 
Z-statistic = -3.688343458 
     
 
p-value =  0.999887141 (one-tailed) 
   
  
1.999774281 (two-tailed) 
   
!
 
ERROR 29: WRTEST 
Chi-squared test for 2x2 table 
      
        
TIME ERROR TYPE 
      
 
WRTEST WRTEST 
  
Expected Values 
 
Post- ICE 0 1616 1616 
 
1.3 1614.7 1616 
Pre- ICE 3 2052 2055 
 
1.7 2053.3 2055 
TOTAL SAMP ERR 3 3668 3671 
 
3 3668 3671 
        
        
     
chi-squared statistic = 2.361053578 
      
p-value =  0.124398148 
        
        
Confidence Interval for Difference P3-P1, based on Normal approximation 
  
        
 
p1 = 0.000% 
 
s.e.(p1 - p3) = 0.000842232 
  
 
p3 = 0.146% 
     
        
 
Confidence 95% 
 
Lower limit -0.00019089 
  
    
Upper limit 0.003110598 
  
 
Difference 0.146% 
     
        
        
        
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
   
        
 
p = 0.000817216 
 
s.e.(p1 - p3) = 0.000950072 (based on null hypothesis) 
        
 
Z-statistic = 1.536572022 
     
 
p-value =  0.062199074 (one-tailed) 
   
  
0.124398148 (two-tailed) 
    
  
ERROR 30: EXAIR 
Chi-squared test for 2x2 table 
      
        
TIME ERROR TYPE 
      
 
EXAIR EXAIR 
  
Expected Values 
 
Post- ICE 0 1616 1616 
 
0.9 1615.1 1616 
Pre- ICE 2 2053 2055 
 
1.1 2053.9 2055 
TOTAL SAMP ERR 2 3669 3671 
 
2 3669 3671 
        
        
     
chi-squared statistic = 1.573606709 
      
p-value =  0.209684004 
        
        
Confidence Interval for Difference P3-P1, based on Normal approximation 
  
        
 
p1 = 0.000% 
 
s.e.(p1 - p3) = 0.000687847 
  
 
p3 = 0.097% 
     
        
 
Confidence 95% 
 
Lower limit -0.000374919 
  
    
Upper limit 0.002321391 
  
 
Difference 0.097% 
     
        
        
        
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
   
        
 
p = 0.000544811 
 
s.e.(p1 - p3) = 0.000775836 (based on null hypothesis) 
        
 
Z-statistic = 1.254434817 
     
 
p-value =  0.104842002 (one-tailed) 
   
  
0.209684004 (two-tailed) 
   
!
 
ERROR 31: EXMATCH 
Chi-squared test for 2x2 table 
      
        
TIME ERROR TYPE 
      
 
EXMATCH EXMATCH 
  
Expected Values 
 
Post- ICE 0 1616 1616 
 
0.4 1615.6 1616 
Pre- ICE 1 2054 2055 
 
0.6 2054.4 2055 
TOTAL SAMP ERR 1 3670 3671 
 
1 3670 3671 
        
        
     
chi-squared statistic = 0.786588967 
      
p-value =  0.375133544 
        
        
Confidence Interval for Difference P3-P1, based on Normal approximation 
  
        
 
p1 = 0.000% 
 
s.e.(p1 - p3) = 0.0004865 
  
 
p3 = 0.049% 
     
        
 
Confidence 95% 
 
Lower limit -0.000466904 
  
    
Upper limit 0.00144014 
  
 
Difference 0.049% 
     
        
        
        
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
   
        
 
p = 0.000272405 
 
s.e.(p1 - p3) = 0.000548674 (based on null hypothesis) 
        
 
Z-statistic = 0.88689851 
     
 
p-value =  0.187566772 (one-tailed) 
   
  
0.375133544 (two-tailed) 
   
!
 
ERROR 32: EXTIME 
Chi-squared test for 2x2 table 
        
          
TIME ERROR TYPE 
        
 
EXTIME EXTIME 
  
Expected Values 
   
Post- ICE 0 1616 1616 
 
0.4 1615.6 1616 
  
Pre- ICE 1 2054 2055 
 
0.6 2054.4 2055 
  
TOTAL SAMP ERR 1 3670 3671 
 
1 3670 3671 
  
          
          
     
chi-squared statistic = 0.786588967 
  
      
p-value =  0.375133544 
  
          
          
Confidence Interval for Difference P3-P1, based on Normal approximation 
    
          
 
p1 = 0.000% 
 
s.e.(p1 - p3) = 0.0004865 
    
 
p3 = 0.049% 
       
          
 
Confidence 95% 
 
Lower limit -0.000466904 
    
    
Upper limit 0.00144014 
    
 
Difference 0.049% 
       
          
          
          
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
     
          
 
p = 0.000272405 
 
s.e.(p1 - p3) = 0.000548674 (based on null hypothesis) 
 
          
 
Z-statistic = 0.88689851 
       
 
p-value =  0.187566772 (one-tailed) 
     
  
0.375133544 (two-tailed) 
     
!
 
ERROR 33: NOPRESV 
Chi-squared test for 2x2 table 
      
        
TIME ERROR TYPE 
      
 
NOPRESV NOPRESV 
  
Expected Values 
 
Post- ICE 0 1616 1616 
 
3.5 1612.5 1616 
Pre- ICE 8 2047 2055 
 
4.5 2050.5 2055 
TOTAL SAMP ERR 8 3663 3671 
 
8 3663 3671 
        
        
     
chi-squared statistic = 6.304737119 
      
p-value =  0.012041577 
        
        
Confidence Interval for Difference P3-P1, based on Normal approximation 
  
        
 
p1 = 0.000% 
 
s.e.(p1 - p3) = 0.001373682 
  
 
p3 = 0.389% 
     
        
 
Confidence 95% 
 
Lower limit 0.001200577 
  
    
Upper limit 0.006585311 
  
 
Difference 0.389% 
     
        
        
        
Z-test for difference P3-P1 (two-sided), based on Normal approximation 
   
        
 
p = 0.002179243 
 
s.e.(p1 - p3) = 0.001550403 (based on null hypothesis) 
        
 
Z-statistic = 2.510923559 
     
 
p-value =  0.006020788 (one-tailed) 
   
  
0.012041577 (two-tailed) 
     
Chi-squared test for 2x2 table 
     
        TIME ERROR TYPE 
     
 
UNLABL UNLABL 
  
Expected Values 
 Post- ICE 300 903514 903814 
 
497.6 903316.4 903814 
Pre- ICE 427 416276 416703 
 
229.4 416473.6 416703 
TOTAL SAMP ERR 727 1319790 1320517 
 
727 1319790 1320517 
        
        
     
chi-squared statistic = #NUM! 
      
p-value =  4.80381E-56 
        
        Confidence Interval for Difference P3-P1, based on Normal approximation 
 
        
 
p1 = 0.033% 
 
s.e.(p1 - p3) = 5.31385E-05 
  
 
p3 = 0.102% 
     
        
 
Confidence 95% 
 
Lower limit 0.000588634 
  
    
Upper limit 0.000796933 
  
 
Difference 0.069% 
     
        
        
        Z-test for difference P3-P1 (two-sided), based on Normal approximation 
  
        
 
p = 0.000550542 
 
s.e.(p1 - p3) = 4.39233E-05 (based on null hypothesis) 




APPENDIX IX 
 
LABORATORY INCIDENT / ACCIDENT / UNTOWARD OCCURRENCE 
INVESTIGATION 
 
Date of Incident 
 
NGH – RHH (Delete as required) 
Date of Investigation Time Sample ID 
Patient / Employee/Other Details (Where relevant) Patient No. 
Name  Inpatient / Out patient (Delete as required) 
Address DOB 
 
Job Title (Staff only) 
Nature of the incident / how was the incident discovered  
 
 
 
 
 
 
 
 
 
 
Corrective Action / how was the incident resolved  
Procedural Change (Y/N) Actioned By Date 
Outcome for patient /Comments/Preventative action 
Reported by  Signed off by 
 
Clinical impact on patient    yes / no     
If yes specify  
1"YEARS"IN"EMPLOYMENT"rwn 2"YEARS"IN"TRAINNING 3"FREQ"OF"VENEPUCTURE 4A"DOCUMENTED"ROUTINES
1 1 EVERY&WEEK DON'T&KNOW
1 1 EVERY&WORKDAY YES
1 1 EVERY&WEEK YES
1 1 EVERY&WORKDAY YES
1 1 EVERY&WEEK YES
1 1 EVERY&WORKDAY YES
3 1 EVERY&MONTH DON'T&KNOW
3 3 EVERY&WORKDAY YES
3 2 EVERY&WEEK YES
3 1 EVERY&WEEK DON'T&KNOW
4 3 EVERY&WORKDAY YES
4 1 EVERY&WORKDAY YES
4 1 EVERY&WEEK YES
4 3 EVERY&WORKDAY YES
4 2 EVERY&WORKDAY YES
4 1 EVERY&WEEK YES
5 1 EVERY&WORKDAY YES
5 5 EVERY&MONTH DON'T&KNOW
5 3 EVERY&WORKDAY YES
5 1 EVERY&WEEK YES
5 3 EVERY&WORKDAY YES
5 4 EVERY&WEEK YES
5 4 EVERY&MONTH YES
5 1 EVERY&WEEK YES
5 1 EVERY&WORKDAY YES
6 1 EVERY&WEEK YES
6 3 EVERY&WEEK DON'T&KNOW
6 1 EVERY&WEEK YES
7 NA EVERY&WORKDAY YES
4B#UNDOCUMENTED#ROUTINES 5A#FURTHER#TRAINING 5B#INFORM#ON#SAMP#TECH PATIENT#ID#6A PATIENT#ID#6B PATIENT#ID#6C
YES YES YES ALWAYS OFTEN NEVER
YES YES DON'T/KNOW ALWAYS NEVER ALWAYS
YES YES YES ALWAYS OFTEN NEVER
YES YES YES ALWAYS NEVER ALWAYS
YES YES YES ALWAYS NEVER NEVER
NO NO YES ALWAYS NEVER SELDOM
YES DON’T/KNOW DON'T/KNOW ALWAYS NEVER NEVER
YES DON’T/KNOW YES ALWAYS NEVER SELDOM
YES NO NO ALWAYS NEVER NEVER
YES YES YES ALWAYS OFTEN NEVER
DON'T/KNOW NO DON'T/KNOW ALWAYS NEVER ALWAYS
NO NO YES ALWAYS NEVER SELDOM
YES YES YES ALWAYS NEVER ALWAYS
DON'T/KNOW NO DON'T/KNOW ALWAYS NEVER ALWAYS
NO NO YES ALWAYS NEVER SELDOM
YES YES YES ALWAYS NEVER ALWAYS
YES NO YES ALWAYS NEVER SELDOM
YES DON’T/KNOW YES ALWAYS NEVER NEVER
YES DON’T/KNOW YES ALWAYS NEVER SELDOM
YES YES YES OFTEN NEVER NEVER
DON'T/KNOW NO YES ALWAYS NEVER ALWAYS
YES YES YES OFTEN NEVER ALWAYS
YES YES NOT/ANSWERED ALWAYS NEVER NEVER
YES YES YES OFTEN NEVER ALWAYS
YES NO YES ALWAYS NEVER SELDOM
YES YES YES OFTEN NEVER NEVER
YES YES YES ALWAYS NEVER NEVER
YES YES YES OFTEN NEVER NEVER
YES NO NO ALWAYS NEVER NEVER
YES NO DON'T/KNOW ALWAYS NEVER NO/ANSWER
YES NO NO ALWAYS NEVER NEVER
YES D DON'T/KNOW ALWAYS NEVER ALWAYS
YES YES YES OFTEN OFTEN NEVER
YES YES YES ALWAYS NEVER NO/ANSWER
YES NO DON'T/KNOW ALWAYS NEVER ALWAYS
YES DON’T/KNOW YES ALWAYS NEVER NEVER
YES YES YES SELDOM NEVER NEVER
YES DON’T/KNOW DON'T/KNOW ALWAYS NEVER ALWAYS
YES YES DON'T/KNOW ALWAYS NEVER ALWAYS
YES NO NO ALWAYS NO/ANSWER NO/ANSWER
YES DON’T/KNOW YES ALWAYS NEVER NEVER
YES YES YES ALWAYS NEVER NO/ANSWER
YES NO NO ALWAYS NO/ANSWER NO/ANSWER
YES NO NO ALWAYS NO/ANSWER NO/ANSWER
YES YES YES ALWAYS NEVER NO/ANSWER
YES YES YES OFTEN OFTEN NEVER
YES YES YES ALWAYS NEVER NO/ANSWER
YES NO NO ALWAYS NEVER NEVER
YES NO NO ALWAYS NEVER NEVER
YES NO NO ALWAYS NO/ANSWER NO/ANSWER
YES YES YES ALWAYS NEVER NO/ANSWER
YES YES YES ALWAYS NO/ANSWER SELDOM
YES NO NO ALWAYS NEVER NEVER
YES NO NOT/ANSWERED ALWAYS NEVER NEVER
YES YES YES ALWAYS NEVER ALWAYS
YES YES YES ALWAYS NEVER ALWAYS
YES YES YES ALWAYS NEVER SELDOM
YES DON’T/KNOW YES ALWAYS NEVER NEVER
YES YES YES ALWAYS NEVER NO/ANSWER
YES YES YES ALWAYS NEVER ALWAYS
YES NO NO ALWAYS NEVER NEVER
YES YES YES ALWAYS NEVER NO/ANSWER
YES YES YES ALWAYS NEVER ALWAYS
YES NO NO ALWAYS NEVER NEVER
YES YES NO ALWAYS NEVER NEVER
YES YES YES ALWAYS NEVER NO/ANSWER
YES YES NO ALWAYS NEVER NEVER
YES NO NO ALWAYS NO/ANSWER NO/ANSWER
PATIENT#ID#6D PATIENT#ID#6E PATIENT#ID#6F PATIENT#ID#7A PATIENT#ID#7B PATIENT#ID#7C PATIENT#ID#7D PATIENT#ID#7E
NEVER NEVER NO/COMMENT OFTEN OFTEN OFTEN SELDOM ALWAYS
ALWAYS NEVER NO/COMMENT ALWAYS NEVER ALWAYS ALWAYS ALWAYS
NEVER NEVER NO/COMMENT OFTEN OFTEN OFTEN SELDOM ALWAYS
ALWAYS NEVER NO/COMMENT ALWAYS NEVER ALWAYS ALWAYS ALWAYS
SELDOM NEVER NO/COMMENT ALWAYS ALWAYS ALWAYS NEVER NEVER
SELDOM NEVER NO/COMMENT ALWAYS ALWAYS ALWAYS SELDOM ALWAYS
NEVER NEVER NO/COMMENT ALWAYS ALWAYS OFTEN NEVER ALWAYS
SELDOM NEVER SEE/COMMENTS ALWAYS ALWAYS ALWAYS ALWAYS ALWAYS
OFTEN NEVER NO/COMMENT ALWAYS ALWAYS ALWAYS ALWAYS ALWAYS
NEVER NEVER NO/COMMENT OFTEN OFTEN OFTEN SELDOM ALWAYS
NEVER NEVER NO/COMMENT ALWAYS NEVER NEVER NEVER NEVER
SELDOM NEVER NO/COMMENT ALWAYS ALWAYS ALWAYS SELDOM ALWAYS
NEVER OFTEN NO/COMMENT ALWAYS NEVER ALWAYS NEVER NEVER
NEVER NEVER NO/COMMENT ALWAYS NEVER NEVER NEVER NEVER
SELDOM NEVER NO/COMMENT ALWAYS ALWAYS ALWAYS SELDOM ALWAYS
NEVER OFTEN NO/COMMENT ALWAYS NEVER ALWAYS NEVER NEVER
SELDOM NEVER NO/COMMENT ALWAYS ALWAYS ALWAYS SELDOM ALWAYS
NEVER NEVER NO/COMMENT ALWAYS ALWAYS OFTEN NEVER ALWAYS
SELDOM NEVER NO/COMMENT ALWAYS ALWAYS ALWAYS SELDOM OFTEN
NEVER OFTEN NO/COMMENT ALWAYS SELDOM SELDOM ALWAYS NEVER
NEVER NEVER NO/COMMENT ALWAYS NEVER NEVER NEVER NEVER
NEVER NEVER SEE/COMMENTS ALWAYS NEVER NEVER NEVER NEVER
SELDOM NEVER NO/COMMENT ALWAYS ALWAYS ALWAYS NEVER NEVER
NEVER NEVER SEE/COMMENTS ALWAYS NEVER NEVER NEVER NEVER
SELDOM NEVER NO/COMMENT ALWAYS ALWAYS ALWAYS SELDOM ALWAYS
NEVER OFTEN NO/COMMENT ALWAYS SELDOM SELDOM ALWAYS NEVER
NEVER NEVER NO/COMMENT ALWAYS SELDOM OFTEN NEVER ALWAYS
NEVER OFTEN NO/COMMENT ALWAYS SELDOM SELDOM ALWAYS NEVER
NEVER NEVER NO/COMMENT ALWAYS NEVER ALWAYS ALWAYS ALWAYS
NO/ANSWER NO/ANSWER NO/COMMENT ALWAYS NO/ANSWER ALWAYS ALWAYS ALWAYS
NEVER NO/ANSWER NO/COMMENT ALWAYS NO/ANSWER ALWAYS ALWAYS ALWAYS
NEVER SELDOM NO/COMMENT ALWAYS SELDOM ALWAYS SELDOM SELDOM
NEVER NEVER NO/COMMENT ALWAYS OFTEN ALWAYS OFTEN NEVER
NO/ANSWER NO/ANSWER SEE/COMMENTS ALWAYS ALWAYS ALWAYS NO/ANSWER SELDOM
SELDOM ALWAYS NO/COMMENT ALWAYS NEVER ALWAYS ALWAYS ALWAYS
NEVER NEVER NO/COMMENT ALWAYS ALWAYS OFTEN NEVER ALWAYS
NEVER NEVER NO/COMMENT ALWAYS ALWAYS ALWAYS NEVER SELDOM
NEVER SELDOM NO/COMMENT ALWAYS SELDOM ALWAYS SELDOM SELDOM
ALWAYS NEVER NO/COMMENT ALWAYS NEVER ALWAYS ALWAYS ALWAYS
NO/ANSWER NO/ANSWER NO/COMMENT ALWAYS NEVER ALWAYS OFTEN NEVER
NEVER NEVER NO/COMMENT ALWAYS ALWAYS OFTEN NEVER ALWAYS
SELDOM NO/ANSWER SEE/COMMENTS ALWAYS ALWAYS ALWAYS NO/ANSWER SELDOM
NO/ANSWER NO/ANSWER NO/COMMENT ALWAYS NO/ANSWER NO/ANSWER NO/ANSWER NO/ANSWER
NO/ANSWER NO/ANSWER NO/COMMENT ALWAYS NO/ANSWER NO/ANSWER NO/ANSWER NO/ANSWER
SELDOM NO/ANSWER SEE/COMMENTS ALWAYS ALWAYS NO/ANSWER NO/ANSWER SELDOM
NEVER NEVER NO/COMMENT ALWAYS OFTEN ALWAYS OFTEN NEVER
SELDOM NO/ANSWER SEE/COMMENTS ALWAYS ALWAYS ALWAYS SEE/COMMENT SELDOM
OFTEN NEVER NO/COMMENT ALWAYS ALWAYS ALWAYS ALWAYS ALWAYS
D NEVER NO/COMMENT ALWAYS ALWAYS ALWAYS ALWAYS ALWAYS
NO/ANSWER NO/ANSWER NO/COMMENT ALWAYS NEVER ALWAYS OFTEN NO/ANSWER
SELDOM NO/ANSWER SEE/COMMENTS ALWAYS ALWAYS ALWAYS SEE/COMMENT SELDOM
NEVER NEVER NO/COMMENT ALWAYS ALWAYS ALWAYS NEVER NEVER
NEVER NEVER NO/COMMENT ALWAYS NEVER ALWAYS ALWAYS ALWAYS
SELDOM NEVER NO/COMMENT ALWAYS ALWAYS ALWAYS ALWAYS ALWAYS
SELDOM NEVER SEE/COMMENTS ALWAYS ALWAYS ALWAYS NEVER SELDOM
NEVER OFTEN NO/COMMENT ALWAYS ALWAYS ALWAYS NEVER NEVER
NEVER NEVER NO/COMMENT ALWAYS ALWAYS ALWAYS NEVER NEVER
NEVER NEVER NO/COMMENT ALWAYS ALWAYS OFTEN NEVER ALWAYS
SELDOM NO/ANSWER SEE/COMMENTS ALWAYS ALWAYS ALWAYS NO/ANSWER SELDOM
TEST$LABEL$10B TEST$LABEL$10C TEST$LABEL$10D TEST$LABEL$10E TEST$LABEL$10F PATIENT$POSTURE$11 STASIS$$12A STASIS$12B STASIS$12C STASIS$12D STASIS$12E SAMP$COLLECTION$13A SAMP$COLLECTION$13B SAMP$COLLECTION$13C
NO#ANSWER NO#ANSWER NO#ANSWER OFTEN NO#ANSWER ZERO#TO#FIVE#MINS NEVER SELDOM A A NA NA NA NA
SELDOM ALWAYS NEVER NEVER NEVER NO#TIME#CHECK# NO#ANSWER NO#ANSWER A NA NA B A C
NO#ANSWER NO#ANSWER NO#ANSWER SELDOM OFTEN ZERO#TO#FIVE#MINS NEVER SELDOM A A NA NA NA NA
SELDOM ALWAYS NEVER NEVER NEVER NO#TIME#CHECK# NO#ANSWER NO#ANSWER A NA NA B A A
NO#ANSWER ALWAYS NO#ANSWER NO#ANSWER NO#ANSWER NO#TIME#CHECK# NO#ANSWER NO#ANSWER A NA NA NA NA NA
ALWAYS OFTEN NEVER NEVER NEVER ZERO#TO#FIVE#MINS NEVER NEVER A D NA B B B
NEVER ALWAYS NEVER NEVER NEVER ZERO#TO#FIVE#MINS NEVER NEVER A D NA D A A
NEVER NEVER NEVER NEVER NEVER ZERO#TO#FIVE#MINS NEVER ALWAYS D A MA B B B
NEVER ALWAYS NEVER NEVER NEVER ZERO#TO#FIVE#MINS NO#ANSWER ALWAYS NA NA NA NA NA A
NO#ANSWER NO#ANSWER NO#ANSWER OFTEN NO#ANSWER ZERO#TO#FIVE#MINS NEVER SELDOM A A NA NA NA NA
NEVER ALWAYS NEVER NEVER NEVER NO#TIME#CHECK# NEVER NEVER A D NA D D A
ALWAYS OFTEN NEVER NEVER NEVER ZERO#TO#FIVE#MINS NEVER NEVER A D NA B B B
NEVER ALWAYS NEVER NEVER NEVER ZERO#TO#FIVE#MINS NEVER NO#ANSWER A A NA B B A
NEVER ALWAYS NEVER NEVER NEVER NO#TIME#CHECK# NEVER NEVER A D NA D D A
ALWAYS OFTEN NEVER NEVER NEVER ZERO#TO#FIVE#MINS NEVER NEVER A D NA B B B
NEVER ALWAYS NEVER NEVER NEVER ZERO#TO#FIVE#MINS NEVER NO#ANSWER A A NA B B A
ALWAYS OFTEN NEVER NEVER NEVER ZERO#TO#FIVE#MINS NO#ANSWER NO#ANSWER A NA NA B B B
NEVER ALWAYS NEVER NEVER NEVER ZERO#TO#FIVE#MINS NEVER NEVER A D NA D A A
NEVER ALWAYS NEVER NEVER NEVER NO#ANSWER NEVER ALWAYS D A NA B B B
ALWAYS SELDOM NEVER NEVER NEVER SIX#TO#TEN#MINS SELDOM ALWAYS D D NA D B C
NEVER ALWAYS NEVER NEVER NEVER NO#TIME#CHECK# NEVER NEVER A D NA D D A
NO#ANSWER ALWAYS NO#ANSWER NO#ANSWER NO#ANSWER ZERO#TO#FIVE#MINS NO#ANSWER ALWAYS NA NA NA NA B NA
ALWAYS NO#ANSWER NO#ANSWER NO#ANSWER NO#ANSWER NO#TIME#CHECK# NO#ANSWER NO#ANSWER A NA NA NA NA NA
NO#ANSWER ALWAYS NO#ANSWER NO#ANSWER NO#ANSWER ZERO#TO#FIVE#MINS NO#ANSWER ALWAYS NA NA NA NA B NA
ALWAYS OFTEN NEVER NEVER NEVER ZERO#TO#FIVE#MINS NO#ANSWER NO#ANSWER A NA NA B B B
ALWAYS SELDOM NEVER NEVER NEVER SIX#TO#TEN#MINS SELDOM ALWAYS D D NA D C C
NEVER ALWAYS NEVER NEVER NEVER ZERO#TO#FIVE#MINS NEVER NEVER A D NA D A A
ALWAYS SELDOM NEVER NEVER NEVER SIX#TO#TEN#MINS SELDOM ALWAYS D D NA D C C
NO#ANSWER ALWAYS NO#ANSWER NO#ANSWER NO#ANSWER NO#TIME#CHECK# NO#ANSWER NO#ANSWER A NA NA A A A
ALWAYS NEVER NEVER NEVER NEVER NO#ANSWER NEVER ALWAYS C D NA B B B
NO#ANSWER SELDOM NO#ANSWER NO#ANSWER NO#ANSWER NO#TIME#CHECK# NEVER NEVER A D NA A A A
NEVER ALWAYS SELDOM NEVER NEVER NO#ANSWER SELDOM ALWAYS B NA NA C C C
SELDOM OFTEN SELDOM SELDOM SELDOM ZERO#TO#FIVE#MINS SELDOM SELDOM B C NA A C B
SELDOM ALWAYS NEVER NEVER NEVER NO#TIME#CHECK# NEVER SELDOM A A NA D D#see#comm A
ALWAYS NEVER NEVER NEVER NEVER NO#TIME#CHECK# NEVER ALWAYS C D NA A A A
NEVER ALWAYS NEVER NEVER NEVER ZERO#TO#FIVE#MINS NEVER NEVER A D NA D A A
SELDOM ALWAYS NEVER NEVER NEVER NO#TIME#CHECK# NEVER SELDOM A A NA D D A
NEVER ALWAYS SELDOM NEVER NEVER NO#ANSWER SELDOM ALWAYS B NA NA C C C
SELDOM ALWAYS NEVER NEVER NEVER NO#TIME#CHECK# NO#ANSWER NO#ANSWER A NA NA B A C
NO#ANSWER OFTEN NO#ANSWER NO#ANSWER NO#ANSWER NO#TIME#CHECK# NO#ANSWER NO#ANSWER A NA NA A A A
NEVER ALWAYS NEVER NEVER NEVER ZERO#TO#FIVE#MINS NEVER NEVER A D NA D A A
SELDOM ALWAYS NEVER NEVER NEVER NO#TIME#CHECK# NEVER SELDOM A A NA D D#see#comm# A
NO#ANSWER ALWAYS NO#ANSWER NO#ANSWER NO#ANSWER NO#TIME#CHECK# NO#ANSWER NO#ANSWER A NA NA NA A A
NO#ANSWER ALWAYS NO#ANSWER NO#ANSWER NO#ANSWER NO#TIME#CHECK# NO#ANSWER NO#ANSWER A NA NA NA A A
SELDOM ALWAYS NEVER NEVER NEVER NO#TIME#CHECK# NEVER SELDOM A A NA D D#see#comm B
SELDOM OFTEN SELDOM SELDOM SELDOM ZERO#TO#FIVE#MINS SELDOM SELDOM B C NA A C B
NEVER ALWAYS NEVER NEVER NEVER NO#TIME#CHECK# NEVER SELDOM A A NA D D B
NEVER ALWAYS NEVER NEVER NEVER ZERO#TO#FIVE#MINS NO#ANSWER ALWAYS NA NA NA NA NA A
NEVER ALWAYS NEVER NEVER NEVER NO#TIME#CHECK# NO#ANSWER ALWAYS NA A NA A A A
NO#ANSWER OFTEN NO#ANSWER NO#ANSWER NO#ANSWER NO#TIME#CHECK# NO#ANSWER NO#ANSWER A NA NA A A A
NEVER ALWAYS NEVER NEVER NEVER NO#TIME#CHECK# NEVER SELDOM A A NA D D B
STORAGE(15C STORAGE(15D STORAGE(15E ERROR(REPORT(16A ERROR(REPORT(16B ERROR(REPORT(16C ERROR(17A ERROR(17B ERROR(17C ERROR(17D ERROR(17E ERROR(17F ERROR(17(G SUGGEST(18
NA NA NA NA B NA NA NA NA NA NA NA NA NA
D D see'comment 0 B NA NA A NA NA NA NA NA NA
NA NA NA 0 B NA NA NA NA NA A NA NA NA
D B see'comment NA B NA NA A NA NA NA NA NA NA
NA NA see'comment NA B NA NA NA NA NA NA NA NA NA
D D NA NA B NA NA NA NA NA A NA NA NA
D D NA NA B NA D D D D D NA SC NA
D D NA NA B NA NA NA NA NA NA NA NA NA
NA NA NA NA B NA NA NA NA NA NAN AN NA NA
NA NA NA NA B NA NA NA NA NA NA NA NA NA
D D SC NA B NA NA D NA NA NA NA NA NA
D D NA NA B NA NA NA NA NA A NA NA NA
B D see'comment 0 NA NA NA NA NA NA A NA see'commentsee'suggestions
D D SC NA B NA NA D NA NA NA NA NA NA
D D NA NA B NA NA NA NA NA A NA NA NA
B D see'comment 0 NA NA NA NA NA NA A NA see'commentsee'suggestions
NA NA NA NA B NA NA NA NA NA A NA NA NA
D D SC NA B NA D D D D D NA SC NA
D D NA NA B NA NA NA NA NA NA NA NA NA
D D NA 2 NA NA NA NA NA NA NA NA NA NA
NA NA see'comment NA B NA A D NA NA NA NA NA NA
NA NA see'comment NA B NA NA NA NA NA D NA see'commentNA
NA NA see'comment 0 B NA NA NA NA NA NA NA NA NA
NA NA see'comment NA B NA NA NA NA NA D NA see'commentNA
NA NA NA NA B NA NA NA NA NA A NA NA NA
D D NA 4 NA NA NA NA NA NA NA NA NA NA
D D SCAS 0 B NA D D D D D NA NA see'suggestions
D D NA 4 NA NA NA NA NA NA NA NA NA NA
NA NA NA NA NA C NA NA NA NA A NA NA NA
D D NA NA B NA NA NA NA NA A NA NA NA
D D NA NA NA C NA NA NA NA A NA NA NA
D D see'comment 0 B NA D D D D D NA NA NA
D D NA 0 B NA NA NA NA NA NA NA NA NA
D D see'comment NA NA NA D D D D D NA NAP see'suggestions
D D NA NA B NA NA NA NA NA A NA NA NA
D D SNC NA B NA D D D DD NA NA SNC NA
D D see'comment 0 B NA NA NA NA NA NA NA NA NA
D D see'comment 0 B NA D D D D D NA NA NA
D D see'comment 0 B NA NA A NA NA NA NA NA NA
NA NA NA 0 B NA NA NA NA NA A NA NA NA
D D SNC NA B NA D D D DD NA NA SNC NA
D D see'comment NA NA NA D D D D D NA NAP see'suggestions
NA NA NA 0 B NA NA NA NA NA A NA NA NA
NA NA NA 0 B NA NA NA NA NA A NA NA NA
D D see'comment 0 NA NA NA NA NA NA NA NA NAP see'suggestions
D D NA NA B NA NA NA NA NA NA NA NA see'suggestions
NA NA see'comment NA B NA NA NA NA NA NA NA NAP see'suggestions

APPENDIX XII 
Pilot Study (Dprof Research) 
 
Project planning 2 – Epistemology, Methodology and Method 
 
 
A list of all samples errors (i.e requests booked in as set code “error” in Clinical 
Chemistry between February-March in 2013 were pulled in from APEX. The total 
number of errors booked into APEX within this time was 333. The table below shows 
the different errors that were booked in and how often they occurred. 
Table 1 
 
ERROR Total % Occurred 
Sample failed acceptance criteria (ZREJ) 99 30 
Sample requirements (incorrect bottle, 
preservative, unsuitable for analysis- 
contamination, viscosity) 
85 26 
Insufficient sample for tests 33 10 
No sample received 90 27 
Laboratory error (mechanical, tests missed off 
when booked into APEX) 
4 1 
Other (test requested multiple times, test not 
required, additional tests required, tests not 
available, sample lost in transit 
22 6 
 
 
 
 
  
 
 
 
The graph on the previous page above shows approximately 30% of these samples 
had to be booked in as an “error” with the ZREJ study code because the sample failed 
the acceptance criteria- (samples/requests that are unlabelled, insufficiently labelled 
or incorrectly labelled as set out in SOP LMCP026). 27% of errors were booked in 
because no sample was received in the laboratory for the specified request.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The chart above shows the majority of samples that failed the acceptance criteria 
came from GP surgeries. From the outpatient samples 58% of samples that failed the 
acceptance criteria came from the locations PHC/AMBRIS studies.  
 
 
 
 
 
 
 
 
Location( %(of(Samples(
Wards&(Inpatients)& 7&
GP's& 50&
Outpatients& 24&
Jessops& 6&
Western&Park& 13&
  
 
 
As table 1 show’s 27% of errors were booked in because no sample was received in 
the laboratory for the specified request. Approximately 41% of these requests were 
for the PTH test and the majority of these requests came from GP surgeries. 23% of 
requests were for urine albumin: creatinine ratio test and again majority of these 
requests were from GP surgeries. 
 
 
 
Error( %(Occurred(
PTH& 41&
ACR& 23&
Other& 35&
 
 
 
 
 
 
 
 
 
 
26% of errors were booked in because of sample requirements failure. The chart below 
shows the various errors that were booked in. 47% of the errors was due  to incorrect 
sample being sent for the specified test. 12% of errors was due to specimen 
contamination such as sample taken from drip arm, EDTA contamination. 18% of the 
errors was because of the incorrect perservative being used for the required test with the 
most common one being sending a 24 urine sample for Catecholmaines and 
Metanepharines in a plain bottle rather than in an acidifed container. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Error( %(Error(Occurred(
Ammonia&EDTA&not&sent&on&ICE& 9&
Specimen&contamination& 12&
Sample&haemolysed& 5&
Incorrect&sample& 47&
Incorrect&preservative& 18&
Sample&not&protected&from&light& 5&
Blood&gas&sample&clotted& 2&
High&viscosity& 2&
!
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Sheffield Teaching Hospitals NHS Trust  Procedure No. LMPH001  
Directorate of Laboratory Medicine   Revision No. 1.5 
Department: OPD Phlebotomy Services Page 1 of  5 
Section: Phlebotomy Unit 
Approver: Andrew Ward 
 
Signature in red:  Active date July 14 
 
   
 
 
Standard Operating Procedure for the Phlebotomy Unit on C-Floor 
(Outpatients Block, Royal Hallamshire Hospital) 
 
Contents 
Introduction Page 1 
Equipment Page 1 
Venepuncture Procedure Page 2 
Protocol for needle-stick injuries Page 4 
 
(i) Introduction 
The operating procedures for venepuncture are outlined below.  Safety is paramount 
in the practice of phlebotomy, and the STHFT Phlebotomy Training Manual 
describes measures aimed at minimising the risk of injury or harm to staff or patient. 
The last section (copy of controlled document from Laboratory Medicine Risk 
Management section) include the protocol for dealing with a needle-stick injury  
! Please refer to the Department of STHFT Phlebotomy Training Manual for 
requirements regarding professional attributes, health and safety, and pre-
analytical variables.  There is a departmental Quality Assurance programme in 
which phlebotomists are assessed according to the standards in the Training 
Manual by means of both observation of practice and assessment of theoretical 
knowledge. 
! Professionalism includes respecting patient confidentiality, and the need to obtain 
informed consent for venepuncture is emphasised. 
 
(ii) Equipment:  
The workstation / trolley must be clean, tidy, and well stocked at all times; and 
contain the following items. 
 
• Medi swab isopropyl alcohol cleaning pad. 
• Cotton wool balls and dental rolls 
• Hand cleansing gel 
• Sharps bin. 
• Assorted plasters and micropore tape 
• Latex free gloves 
• Vacutainer barrels  
• 21G (green) and 22G (black) Vacutainer ‘safer’ needles *  
• Assorted Vacutainer bottles. 
• Assorted luer slip syringes 
• Disposable needles for use with luer slip syringes 
• Butterfly ‘safer’ needles 21G and 22G * 
• Vacutainer adapters for luer fittings. 
• Tourniquet 
• Spillage kit 
* Needles must be of a type that have integrated features to protect staff and 
patients from needle-stick injury by shielding the needle tip after venepuncture. 
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(iii) Venepuncture Procedure: 
! Call a patient into phlebotomy area by pressing ‘NEXT’ on the QMS keypad. 
Maintain a professional attitude and courtesy towards all patients at all times. 
Remember to prioritise ambulance patients. 
! Direct your patient to the appropriate cubicle 
! Approach the patient in a confident manner, explain the procedure and obtain 
consent. 
! Check patient details against the request form by asking them for their full name 
and date of birth.  
! Allow the patient time to discuss any previous problems with venepuncture. 
! Ask patient if they have a ‘preferred’ arm. 
! Check the request forms and assemble the correct bottles. Take note of any 
variables which need recording: e.g. fasting, time of day. 
! Wash hands, or use hand sanitizer, between each patient.  
! Support the chosen arm 
! Apply tourniquet to the upper arm on the chosen site approximately 4 to 5 cms 
above the elbow. The tourniquet must be applied with just enough tension to 
distend the vein. 
! Select a vein by feeling (‘palpating’) with a finger (never a thumb). The vein 
should give under pressure from your finger, it should not pulsate. Check also the 
direction of the vein.  
! If a prominent vein does not appear, ask to look at the patient’s other arm. Veins 
can be encouraged to ‘show ‘ by moving the tourniquet slightly, or by warming the 
arm. Release tourniquet if necessary.  
! Select device required to obtain the correct amount of blood for the size and site 
of the vein, etc.  
! Gloves must be worn unless the phlebotomist has difficulty locating a vein, (and 
always with Category 3 patients). 
! Reapply tourniquet if necessary. 
! Clean skin over vein with alcohol swab leave to air dry 
! Unwrap and visually inspect all needles carefully to detect any barbed or faulty 
equipment. 
! Assemble the vacutainer system or syringe and needle maintaining asepsis. Do 
not touch the steel part of the needle or let it touch anything else.  
! Hold the barrel with two fingers underneath the barrel and your thumb on the top, 
This will leave the lower end of the barrel free for careful insertion of vacutainer 
blood tubes. 
! Anchor the vein by applying traction with the thumb on the skin a few centimetres 
below the proposed insertion site. The skin must be pulled in alignment with the 
course of the vein. 
! Insert the needle smoothly with the ‘eye’ uppermost in a single ‘gliding’ motion 
aiming for the centre of the vein. To ensure correct angle, your fingers should 
gently brush the patient's arm as you approach with the needle. A ‘flashback’ of 
blood should be seen in the hub of a needle and syringe, but is not seen with a 
vacutainer. 
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! From now on, hold the device so that the tip of the needle remains perfectly still. 
Rest your fingers on the patient’s arm to achieve this. 
! If you are collecting blood into sample tubes containing anticoagulants or other 
additives, consider the order of draw carefully.  
! If using the vacutainer system, slide the appropriate empty vacutainer tubes into 
the holder (taking care not to move the tip of the needle) and withdraw the 
required amount of blood. This can be achieved by applying counter-pressure via 
the flange on the holder. 
! If using needle and syringe, pull back the plunger gently but steadily (taking care 
not to move the tip of the needle) to collect the correct amount of blood. 
! Release the tourniquet. 
! Remove the last sample tube or stop pulling back the syringe plunger. 
! Place a clean dental roll or cotton wool ball over the puncture site, remove the 
needle and apply digital pressure directly over puncture site. Do not press until 
needle is removed. Whilst keeping fingers away from the needle tip, flip the 
needle-guard over the needle. 
! Apply pressure until bleeding ceases. Patients can apply pressure themselves, 
but you must ensure they understand the need to press for 2 – 3 minutes. 
(Especially those on anticoagulants.) 
! Dispose of vacutainer guarded-needle and holder immediately into sharps bin. 
Never re-sheath needles. Refer to lab guidelines regarding waste disposal. 
Should needlestick occur refer to lab guidelines. Procedures available above both 
hand wash basins in phlebotomy.  
! Mix contents of all tubes by gently inverting 5 or 6 times. If using a syringe, use 
vacuette adaptor to transfer blood into vaccutainer bottles.   Allow the correct 
quantity to be drawn into each vacutainer in the correct order. Invert to mix as 
above. 
! Dispose of syringe and guarded-needle into sharps bin.  
! Label all sample tubes with patient’s details ie:, Surname, Fore name, 
Registration Number (or NHS number for GP patients), and D.O.B. Sign, date 
and time the sample. Refer to Laboratory Medicine Safer Labelling Policy. 
! Check bleeding has ceased by gently stroking in the direction of the vein. Do not 
wipe over the puncture site, as this will initiate further bleeding.  
! Ask the patient if they are allergic to elastoplast and if not, cover the puncture site 
with an elastoplast. Fasten a clean piece of cotton wool or dental roll in place with 
micropore if the patient is allergic to elastoplast or prefers this option 
! Ensure the patient is comfortable and fit to leave the department. Ambulance 
patients may require assistance of porters to return to waiting area. 
! Clear workstation or trolley of any soiled cotton wool/dental rolls, or any paper 
debris to ensure area is clean and tidy for next patient.  No specimens or forms 
from the previous patient should be in the cubicle when a new patient is called.  
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(iv) Needlestick and contamination incidents 
 
Any injury or splash incident which causes exposure to blood or high-risk body fluids 
  
More detailed information for staff and managers is available in the ‘Blood and Body Fluid 
Exposure Incident Management Pack’. These packs must be used when dealing with any 
contamination incident. All supervisory staff should be aware of the procedure; this guideline 
must be used in conjunction with the Incident Management Pack. 
 
HOW CAN THIS OCCUR?  
• Puncture of the skin with a dirty needle or sharp. 
• Exposure through cuts or breaks in the skin, e.g. cuts or skin conditions 
• Splashes of blood or body fluids in the eye or mouth.     
 
WHICH BODY FLUIDS ARE INFECTIOUS?    
• High risk :- Blood, visibly blood stained body fluids and those derived from 
blood, e.g. amniotic fluid, vaginal secretions, semen, breast milk, cerebrospinal fluid, 
peritoneal fluid, saliva in association with dentistry, unfixed tissues and organs, and 
synovial fluid. 
• Low risk :- Urine, vomit, saliva, faeces with no visible blood staining.    
 
IF I HAVE A CONTAMINATION INJURY WHAT SHOULD I DO? 
 
FIRST AID.           SPEED IS ESSENTIAL ! 
 
For a wound  
Encourage bleeding by gently squeezing the site - do not suck! Wash in warm running water 
with soap or handwash liquid, dry. Apply a waterproof dressing. 
 
For a splash in the eye 
Irrigate thoroughly for at least five minutes with eyewash solution or sterile water (or tap 
water if others not available).   Remove contact lenses. 
 
For a splash in the mouth 
Irrigate thoroughly for at least five minutes with drinking water. Do not swallow this water. 
 
CONTACT THE OCCUPATIONAL HEALTH SERVICE AS FOLLOWS: 
 
Monday - Friday 8.30 - 4.30  
Northern General Department ext 4737 or Direct Line (0114) 271 4737 
Royal Hallamshire Department ext 3360 or Direct Line (0114) 271 3360  
  
Out-of hours  
If the source patient is HIV or Hepatitis B positive contact the on-call occupational 
physician through the NGH switchboard. 
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Inform your supervisor or manager -  
As soon as possible after the incident so that they can ensure that correct action is 
taken and complete both the blood exposure incident form an accident report form. 
 
All contamination incidents must be reported on Datix as soon as possible. 
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Service Evaluation Report 
 
Please note:  If the project is performance managed this report will be submitted to the Clinical Effectiveness Committee 
 
Abstract: This section must be completed and written as a short paragraph only. 
 
Efficient laboratory service is the cornerstone of modern health care systems. The RHH clinical chemistry 
laboratory services play a major role in modern healthcare. Attending patients are entitled to health care 
with a high degree of quality and safety. Diagnostics in Clinical Chemistry laboratory is a pivotal part of 
clinical decision-making but not exempt from ‘human errors’. Scientific innovations have contributed to 
substantial improvements in the field of laboratory science, but errors still occur. One major example of 
such failing is connected to the prevalence of errors occurring in the Total Testing Process (TTP). 
 
The results of the first part of the study indicate that of the 416,703 specimens collected pre-Anglia ICE, 
2,055 (0.49%) were recorded as errors compared with 1,616 errors (0.11%) of 903,814 specimens 
collected post-Anglia ICE implementation, which represents a 0.31% (p<0.05) absolute error reduction 
rate, although more samples were received post-Anglia-ICE.   
 
The results of the second part (questionnaire survey) indicate that recommended procedure for phlebotomy 
practice was not strictly followed by a large percentage of the staffs. The results suggests low compliance 
by staffs with recommended practice, which may be responsible for the prevalence of certain categories of 
pre-analytical errors in the TTP and may also be associated with increased risks to attending patients. It is 
suggested that the development of a local guideline for VBS and compliance to this guideline will improve 
phlebotomy practice, improve the quality of sample testing in clinical chemistry laboratory, reduce pre-
analytical errors in TTP and consequently improve the safety of patients. 
 
Project Title:  Identification and Reduction of Pre-analytical Errors in Clinical Chemistry 
 
Site:  RHH/NGH Project Registration Number: 5683 Project Priority: 
 
1. Project Team 
Name Job Title Role 
Ben Sholademi Biomedical Scientist Specialist BMS 
   
   
   
 
2. Background 
Diagnostics in Clinical Chemistry laboratory is a pivotal part of clinical decision-making but is not exempt 
from ‘human errors’.  Scientific innovations such as automation and electronic order test requesting have 
contributed to substantial improvements in the field of laboratory science, but errors still occur.  One 
major example of such failing is connected to the prevalence of errors occurring in pre-analytical phase of 
the Total Testing Process (TTP). Pre-analytical errors can occur at the time of patient assessment, test 
order entry, patient identification, sample collection, sample transport, or sample receipt in the laboratory. 
Such errors are frequently the results of human mistakes during phlebotomy practice. Previous work and 
clinical insights suggest that most errors in the TTP are extra-laboratory (i.e. they occur before the sample 
reaches the laboratory for analysis). Therefore to reduce these errors the pre-analytical phase of the TTP 
must be prioritized. 
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3. Aim and Objectives 
 
The first part of this study involved an interrogation of the laboratory information management system to 
compare two separate periods before and after the implementation of Anglia-ICE (electronic test ordering) 
to find out whether the introduction of Anglia-ICE played a key role in reducing the occurrences of these 
pre-analytical errors. This study also included a survey of pre-analytical procedures in the phlebotomy 
units of Sheffield Teaching Hospitals NHS Foundation Trust (STH NHS FT), in order to identify the 
potential sources of these errors and whether these practices play a role in reducing the pre-analytical 
errors encountered in clinical chemistry laboratory. 
 
Specific aims are:  
• To investigate, categorise and determine the frequencies of pre-analytical errors in the TTP. 
• To conduct a survey of pre-analytical procedures by phlebotomy staff to identify key error prone steps 
in the TTP. 
• To draw any conclusions from phlebotomy staff practice and specific errors identified in the TTP. 
• To engage with experts and seek advice to improve phlebotomy practice in STH NHS FT and to 
communicate the outcomes from the study to service users with the aim of improving the service and 
promote patient safety. 
 
4. Methodology 
 
1. Interrogating the Laboratory Information Management System (LIMS) 
The first part of this project is a restrospective interrogation of LIMS to retrieve data of pre-analytical 
errors. This included all test requests booked in as a set code “ERROR” in the clinical chemistry 
laboratory of RHH (STH FT) to cover 2 periods: 
a) Pre-introduction of electronic test requesting (2007 - 2008) 
b) Post implementation of electronic test requesting (2012 - 2013) 
 
Statistical Analysis – LISM study 
Pre-analytical raw data extracted from LIMS were entered into Excel 2010 spread sheet (Microsoft Corp., 
Redmond, WA) for pre-processing and coding. Differences in error frequencies between Pre-ICE 
procedure requesting and Post-ICE requesting procedure were compared using Chi-squared test.  A p-
value less than 0.05 was considered statistically significant.   
 
2. Questionnaire Study 
The second part of the project was a questionnaire survey of pre-analytical practice in the phlebotomy unit 
in STH NHS FT. This also involved a pilot study (that included a small group of the target population) to 
test the validity of the study design. 
 
Statistical analysis of questionnaire data 
Completed questionnaire data and background characteristics of the respondents were typed in to an Excel 
2010 for Macintosh data sheet (Microsoft Corp., Redmond, WA) and then transferred to Statistical 
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package for Macintosh, Version 23 (SPSS Inc., Chicago, IL), and basic descriptive statistics were used.  
Further analyses of data were performed with Prism 7 statistical software (GraphPad Software, Inc. 7825 
Fay Avenue, La Jolla, CA 92037, USA) and Stats Direct statistical package (Stats Direct Ltd, 9 Bonville 
Chase, Altrincham, Cheshire WA14 4QA, UK).   
 
Participants: study population and sampling 
The population was drawn from a group of staff working in the phlebotomy units and wards at STH NHS 
FT. 80 copies of anonymous questionnaires were sent out to respondents. The questionnaire contained 18 
questions, including open-ended questions and sections for comments/suggestion.  A copy of the study 
questionnaire is included in the appendices section. 
 
Ethical considerations  
This study did not involve patients attending STH. This study was a survey of volunteer phlebotomy unit 
staffs across both campuses of STH only. Respondents were asked to state how they performed 
phlebotomy/error-reporting practices (Soderberg, 2009). The survey was to identify error prone steps in 
the TTP in order to be able to appropriately target interventions to improve practice. The questionnaire 
was strictly anonymous and informed consent was made available to the respondents, explaining fully the 
procedures involved in the research; the return of the completed questionnaires was translated as 
acceptance of consent to participate in the study, which was stated on the questionnaire. 
 
5. Results and Discussion 
 
Results show a definitive decrease in the occurrence of some pre-analytical errors following the 
implementation of the Anglia-ICE system in 2012. The introduction and implementation of electronic 
requisitioning of laboratory samples has almost certainly drastically reduced the rate of one error-prone 
manual test requesting procedure that is related to patient identification (incorrect patient details).  Overall 
an absolute error reduction rate of 0.31% was attained and the result agrees with previous findings of Hill 
et al., (2010) who similarly achieved a 0.31% reduction in institutional sample labelling error rate. 
Although it has been argued that introduction of new and advanced technology such electronic ordering 
combined with sample bar-coding systems (Valenstein et al., 2006) can go far in reducing patient 
identification errors, it is certainly also the case that electronic systems will increase other types of 
ordering errors (Hill et al., 2010) not detected or reported to the laboratory such as electronic order 
generated errors, no-test request errors and unspecified pre-analytical error types.  For illustration, it is 
fairly easy to select the wrong patient’s details from two different patient’s with very similar surnames and 
their names appear closely together on computer screen of an electronic order system. There is therefore a 
need for continuous evaluation of practice and monitoring (Sölderberg, 2009) by experts in clinical 
chemistry laboratory practice.  
 
A number of patient identification and test ordering errors were still recorded in the LISM post Anglia-
ICE implementation (e.g. patient’s details illegible, incomplete patient’s details, swapped patient 
demographics, test not routinely available in laboratory, unspecified pre-analytical error type, unlabelled 
sample received, unrequested test received, wrong test request received - indicating that the electronic test 
ordering alone is not sufficient for a reliable error-free pre-analytical procedure. Nonetheless the 
implementation of Anglia-ICE technology is still the way forward to reduce errors associated with manual 
paper-based test requests.   
 
Evidence of possible linkage between the pre-analytical error frequency statistics from LIMS and the 
questionnaire survey exists.  High frequencies of unlabelled tubes, mislabelled tubes, incorrect sample 
tubes and incomplete patient demographics on sample tubes have been identified through the LISM 
database, which directly supports the results in the questionnaire survey relating to patient identification 
procedures and vacutainer tube labelling. A high percentage of the respondents were not following the 
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recommended standard procedure for identification of patients. In this study, nearly half of the 
respondents never to checked wristbands for the purpose of patient identification; this is undesirable 
practice and may lead to improper identification of the patient. Correct patient identification and correct 
tube labelling are undoubtedly the most crucial procedures in laboratory medicine.  Hence, there is need to 
prioritize efforts to ensure compliance by staff with standardized patient identification practices.   
 
The demonstration that occurrence of vacutainer tube labelling errors have increased post Anglia-ICE, 
raises some concerns.  Results from the questionnaire survey show low compliance with recommended 
practice.  According to recommended guidelines, vacutainer tubes should always be labelled immediately 
alongside the patient (CLSI, 2010; WHO, 2014) after VBS to avoid labelling errors (Wallin et al., 2009; 
Kiechle, 2013; WHO, 2014).  Regrettably a significant number of the respondents reported to always label 
the vacutainer tubes alongside the patient, before VBS procedure. This is not in line with recommended 
practices (CLSI, 2007, 2008, 2010; WHO, 2014; IBMS, 2016).  About a third of the total numbers of 
respondents were unsure about which standard procedure was available for vacutainer tube labelling in 
VBS. This indicates unacceptable practice and associated with increased risks of the wrong patient’s blood 
in the labelled vacutainer tube (CLSI, 2007; Soderberg et al., 2009, IBMS, 2016).  
 
The survey also revealed that close to 30% of the phlebotomy staff will ask another colleague to label a 
vacutainer tube, either before or after sampling, a practice which increases the risk of unlabelled, 
mislabelling or sample mismatches and are important sources of pre-analytical errors in the clinical 
chemistry laboratory (Plebani and Carraro, 2007; Plebani, 2007; Sciacovelli and Plebani, 2009). These 
findings appear to be a combination of factors relating to staff shortages and time pressures on the service. 
Therefore there is a need for adequate staffing to maintain VBS standards (Lippi et. al., 2006), which 
provides an additional edge of expertise (Ashikiran et. al., 2011). Mislabelled tubes or tubes with 
incomplete patient demographics may result in adverse events (Kalra, 2004; Valenstein et al, 2006) and in 
some cases, fatalities. Drawing blood from the wrong patient, or labelling the correct patient’s sample with 
a different patient’s label can undoubtedly contribute to pre-analytical errors in the laboratory (CLSI, 
2008; IBMS, 2016).  
 
The vacutainer tube labelling procedures adopted by staff as reported in the questionnaire survey clearly 
demonstrates an association with a significant risk  (CSLI, 2010; ISO 15189; 2012; IBMS; 2015), 
resulting from mislabelling / inadequate labelling of vacutainer tubes, and represents a significant area for 
patient safety improvement (Kalra, 2004; Plebani, 2009) that needs to be addressed. Results also show that 
the occurrences of other common errors such as sample received contaminated, sample received in wrong 
container, and sample received in wrong preservative have increased in frequency. These pre-analytical 
errors can be avoided by implementing good practices, such as strictly adhering to the correct order of 
draw, not drawing the blood sample immediately after catheter insertion, and never collecting from an 
infusion line. Common errors can be also made in the transportation of phlebotomy samples, thus it is 
important that laboratory staff are made aware of the optimum time and transport conditions.  
 
Lastly there appears to be considerable underreporting of pre-analytical errors in the phlebotomy units of 
STH NHS, where this study was carried out.  Underreporting of filing of pre-analytical incidents can lead 
to clinically important errors (Kolovos et al., 2008).  Results show that more than 95% of phlebotomy 
staff had never filed an error incident regarding VBS procedure.  These findings supported by results from 
a previous study by Söderberg (2009), where 69% of respondents in the investigated primary health care 
setting, stated to have never filed an incident report regarding VBS practice. Shortage of time and the 
complicated process of error reporting currently in place have been voiced as possible reasons for the 
majority of the VBS staff refraining from filing an error report. Other reasons for a lack of compliance are 
fear of punishment, and a lack of perceived benefits (Kalra et al., 2013). This is in contrast to practice that 
exists in the clinical chemistry laboratory, where error reporting by staff is greatly encouraged.  
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Therefore, it is crucial to douse the blame and shame culture that surrounds staffs, causing them to keep 
vital evidence or information about errors away from other colleagues or senior members of staff (Darosa 
and Pugh, 2012). Increased reporting of pre-analytical incidents regarding phlebotomy practices in STH 
NHS should be intensified through continuous education and training, specifically defining whose 
responsibility it is to report or file errors. Education about errors and their preventability may result in 
approaches to decrease errors and improve quality, and prevention can better happen through learning 
about mistakes and near misses (Kalra et al., 2013). 
 
The finding of undesirable practices within the questionnaire survey largely reflect the lack of compliance 
with standardised procedures in place for VBS, including sample handling, storage and transport. Staff 
relied mainly on uncontrolled documents (such as leaflets kept in the unit), asking other colleagues or 
calling the laboratory for information when they are confronted with any challenging aspect of their 
practice. There was no correlation between the length of employment of staff and their period of recent 
training when a statistical test was applied.  
 
 
 
 
 
6. Limitations 
One of the limitations of this present study was the relatively small sample size of 68 respondents involved 
in the questionnaire survey. A larger sample size would perhaps be more representative of the findings. 
This study was conducted in the phlebotomy units of the inpatient and outpatient wards of STH NHS only 
and excludes A&E department and GP surgeries. 
Another restrain to this study is that the research methodology was restricted to questionnaire study only. 
Although the anonymity offered by the questionnaire approach may well have yielded more open 
responses from respondents, a mixed methodology to include direct observational studies combined with 
structured interviews could have offered more participant involvement. 
This study is the first inquiry to linking VBS practices in phlebotomy to retrospective LISM pre-analytical 
data by comparing two separate periods pre- and post electronic order requesting in an NHS Hospital, 
which meant that there were very few published work available for reference purposes or to compare 
results of findings, although there were a number published articles on electronic order requesting, which 
relates to this present study and have already been cited in this thesis. It is important to emphasize that the 
data presented in this study represent only those pre-analytical errors that were identified by laboratory 
personnel and recorded in LIMS. Nonetheless, an electronic test requisition system can introduce new 
source(s) of error not readily detectable by laboratory staff. There is no knowledge of how many pre-
analytical sample errors went undetected or unreported. No harm or injury were linked to any patient as a 
direct result of a pre-analytical event during the period of this study.  
Lastly, there were some difficulties encountered with the returns of completed questionnaire. A number of 
participants took over two months to return their completed questionnaires. 
 
7. Recommendations and Action Plan 
Recommendation Action Deadline 
(Date) 
Person 
Responsible  
The development of a vigorous 
incident reporting and error filing 
system. Error reporting can be a   
valuable data collection tool for 
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designing approaches for future 
VBS training. 
A thorough review of all pre-
analytical procedures in the TTP, 
with specific focus on manual 
tasks involving patient 
identification and vacutainer test 
tube labelling. 
   
Focus on frequent training and 
competency assessment to involve 
all phlebotomy staff performing 
VBS procedures. 
   
Development of a standardized 
coding system for entry of all 
categories pre-analytical errors  
 
   
 
8. Conclusion 
 
In general improvements to clinical chemistry laboratory services requires periodic objective evaluation of 
practices (Shaw, 2003), procedures, staffs and organizations against valid and unambiguous standards in 
order to identify and implement appropriate changes.  The majority of pre-analytical errors detected in the 
clinical chemistry laboratory are avoidable.  By strengthening the education of healthcare professionals 
(doctors, nurses, phlebotomists and clinical support staffs) about pre-analytical quality, and establishing a 
comprehensive system of quality in the pre-analytical phase that entails systematic monitoring of non-
conformance, desired outcomes of reduction in errors can be achieved.  Continual local observational 
studies with error frequency assessment and risk analysis (The Pathologist, 2015) of pre-analytical 
practice errors, combined with direct feedback, discussions and reflection amongst involved personnel, 
seems to be the most efficient strategy for sustained good pre-analytical practices.  
 
Overall the key steps to improve the pre-analytical phase are standardization of VBS procedures, 
education, re-training, clear definition of responsibilities and fluid communication with phlebotomy staff, 
development of new technologies and automation, all of which require continuous funding and monitoring 
(The Pathologist, 2015). The loop will not be complete without continuous feedback from the users of the 
laboratory service –as we can only improve the phases of laboratory services that we can measure.  
 
 
 
 
9. Dates for future re-evaluation 
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12. Please attach any appendices and or supporting documentation. 
 
Appendix I (LISM Study) 
Please see the attached file on categorisation of error and their frequencies in the pre-analytical phase of 
TTP 
Appendix II (Questionnaire survey for second part of study) 
 
Please see the attached Questionnaire file  
 
Appendix III (SPSS and Prism 7 Analysis of Questionnaire Study) 
 
Please see the attached SPSS Analysis file  
